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Stellingen 
1. Als een gistsoort een lage epoxidehydrolase activiteit bezit dan is de bepaling van 
de bijbehorende enantioselectiviteit pas mogelijk als er een recombinante gastheer 
wordt gebruikt waarin het desbetreffende epoxidehydrolase coderende gen in 
voldoende hoge mate tot expressie wordt gebracht. 
Dit proefschrift. 
2. Het epoxidehydrolase coderende gen van Xanthophyllomyces dendrorhous is niet 
essentieel voor groei van deze gist onder laboratorium condities. 
Dit proefschrift. 
3. Het oplosbare epoxidehydrolase van Aspergillus niger vertoont sterke gelijkenis 
met het membraan gebonden microsomale epoxidehydrolase (mEH) en niet met het 
oplosbare (soluble) epoxidehydrolase (sEH). Dit leidt tot verwarring over de aard 
en intracellulaire locatie van dit enzym. 
Arand etal. (1999). Biochem. J. 344: 273-280. 
4. Het succes van de ontwikkeling van een op een specifieke omzetting toegespitst 
mutant enzym, via technieken zoals "error prone PCR" en "DNA shuffling", is in 
hoge mate afhankelijk van het voorhanden zijn van een geschikte 
screeningsmethode. 
5. Leukoprotoxine is een betere naam voor leukotoxine aangezien leukotoxine zelf 
niet toxisch is maar het daaruit gevormde leukotoxine diol wel. 
Moghaddamefa/. (1997). Nat. Med. 3: 562-566. 
6. In landen die in staat zijn tot het reproductief klonen van mensen zou deze techniek 
bij wet verboden moeten worden. 
7. Bij de overgang op de wintertijd zouden de televisieomroepen hun 
kinderprogramma's een uur eerder moeten laten beginnen. 
8. De Rijn komt bij Spijk ons land binnen. 
Stellingen behorend bij het proefschrift "Cloning and application of epoxide hydrolases 
from yeasts". 
Hans Visser. 
Wageningen, 1 maart 2002. 
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Introduction 
Chapter 1 
EPOXIDES 
Epoxides are cyclic ethers that, due to the strong tension of the three-membered 
ring structure and the electronic polarization of the two C-0 bonds, readily react with 
various nucleophilic compounds. Additionally, the epoxide ring of unsymmetrical 
epoxides can be opened at either the less hindered epoxide carbon atom (base-catalyzed 
reaction) or the more hindered epoxide carbon atom (acid-catalyzed reaction). Because 
of these properties, epoxides are versatile intermediates in organic synthesis (Swaving 
and de Bont, 1998). Consequently, epoxides are valuable building blocks for the 
synthesis of biologically active compounds such as clinical drugs or insecticides by the 
pharmaceutical and agrochemical industries. 
Two enantiomeric forms (enantiomers) of an epoxide are possible if one of the 
epoxide carbon atoms is chiral. This means that such an epoxide is actually a racemic 
mixture of its enantiomers (Figure 1). For pharmaceutical companies it is very 
important to produce drugs that are as safe and effective as possible. It is therefore of 
great importance that, instead of the racemic epoxide mixtures, enantiopure epoxides 
are used in the chiral epoxide-dependent synthesis route of clinical drugs. 
Racemic mixture (S)-Enantiomer (R)-Enantiomer 
Figure 1. Chemical structures of both racemic and the separate enantiomers of phenylethylene oxide 
(styrene oxide). 
Enantiopure epoxides can be obtained by using both chemical and biological 
procedures (for reviews see de Bont, 1993; Besse and Veschambre, 1994; Archelas and 
Furstoss, 1997). The chemical methods that are used usually introduce an epoxide 
moiety (epoxidation) at the position of a double bond in e.g. alkenes or allylic alcohols. 
Despite several successful asymmetrical epoxidations, these chemical methods have 
some drawbacks (Besse and Veschambre, 1994). First, the reactions are catalyzed by 
toxic heavy metals. Second, for some methods the catalyst (metalloporphyrines) has to 
be synthesized, which can be difficult. Third, a limited number of compounds can be 
used as substrate for epoxidation. Fourth, the yield of enantiopure epoxides can be low. 
Biological procedures involve enzyme-catalyzed reactions, which have the 
advantage to allow stereospecific oxygenation reactions that are difficult to carry out 
chemically. For example, monooxygenases can be used in the stereospecific 
epoxidation of alkenes to generate enantiopure epoxides. Alternatively, enantiopure 
epoxides can be obtained by the enzyme-catalyzed kinetic resolution of a racemic 
epoxide mixture. One of the enzymes, which can be used for the kinetic resolution of 
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racemic epoxides is lipase. Ideally, lipase only modifies one of the two epoxide 
enantiomers e.g. by ester hydrolysis. This allows the separation of the remaining 
enantiopure epoxide enantiomer from the other (converted) enantiomer. 
The use of both the chemical and biological (biocatalytic) methods, which are 
successful in the production of enantiopure epoxides are protected by patents. 
Therefore, from an industrial point of view it is of great interest to search for new 
catalysts that can be used to produce enantiopure epoxides. A biocatalyst that meets 
this demand is the epoxide hydrolase. 
O HO OH 
/ \ EH | | 
H-C — C - H „ » H —C — C—H 
I I H20 i i 
H H H H 
Figure 2. General scheme of the hydrolysis of a simple epoxide into its corresponding diol by an EH. 
Epoxide hydrolases (EHs, E.C. 3.3.2.3) catalyze the hydrolysis of epoxides to the 
corresponding diols (Figure 2). They act cofactor independently using only water and 
they are ubiquitous in nature. Most interestingly, EHs can hydrolyze racemic epoxide 
mixtures in an enantioselective manner, which can result in enantiopure epoxides. 
Because of these properties, EHs might be promising candidate biocatalysts for the 
production of enantiopure epoxides from cheap and readily available racemic epoxides. 
OUTLINE OF THIS THESIS 
At the start of the work that is presented in this thesis, EHs from yeast origin were 
already subject of investigation in the group of Industrial Microbiology headed by 
Professor J. A. M. de Bont. The red-colored yeast Rhodotorula glutinis in particular 
showed the enantioselective hydrolysis of various structurally different epoxides 
leading to encouraging yields of enantiopure epoxides or diols (Weijers, 1997). 
Meanwhile, additional research has been performed on the biochemistry and 
application of EHs from basidiomycetous yeast species in both the analytical and 
preparative scale enantioselective hydrolysis of various epoxides (Botes, 1999; Botes et 
al., 1998, 1999; Choi et al, 1999, 2000; Kronenburg et al, 1999; Weijers et al, 1998). 
The research described in this thesis was part of two successive research projects, 
which both focused on the potentials of yeasts EHs in enantioselective epoxide 
hydrolysis. The main objectives of these projects were to gain important fundamental 
knowledge on yeasts EHs and to develop biotechnological processes based on the use 
of these enzymes for the production of enantiopure epoxides. 
To introduce EHs an overview of the molecular biology, biochemistry and potential 
application of these enzymes is given in chapter 2. In chapters 3 and 4 the isolation and 
characterization of the EH-encoding genes from the carotenoid producing yeast species 
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Xanthophyllomyces dendrorhous (perfect state of Phaffia rhodozyma, Golubev, 1995) 
and R. glutinis is described. The relationship of the EHs from these yeast species to 
other EHs was analyzed. 
The EH from R. glutinis is a potential candidate to be applied in the 
enantioselective hydrolysis of epoxides. In order to develop an efficient EH-catalyzed 
epoxide hydrolysis system the EH-encoding gene of R. glutinis was over-expressed in 
Escherichia coli. When compared to homologous expression in R. glutinis itself, the 
recombinant expression system showed a strong increase in activity, due to the 
overproduction of EH, without loss of enantioselectivity. The utility of this system was 
demonstrated for the hydrolysis of l-oxa-spiro[2.5]octane-2-carbonitrile, which is a 
versatile building block in organic synthesis. 
Other yeast strains having high and low quality EH activities were reported (Botes 
et al., 1999). The EH-encoding genes from a few of these strains were isolated and 
expressed in E. coli. The corresponding amino acid sequences and activities toward 
trans-\-phenyl- 1,2-propane oxide were examined. A highly efficient recombinant EH 
was obtained for the enantioselective hydrolysis of trans-\-phenyl- 1,2-propane oxide. 
The results of this study are described in chapter 5. 
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Molecular biology, biochemistry and potential application 
of epoxide hydrolases 
Chapter 2 
INTRODUCTION 
Epoxides are cyclic ethers that readily react with a number of reagents, nucleophiles 
in particular. Commonly used nucleophiles reacting with epoxides are oxygen, 
nitrogen, sulfur, halide and carbon compounds. This is one of the properties, which 
causes epoxides to be versatile intermediates in organic synthesis (Swaving and de 
Bont, 1998). However, due to their highly reactive nature epoxides can easily react and 
damage biologically important molecules such as proteins (enzymes) or nucleic acids 
(DNA). Therefore, on one hand epoxides are useful building blocks in organic 
chemistry, and on the other hand they are a threat to human health as a consequence of 
their potentially cytotoxic and carcinogenic properties. 
Epoxide hydrolases (EHs; EC 3.3.2.3) are enzymes that catalyze the addition of 
water to epoxides, thereby usually generating the corresponding vicinal trans-diols 
(Figure 1). EHs have been found in many organisms, including mammals, insects, 
plants, fungi and bacteria and may therefore be regarded as ubiquitous enzymes. 
Several types of EHs are recognized that are involved in processes such as the 
detoxification of noxious epoxides, catabolism or biosynthetic pathways. 
A EH H ? V 
-C — C - H
 u » H — C — C - H 
H H H OH 
Figure 1. Epoxide hydrolysis by an EH resulting in the corresponding (rans-diol. 
In this chapter an overview will be given of EHs. First, different types and 
functions of epoxide hydrolases will be presented. Next, the relatedness of these EHs 
and their mechanisms of action will be evaluated. Finally, the use of EHs as biocatalyst 
in the enantioselective hydrolysis of epoxides is presented. 
MAMMALIAN EHs 
Microsomal EH 
Microsomal EH (mEH) from rodents was the first epoxide hydrolase described 
(Oesch and Daly, 1971; Oesch et al., 1971b). Microsomal EH activity has been 
detected in essentially all organs and tissues of rats and mice (Oesch, 1977). However, 
the enzyme is located primarily in the endoplasmic reticulum of hepatocytes (Oesch 
and Daly, 1971) and it has been suggested to use mEH as a marker enzyme for 
microsomal membranes (Oesch et al., 1971a). Microsomal EH has been purified to 
homogeneity from livers and other tissues of several mammalian species revealing a 
minimum molecular weight ranging from approximately 46 to 54 kDa (Halpert et al., 
1979; Lu et al, 1975, 1979; Papadopoulos et al., 1994). Molecular studies indicated 
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that mEH is co-translationally inserted into the membrane of the endoplasmic reticulum 
by means of a single membrane signal anchor sequence, which is dispensable for 
catalytic activity (Okada et al, 1982; Friedberg et al, 1994). 
Microsomal EH encoding-genes and cDNA's from several mammalian organisms 
have been isolated (Porter et al, 1986; Falany et al, 1987; Skoda et al., 1988; Hassett 
et al., 1989, 1994b). The mEH polypeptide from rabbit, rat and human comprises 455 
amino acids with a calculated molecular mass of approximately 53 kDa (Heinemann 
and Ozols, 1984; Porter et al, 1986; Skoda et al., 1988). In human and rat single 
functional mEH-encoding genes per haploid genome have been proposed (Falany et al., 
1987). The human mEH gene is located to the long arm of chromosome 1 (Skoda et al., 
1988). The primary transcript of the human mEH gene extending from the start of 
transcription to the poly(A) addition site, is 20,271 nucleotides in length (Hassett et al., 
1994b). The rat mEH gene measures approximately 16,000 base pairs (Falany et al., 
1987). Despite the difference in size the human and rat mEH genes are organized very 
similar. Both genes consist of 9 exons, which are separated by 8 introns. In both species 
exon 1 does not encode protein. The sizes of introns 2 to 8 are identical, whereas the 
sizes of the human exons 1 and 9 are 100 nucleotides longer and 5 nucleotides shorter 
respectively than the rat exons 1 and 9. The difference of the latter is in the length of 
the non-coding tail (Hassett et al., 1994b). 
Two prominent genetic polymorphisms of human mEH exist (Hassett et al., 1994a). 
The first one is found in exon 3 and results in the substitution of Tyr by His at amino 
acid position 113. The second is found in exon 4 and concerns the substitution of His 
by Arg at amino acid position 139. These polymorphisms have been associated with 
human diseases such as an altered risk to different types of cancer (Harrison et al, 
1999; Wu et al., 2001) and emphysema (Smith and Harrison, 1997). In vitro studies 
indicate that the Tyr/His and His/Arg amino acid variations do not exert a primary 
influence on the mEH catabolic function, but may instead affect the mEH stability 
(Hassett et al, 1994a). 
Microsomal EH is regarded as the EH most contributing in the detoxification of 
potentially cytotoxic and carcinogenic epoxide metabolites of xenobiotic compounds, 
which are generated by the cytochrome P450 monooxygenase systems. Most mEH 
substrates are converted into less reactive and better water-soluble metabolites that can 
be readily conjugated or excreted, which explains the detoxifying role of mEH. It 
exhibits broad substrate specificity, ranging from simple short chain aliphatic epoxides 
to large polycyclic aromatic hydrocarbons such as benzo-(a)-pyrene-4,5-oxide (Figure 
2) (Oesch et al., 1971b; Jerina et al., 1977). In addition to the epoxide derivatives of 
environmental chemicals e.g. polycyclic aromatic hydrocarbons, mEH is also involved 
in the metabolism of the epoxide derivatives of clinical drugs such as the anti-epileptic 
drugs carbamazepine and phenytoin (Eugster et al., 1991; Riley et al., 1988). 
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Figure 2. Chemical structures of mEH substrates. 1, Styrene oxide. 2, 1,2-Epoxyoctane. 3, c/s-Stilbene 
oxide. 4, Benzo-(a)-pyrene-4,5-oxide. 
In contrast to its protective role, mEH is also involved in the bio-activation of the 
ultimate carcinogenic metabolite 7,12-dimethylbenz(a)antracene-3,4-diol-l,2-epoxide 
(Miyata et al., 1999), which is capable of producing DNA adducts (Dipple and 
Nebzydoski, 1978). 
Furthermore, mEH was identified as a subunit of the anti-oestrogen-binding site 
(Mesange et al., 1998) and it is active in endogenous steroid epoxide metabolism 
(Vogel-Bindel et al., 1982) and sodium-dependent bile acid transport (von Dippe et al., 
1996). However, Honscha et al. (1995) showed that heterologously expressed mEH 
was unable to mediate the transport of the bile acids taurocholate and cholate. 
Additionally, in mice mEH is not essential for reproduction and physiological 
homeostasis (Miyata et al, 1999). 
Several mEH inhibitors have been described. Among these are l,l,l-trichloro-2,3-
propene oxide (Oesch et al., 1971c), cycloalkene oxides e.g. cyclohexene oxide (Oesch 
et al., 1973; Magdalou and Hammock, 1988), the anti-epileptic drug valpromide (Kerr 
et al, 1989) and pentachlorophenol (Moorthy and Randerath, 1996). More recently 
metals such as zinc and mercury (Draper and Hammock, 1999) and ureas, amides and 
amines (Morisseau et al., 2001) were reported to inhibit mEH. 
Figure 3. Chemical structure of the steroid epoxide estroxide, which is an endogenous substrate of rat 
mEH (Fandrich era/., 1995). 
A number of chemicals induce rat mEH gene expression e.g. phenobarbital 
(Hardwick et al., 1983), nitrosamines (Craft et al., 1988), diazines (Cho and Kim, 
1998), 2-acetylaminofluorene (Astrom et al., 1987), ?ra«5-stilbene oxide 
(Schmassmann and Oesch, 1978) and others. In addition to these exogenous 
compounds, rat mEH is also induced by its endogenous substrate, which is the steroid 
14 
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epoxide estroxide (Figure 3) (Fandrich et al, 1995). Human mEH expression in 
primary hepatocyte cultures indicated that mEH gene expression is only modestly 
induced by common mEH inducers (Hassett et al, 1998). Dexamethasone, a 
glucocorticoid, was reported to repress mEH gene expression (Bell et al, 1990). 
Soluble EH 
Soluble EH (sEH, formally known as cytosolic EH) is an enzyme, which is like 
mEH involved in the metabolism of epoxides derived from both exogenous and 
endogenous sources (Meijer and DePierre, 1988). Soluble EH activities have been 
demonstrated in different tissues from mammals such as mice, rats and rabbits. In 
general, liver, heart and kidney tissues show the highest sEH activities (Gill and 
Hammock, 1980; Schladt et al, 1986). The sEH protein has been purified from e.g. rat 
and human livers. Native sEH exists as a homodimeric protein with an estimated 
molecular mass of 120 kDa and a subunit mass of 58 to 61 kDa (Schladt et al., 1988; 
Wang et al., 1982). In addition to the protein, sEH-encoding genes and cDNAs have 
been isolated (Beetham et al., 1993; Grant et al, 1993; Knehr et al., 1993; Sandberg 
and Meijer, 1996). The human sEH gene measures approximately 45 kbp in length, 
contains 19 exons (Sandberg and Meijer, 1996) and is located on chromosome 8 
(Larsson et al., 1995). The open reading frames of sEH cDNA clones predict 
corresponding polypeptides of 554 amino acids with a calculated molecular mass of 62 
kDa (Beetham et al, 1993; Knehr et al, 1993). 
Initially, sEH was localized to the cytosolic and mitochondrial fraction of 
mammalian cells (Gill and Hammock, 1980, 1981). Additional studies showed that 
sEH is present in the cytosol and in peroxisomes (Waechter et al, 1983; Messing 
Eriksson et al, 1991). The C-terminus of sEH contains the amino acid sequence Ser-
Lys-Ile, which is highly homologous to the peroxisomal targeting sequence Ser-Lys-
Leu. It was suggested that this difference might turn the signal sequence into an 
impaired peroxisomal targeting sequence, which causes the presence of sEH in both 
peroxisomes and the cytosol (Arand et al, 1991). However, Mullen et al. (1999) 
presented evidence that the dual localization of sEH in the cytosol and peroxisomes of 
rodents is not due to an inefficient peroxisomal targeting sequence. Instead, they 
suggest the existence of two sEH isozyme variants (cytosolic and peroxisomal) in 
mammalian cells. 
Also soluble EH exhibits a broad substrate range. This range partly overlaps with 
and is complementary to that of mEH. In general, /raws-substituted epoxides are the 
better sEH substrates (Fretland and Omiecinski, 2000). Examples of xenobiotic 
epoxides accepted by sEH are fraw.s-8-ethylstyrene 7,8-oxide (Wang et al, 1982) and 
fr-aHs-P-methylstyrene oxide (Ota and Hammock, 1980). rraras-stilbene oxide (TSO) is 
the typical sEH model-substrate to distinguish sEH activity from mEH activity (Figure 
4). The broad range of xenobiotic epoxides metabolized by sEH suggests a protective 
role of this enzyme against these harmful compounds (Grant et al, 1996). 
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Figure 4. Chemical structure of frans-stilbene oxide, a typical sEH substrate. 
Another role of sEH is found in the metabolism of fatty acid epoxides. In mammals, 
cytochrome P450 epoxygenase mediated conversion of arachidonic acid results in the 
formation of a class of biologically active metabolites known as cis-
epoxyeicosatrienoic acids (EETs) (Capdevila et al., 2000). These EETs are hydrolyzed 
by sEH to their corresponding dihydroxyeicosatrienoic acids (Fang et al., 2001). In 
mice, the sEH-dependent metabolism of arachidonic acid was identified to play an 
important role in the control of blood pressure regulation and renal function (Sinai et 
al., 2000). Additionally, linoleic acid is a polyunsaturated lipid, which is a very 
abundant fatty acid in the average American diet. It can be oxidized by autooxidation or 
P450 enzymatic action to epoxides known as leukotoxin and isoleukotoxin. Both 
epoxides are believed to be protoxins that upon hydrolysis by sEH are converted to the 
cytotoxic isoleukotoxin- and leukotoxin diols (Figure 5) (Moghaddam et al., 1997). 
COOH 
sEH 
HO OH 
COOH 
Figure 5. Hydrolysis of leukotoxin into leukotoxin diol by sEH. 
Two genetic polymorphisms, altering the sEH amino acid sequence, were identified 
and characterized. The first concerns a substitution of an Arg at amino acid position 
287 by a Glu. The second involves the insertion of an Arg following Ser at position 402 
resulting in two adjacent Arg residues at positions 403 and 404 instead of the more 
common Arg at position 403. Soluble EH proteins containing the Arg insertion exhibit 
strikingly lower activity, which may have important physiological implications 
(Sandberg et al., 2000). 
16 
Molecular biology, biochemistry and potential application of EHs 
In rodents, sEH is induced by a diverse group of compounds collectively termed 
peroxisome proliferators. Among these are clofibrate, di(2-ethylhexyl)phthalate, p-
chlorophenoxyacetic acid and 2-ethylhexanoic acid. In general, peroxisome 
proliferation is accompanied by increased sEH activity (Meijer and DePierre, 1988). 
Chalcone oxide and derivatives thereof e.g. 4-phenylchalcone oxide are very potent 
inhibitors of sEH (Mullin and Hammock, 1982). In addition to these, sEH activity is 
also inhibited by fr-an.s-3-phenylglycidols (Dietze et al, 1991), ureas and carbamates 
(Morisseau et al, 1999b) and metals such as Zn2+, Cd2+, Hg2+ and Cu2+ (Draper and 
Hammock, 1999). 
Cholesterol 5,6-oxide hydrolase 
Cholesterol 5,6-epoxide hydrolase is an enzyme, which is, like mEH, 
predominantly present in liver microsomes but has also been detected in all other 
tissues tested (Astrom et al, 1986). There is no protein purification protocol reported 
for cholesterol 5,6-epoxide hydrolase, nor has the gene or cDNA encoding this enzyme 
been isolated. It hydrolyzes cholesterol 5,6cc-epoxide and cholesterol 5,6(J-epoxide to 
cholestane 3(3, 5a, 6(3-triol solely (Figure 6) (Watabe et al, 1981; Nashed et al, 1985). 
However, the a-epoxide is a better substrate than the (3-epoxide (Nashed et al, 1985) 
and enzymatic activity is inhibited by the product of the reaction through a competitive 
mechanism (Sevian and McLeod, 1986). 
Cholesterol EH 
Figure 6. Conversion of cholesterol 5,6a-epoxide into cholestane 3(i, 5a, 63-triol by cholesterol EH. 
Furthermore, cholesterol 5,6-epoxide hydrolase is inhibited by iminocholestanols 
(Watabe et al, 1981; Nashed et al, 1985), 7-ketocholesterol and 6- or 7-
ketocholestanol (Sevanian and McLeod, 1986), 7-dehydrocholesterol 5,6p-oxide 
(Nashed et al, 1986) and detergents such as Emulgen 108 and Lubrol PX (Watabe et 
al, 1986). 
In rodents, cholesterol 5,6-epoxide hydrolase is induced by clofibrate, which is a 
clinical drug commonly prescribed to patients unable to control serum cholesterol 
(Finley and Hammock, 1988). 
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The oxidation of cholesterol proceeds as part of the lipid peroxidation proccess in 
membranes. Among the most typical cholesterol oxidation products are the, already 
mentioned, enantiomeric (a and p) cholesterol 5,6-epoxides, which have been shown to 
be weak direct-acting mutagens. Therefore, it is likely that the cholesterol epoxide 
hydrolase functions to detoxify the mutagenic cholesterol epoxides (Fretland and 
Omiecinski, 2000). 
However, cholestane 3p,5a,6p-triol is more toxic and a more potent inhibitor of 
DNA synthesis than the epoxide. In case of low epoxide hydrolase activity 
mutagenicity, caused by the cholesterol epoxide, is favored. On the other hand, a fast 
conversion to the cholestanetriol favors cytotoxicity (Sevanian and Peterson, 1984, 
1986). 
Leukotriene A4 hydrolase 
Leukotrienes are important chemical signaling molecules in a variety of 
inflammatory and allergic conditions. Leukotriene B4 is a powerful chemotactic agent 
that seems to play a role in the recruitment of inflammatory cells to the site of tissue 
injury (Samuelsson, 1983; Haeggstrom, 2000). Leukotriene A4 hydrolase is a cytosolic 
EH that catalyzes the last step in the biosynthesis of LTB4: it converts LTA4 ((55)-
/ra«5-5,6-oxido-7,9-/ra«i-ll,14-cw-eicosatetraenoic acid) into LTB4 ((5S,\2R)-
dihydroxy-6,14-cw-8,10-/ra«5-eicosatetraenoic acid) (Figure 7). However, it does not 
hydrolyze styrene oxide or trans-stilbene oxide (McGee and Fitzpatrick, 1985). 
H. J3H 
COOH 
LTA4 hydrolase 
Figure 7. Conversion of LTA4 into LTB4 by LTA4 hydrolase. 
LTA4 hydrolase displays some typical features. First, it is a bifunctional zinc 
metalloenzyme that, in addition to its EH activity, also possesses an aminopeptidase 
activity (Haeggstrom et ah, 1990a, 1990b; Minami et ah, 1990). It contains a zinc-
binding domain, which is required for both enzymatic activities (Haeggstrom, 2000). 
Second, in contrast to hydrolysis of epoxides by other EHs, hydrolysis of LTA4 into 
LTB4 by LTA4 hydrolase does not result in a vicinal diol. Instead, the introduced 
hydroxyl groups are 8 carbon atoms apart from one another. Third, LTA4 hydrolase is 
covalently modified and inactivated by its endogenous substrate LTA4 during catalysis. 
After initial binding of LTA4 to the active site, the hydroxyl group of Tyr378 may 
attack the reactive epoxide to cause covalent modification and enzyme inactivation 
(Haeggstrom, 2000). 
LTA4 hydrolase has been purified from a number of mammalian cells and tissues 
and the molecular masses of the purified protein varies between 67 and 70 kDa (Evans 
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et al, 1985; Haeggstrom et al, 1988; Iversen et al, 1995). Isolated LTA4 hydrolase-
encoding cDNA encodes a protein of 610 amino acids with a corresponding molecular 
weight of 69 kDa (Funk et al, 1987; Medina et al, 1991; Minami et al, 1995). The 
human LTA4 hydrolase-encoding gene is larger than 35 kb and contains 19 exons. A 
single copy of the gene is present, which was localized to chromosome 12 (Mancini 
and Evans, 1995). 
LTA4 hydrolase contains 1 mole of zinc, which primary function is catalytic, per 
mole of protein. However, at zinc concentrations exceeding a 1:1 (metal:enzyme) ratio, 
zinc is inhibitory to the epoxide hydrolase activity. In addition to zinc, other divalent 
cations such as Cd2+ and Hg2+ are effective inhibitors of LTA4 hydrolase (Wetterholm 
et al, 1994). The homology of LTA4 hydrolase to zinc proteases led to the analysis of 
the inhibitory effect of protease inhibitors on LTA4 hydrolase activity. As a result of 
this, bestatin and captopril, inhibitors of aminopeptidases and angiotensin-converting 
enzyme respectively, were found to inhibit LTA4 hydrolase too (Orning et al, 1991). 
Furthermore, more powerful and selective synthetic inhibitors (cc-keto-p-amino ester, 
thioamine and hydroxamate compounds) of LTA4 hydrolase have been developed in 
several laboratories (Haeggstrom, 2000). 
Hepoxilin A3 hydrolase 
Arachidonic acid is converted by 12-lipoxygenase to yield (125)-
hydroperoxyeicosatetraenoic acid ((12S)-HPETE). Hypoxilins A3 and B3 are hydroxy 
epoxide metabolites formed through the rearrangement of (12S)-HPETE by a putative 
hepoxilin synthetase enzyme activity. Changes in intracellular calcium and potassium 
concentrations as well as changes in secondary messenger systems appear to be the 
basic biological actions achieved by hepoxilins (Pace-Asciak, 1994). 
Hepoxilin A3 hydrolase is a cytosolic enzyme, which has been purified from the rat 
liver (Pace-Asciak and Lee, 1989). The molecular mass of the purified enzyme was 53 
kDa. The presence of hypoxilin A3 hydrolase activity in crude homogenates of rat 
kidney, ovaries, spleen, liver, lung, skin and other tissues indicates the ubiquity of this 
enzyme in the rat. Both hypoxilin A3 and B3 are converted by hypoxilin A3 hydrolase to 
their corresponding triols trioxilin A3 and B3 (Figure 8). However, hepoxilin A3 is the 
better substrate (Pace-Asciak et al, 1983). In addition, hypoxilin A3 hydrolase is only 
marginally active toward other epoxides such as leukotriene A4 and styrene oxide 
(Pace-Asciak and Lee, 1989). 
Trichloropropene oxide, an inhibitor of mEH, also inhibits the hepoxilin epoxide 
hydrolase from intact human platelets (Margalit et al, 1993). Human neutrophils 
contain specific hepoxilin A3 binding sites, which might implicate a receptor-mediated 
action of this epoxide (Reynaud et al, 1996). 
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Figure 8. Conversion of hepoxilin A3 into trioxilin A3 by hepoxilin A3 hydrolase. 
The knowledge of hepoxilin A3 hydrolase is rather limited when compared to the 
other mammalian epoxide hydrolases. Isolation and characterization of hepoxilin A3 
hydrolase-encoding cDNAs or genes would increase the knowledge of this epoxide 
hydrolase and its relation to the other epoxide hydrolases. 
PLANT EH 
One of the first reports on epoxide hydrolase activity in plants described the 
hydrolysis a fatty acid epoxide, 18-hydroxy-9,10-epoxystearic acid, to 9,10,18-
trihydroxystearic acid by a 3000 x g precipitate from an apple skin homogenate 
(Croteau and Kolattukudy, 1975). The common precursor of the former compound, 
9,10 epoxystearic acid, is formed by the epoxidation of oleic acid (Blee and Schuber, 
1990; Pinot et al., 1992). In soybean, 9,10-epoxystearic acid is a better EH substrate 
than 18-hydroxy-9,l 0-epoxystearic acid. Furthermore, the enantioselective hydrolysis 
of m-9,10-epoxystearic acid results exclusively in the formation of threo-(9R,\0R)-
dihydroxystearic acid (Figure 9), which is a naturally occurring metabolite in higher 
plants (Blee and Schuber, 1992b). All the fatty acid compounds mentioned above are 
major components of the plant protective biopolymer cutin (Kolattukudy, 1981). 
Therefore, plant EH is likely to be involved in the biosynthesis of this plant envelope 
polymer. In addition, soybean EH also hydrolyzes linoleic acid mono-epoxides. An 
example of such an epoxide is 9,10-epoxy-12-octadecenoate, which is also known as 
the leukotoxin found in mammals (Blee and Schuber, 1992a). 
H O O < O 0 0 C X -**- HOO° 'OH 
Figure 9. Hydrolysis of (9R,10S)-epoxystearic acid into tf)reo-(9R,10R)-dihydroxystearic acid by soybean 
sEH. 
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In addition to the involvement in cutin biosynthesis, fatty acid epoxides as well as 
the EH generated hydroxylated derivatives play an important role in the plant defense 
mechanism against plant pathogens i.e. plant pathogenic fungi. For example, a 
trihydroxy-octadecenoic acid is produced in plant suffering from rice blast disease and 
it exerts a growth inhibitory effect against the rice blast fungus Pyricularia oryzae 
(Katoetal., 1985). 
Furthermore, an enzyme similar to soybean EH is involved in the biosynthesis of 
dodecano-4-lactone in ripening nectarines. Therefore, plant EH might also be important 
in the biosynthesis pathway of fruit aroma components (SchSttler and Boland, 1996). 
In addition to these natural lipid epoxides, plant EH is also able to hydrolyze 
benzyl- or phenyl- substituted epoxides such as trans-1,3- diphenylpropene oxide and 
0-an.s-stilbene oxide (Morisseau et al., 2000). 
Fatty acid epoxide hydrolase activity is present in numerous plant species (Stark et 
al, 1995). The enzyme has been purified from soybean seedlings as a soluble 64-kDa 
dimeric protein with an apparent subunit mass of 32 kDa (Blee and Schuber, 1992c). 
However, the soluble EH purified from soybean seed was present as a monomelic 
enzyme with a molecular mass of 36 kDa (Arahira et al, 2000). Furthermore, 
recombinant soluble EHs from cress and potato were expressed as monomelic proteins 
with masses of 36 and 39 kDa respectively. In addition to the proteins, plant EH-
encoding genes and cDNA sequences have been isolated too (Stapleton et al, 1994; 
Kiyosue et al., 1994; Guo et al, 1998; Arahira et al, 2000). The EH cDNAs encode 
proteins of 312-321 amino acids in length with corresponding molecular masses of 35-
39 kDa. Amino acid sequence comparison studies indicate that these plant soluble 
epoxide hydrolases are very similar to mammalian sEH. The main difference is the 
absence of the first approximately 235 N-terminal amino acids of mammalian sEH in 
plant sEH, i.e. plant sEHs are missing the N-terminal domain of the mammalian sEHs 
(Kiyosue et al, 1994; Stapleton et al, 1994; Guo et al, 1998). 
The expression of soluble plant EH-encoding genes is induced after exposure to 
stress-like situations. The cress sEH gene is induced by plant hormones such as auxin 
and by draught stress (Kiyosue et al, 1994). Potato sEH mRNA accumulates on 
wounding and application of the plant hormone methyl jasmonate (Stapleton et al, 
1994). The tobacco sEH gene is induced during the resistance response to tobacco 
mosaic virus (Guo et al, 1998) and the soybean sEH gene is induced by the 
phytohormone ethylene (Arahira et al, 2000). 
Plant sEH is inhibited by 4-fluorochalcone-oxide and Zra«.s-3-phenylglycidol in a 
similar way as mammalian sEH (Kiyosue et al, 1994; Stapleton et al, 1994). Other 
substituted chalcone oxides are potent inhibitors of plant sEH. However, 4-phenyl-
chalcone-oxide does not inhibit plant sEH, while it is an excellent inhibitor of 
mammalian sEH (Morisseau et al, 2000). Furthermore, the mEH inhibitor 1,1,1-
trichloropropene-2,3-epoxide only weakly inhibits plant sEH (Pinot et al, 1997a). 
A few reports discuss the existence of an additional plant EH located in the 
microsomal fraction of plant cells (Blee and Schuber, 1992c; Pinot et al, 1997a). 
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Despite these indications, more research is necessary to confirm the presence of a 
mEH-type plant EH. 
INSECT EH 
Juvenile hormones (JHs) I, II and III are epoxide-containing sesquiterpenoids which 
regulate embryogenesis, larval growth and development, metamorphosis and 
reproduction in insects. The corpora allata secrete JHs into the hemolymph of the insect 
and during development and reproduction hemolymph JH concentrations change. JHs 
biosynthesis and degradation determine the JH titer in the hemolymph. Two metabolic 
enzymes, JH esterase (JHE) and JH epoxide hydrolase (JHEH), are involved in the 
degradation of JHs and thereby regulating JH titers (Figure 10) (de Kort and Granger, 
1996). 
In addition, insect EH activity has been associated with the clearance of pheromone 
concentrations from insect sensory tissues. Analogues of disparlure, an epoxide-
containing pheromone, have been shown to be inhibitory to gypsy moth EH and 
therefore to pheromone metabolism (Graham and Prestwich, 1994). 
EH activity, both soluble and microsomal, has been demonstrated in insects such as 
tobacco hornworm {Manduca sexto) (Touhara and Prestwich, 1993), southern 
armyworm (Spodoptera eridania) (Mullin and Wilkinson, 1980), bulb mite 
(Rhizoglyphus robini) (Cohen et al., 1993), fruit flies (Drosophila melanogaster) 
(Harshman et al., 1991) and the cabbage looper {Trichoplusia ni) (Hanzlik and 
Hammock, 1988). The enzyme associated to the microsomal compartment (JHEH) has 
been purified and contains a molecular weight of 46-50 kDa (Touhara and Prestwich, 
1993; Mullin and Wilkinson, 1980). 
JS' /K^^^^-^^Q' 
Figure 10. Conversion of juvenile hormone III into its corresponding diol by JHEH. 
Although JHs are its endogenous substrates, insect EH shows high activity toward 
monosubstitued epoxides such as 1,2-epoxyoctane and styrene oxide and lower activity 
toward cw-l,2-distubstituted epoxides such as cyclohexene oxide (Mullin and 
Wilkinson, 1980). Therefore, an additional role for the insect EH might be the 
detoxification of harmful epoxides. Interestingly, EH activity is considerably induced 
(4-5 fold) in mites ingesting ?ra«.s-stilbene-oxide-impregnated filter papers or plant 
material from onions and garlic. Nevertheless, tobacco hornworm JHEH showed 
highest activity toward JH III. The relative activities for other substrates such as JH I, 
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JH II, trans- and m-l,3-diphenylpropene oxide, trans- and cw-stilbene oxide and cis-
9,10-epoxystearic acid were all less than 16% compared to JH III (100%) (Debernard et 
al., 1998). 
Phytochemicals such as sinigrin, flavone, menthol, trans-$-c&ro\zne, chalcone and 
/rans-cinnamic acid decrease bulb mite EH activity (Cohen et al., 1993). In addition, 
several epoxides such as l,l,l-trichloro-2,3-epoxypropane and mixed-function oxidase 
inhibitors inhibit southern armyworm EH (Mullin and Wilkinson, 1980). Recently, two 
classes of inhibitors, a glycidol-ester series and an epoxide-ester series, of JHEH from 
the cabbage looper were developed and found to be highly effective (Linderman et al., 
2000). 
Insect JHEH-encoding cDNAs have been isolated from tobacco hornworm 
(Wojtasek and Prestwich, 1996) and cabbage looper (VanHook Harris et al., 1999). 
These cDNA sequences encode proteins of 462 and 463 amino acids respectively. The 
respective predicted amino acid sequences share 44% and 39% sequence identity to 
human mEH. Southern blot analysis suggests that multiple epoxide hydrolase genes are 
present in the cabbage looper (VanHook Harris et al., 1999). 
FUNGAL EH 
Fungi 
The plant pathogenic fungus Fusarium solani pisi was one of the first fungi found to 
contain an epoxide hydrolase activity (Kolattukudy and Brown, 1975). A cell-free 
extract prepared from cutin grown F. solani pisi cells catalyzed the hydrolysis of a 
cutin epoxide-containing monomer, 18-hydroxy-9,10-epoxyoctadecanoic acid (18-
hydroxy-9,10-epoxystearic acid), to 9,10,18-trihydroxyoctadecanoic acid. Interestingly, 
less than 6 % of this activity was observed when cells were grown on glucose instead 
of cutin. Therefore, the epoxide hydrolase of this fungus is induced by cutin 
(monomers). Moreover, it might take care of the detoxification of toxic epoxy acids, 
which are released from the plant by fungal hydrolysis of the cutin-polymer thus 
making a successful invasion possible. However, 9,10-epoxystearic acid, another cutin 
monomer, as well as styrene oxide were not readily hydrolyzed by this fungus 
(Kolattukudy and Brown, 1975). 
Other fungal epoxide hydrolase activities have been reported and are involved in 
the metabolism of phenanthrene by white rot fungi (Bezalel et al., 1996; Sutherland, 
1991) or coincide with secondary metabolite pigment production in dematiaceous fungi 
(Grogan et al., 1996). 
In addition, multiple EHs are believed to be related to the production of host-
specific toxins by the tomato pathogenic fungus Alternaria alternata f. sp. lycopersici 
(Morisseau et al., 1999c). With molecular masses of 20-25 kDa, these EHs are different 
from sEH and mEH. One of the EH activities was located in the soluble fraction of a 
cell extract and hydrolyzes its possible physiological substrate 9,10-epoxystearic acid 
more efficiently than the model sEH and mEH substrates trans- and cw-stilbene oxide 
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and trans- and cw-diphenylpropane oxide. In vivo treatment of the fungal culture with 
the peroxisome proliferator clofibrate stimulated EH activity by 83% and enhanced 
toxin production 6.3 fold. Potent inhibitors of mammalian sEH e.g. 4-fluorochalcone 
oxide also inhibited this fungal sEH activity (Pinot et al., 1997b). 
The EH from A. niger has been purified to homogeneity using p-nitrostyrene oxide 
as substrate. This soluble enzyme is a tetramer composed of four identical subunits 
with a molecular mass of 45 kDa. A DNA probe for the enzyme has been obtained by 
genomic PCR using degenerate primers derived from internal peptide sequences 
(Morisseau et al., 1999a). Subsequently, the gene has been cloned and characterized. It 
encodes a polypeptide of 398 amino acids with a calculated molecular weight of 44.5 
kDa. The deduced amino acid sequence of this soluble A. niger EH shares significant 
sequence similarity to membrane bound mammalian mEH. However, the mEH N-
terminal membrane anchor sequence is missing in the fungal enzyme, which explains 
its soluble character (Arand et al., 1999). 
Yeasts 
Information on biological functions of yeast EHs is very limited. Nevertheless, an 
EH activity has been demonstrated in the biosynthesis route of the aroma compounds y-
decalactone and y-dodecalactone in the lactone producing yeast Sporidiobolus 
salmonicolor. The EH involved catalyzes the hydrolysis of 9,10- and 11,12-
epoxystearic acid esters, which is the first step in this pathway (Haffner and Tressl, 
1998). 
Following research on the potential of fungal and bacterial EH activities, a number 
of different yeast strains have been screened for the hydrolysis of styrene oxide 
(Weijers and de Bont, 1999). From this study, Rhodotorula glutinis CDVIW 147 was 
selected for further analysis. It exhibits a remarkably broad substrate range including 
aryl-, alkyl- and alicyclic epoxides. High enantioselectivity was demonstrated in the 
hydrolysis of methyl substituted aryl and aliphatic epoxides, whereas lower selectivity 
was seen with terminal epoxides (Weijers, 1997). Maso-compounds 2,3-epoxybutane, 
1,2-epoxycyclopentane and 1,2-epoxycyclohexane are also accepted, which is of 
special interest since enantiopure trans diols could be obtained with a theoretical yield 
of 100% (Weijers and de Bont, 1999). In general, the asymmetric hydrolysis of meso-
epoxides by microbial epoxide hydrolases is rare (Archer, 1997). The hydrolysis of a 
homologous range of unbranched 1,2-epoxyalkanes (Figure 11) revealed that both 
enantioselectivity and reaction rate are strongly influenced by the chain length of the 
epoxide. The enantioselectivity was optimal in the hydrolysis of 1,2-epoxyhexane, 
while 1,2-epoxyheptane was converted at the highest initial reaction rate (Weijers et al., 
1998). 
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Figure 11. 1,2-Epoxyalkanes, substrates of the R. glutinis EH. 1, 1,2-Epoxyhexane. 2, 1,2-Epoxyheptane. 
3, 1,2-Epoxyoctane. 
Low enantioselectivity in the hydrolysis of 1,2-epoxyoctane by many EHs 
prompted Botes et al. (1998) to screen for a 1,2-epoxyoctane enantioselective EH 
containing yeast strain. A total number of 187 yeast strains from 25 genera were 
analyzed. Of these, 8 yeast strains belonging to the basidiomycetes genera 
Rhodotorula, Rhodosporidium and Trichosporon hydrolyzed 1,2-epoxyoctane in an 
asymmetric way. Rhodotorula araucariae CBS 6031 and Rhodosporidium toruloides 
CBS 349 exhibited excellent enantioselectivity for this aliphatic epoxide. Taken 
together, it is evident that substrate specificity and enantioselectivity in basidiomycetes 
yeasts are strain dependent (Botes et al., 1998). 
The EH from R. glutinis CIMW 147 is membrane associated and has been purified 
after solubilization by Triton X-100. The native enzyme exists as an homodimeric 
protein with a subunit molecular mass of 45 kDa. Peptide analysis revealed an amino 
acid sequence very similar to that of mEH (Kronenburg et al., 1999). Additionally, the 
membrane associated EH from R. toruloides CBS 349 was purified to homogeneity. 
The enzyme has an apparent monomeric molecular mass of 54 kDa. A carbohydrate 
content of over 42% indicates heavy glycosylation of this yeast EH (Botes, 1999). In 
addition to the EH activities of R. glutinis CIMW 147 and R. toruloides CBS 349, the 
EH activities of other related Rhodotorula and Rhodosporidium as well as 
Trichosporon species were membrane associated (Botes et al., 1999b). 
The R. toruloides enzyme is inactivated by chemical residue-specific modification 
of Asp/Glu, His and Ser residues. In addition, metals such as Co2+, Hg2+, Ag2+, Mg2+ 
and Ca2+ inhibited enzyme activity, whereas EDTA increased enzyme activity (Botes et 
al, 1999a). 
Detergents have been shown to affect the R. glutinis EH. Several non-ionic 
detergents stimulated both the specific activity of the enzyme as well as the 
enantioselectivity. Thesit and sucrosemonolaurate had the most pronounced effect 
(Kronenburg and de Bont, 2001). 
Kull et al. (1999) have cloned and characterized a bifunctional leukotriene A4 
hydrolase from S. cerevisiae, which is 42% identical to the human LTA4 hydrolase. 
The human LTA4 hydrolase converts LTA4 into LTB4. However, S. cerevisiae LTA4 
hydrolase does not. In the hydrolysis of LTA4, a compound identified as (5S,6S)-
dihydroxy-7,9-rrans-ll,14-c/s-eicosatetraenoic acid was produced instead of LTB4 
((55,12^)-dihydroxy-6,14-c;s-8,10-fra«5-eicosatetraenoic acid). It has been suggested 
that, as no leukotriene biosynthesis and LTA4 formation has been described in yeast, 
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the S. cerevisiae LTA4 hydrolase active site accommodates some other lipid, which is 
structurally related to LTA4 (Kull et al, 1999). 
BACTERIAL EH 
Initially, research on bacterial epoxide hydrolases was focused on the use of these 
enzymes as asymmetric biocatalysts in the process of obtaining enantiopure epoxides 
and/or vicinal diols. Therefore, most EH-containing bacteria were isolated in epoxide 
hydrolase screening programs for the hydrolysis of certain types of epoxides (Mischitz 
et al., 1995; Zocher et al., 2000). Especially the group of K. Faber (Graz, Austria) 
analyzed a great number of different bacteria for their abilities to hydrolyze epoxides. 
Among these bacterial species, which showed interesting EH activity, are several 
Rhodococci (Hechtberger et al., 1993; Faber et al., 1996), Corynebacterium sp. UPT 9 
(Mischitz et al., 1995), Mycobacterium paraffinicum NCIMB 10420 and Nocardia 
species (Kroutil et al., 1996). In general, 2,2- and 2,3-disubstituted epoxides are 
hydrolyzed with good to excellent enantioselectivity by these bacterial enzymes (Orru 
and Faber, 1999). 
Contrary to the "random" screening of bacterial strains in order to find an EH-
containing bacterium, other bacteria were isolated by selection for growth on an 
epoxide as sole source of carbon and energy. Thus indicating a specific metabolic 
function of these enzymes. Corynebacterium sp. C12 was isolated on cyclohexene 
oxide (Carter and Leak, 1995), while Agrobacterium radiobacter AD1 was isolated on 
epichlorohydrin (van den Wijngaard et al., 1989) (Figure 12). 
1 2 
Figure 12. Chemical structures of cyclohexene oxide (1), epichlorohydrin (2) and limonene-1,2-
epoxide (3). 
The enzymes purified from Corynebacterium sp. C12 and A. radiobacter AD1 have 
subunit sizes of 32 and 35 kDa respectively. While the Corynebacterium sp. C12 EH 
was found to be a multimeric (probably tetrameric) protein, the A. radiobacter AD1 EH 
was isolated as a monomelic protein (Misawa et al., 1998; Jacobs et al., 1991). 
The genes encoding the Corynebacterium sp. C12 and A. radiobacter AD1 
enzymes have been isolated and encode polypeptides of 287 amino acids (32 kDa) and 
294 amino acids (34 kDa) respectively. Amino acid sequence comparison to protein 
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databases indicates that these bacterial enzymes are similar to one another and to the 
sEHs found in mammals and plants (Misawa et al., 1998; Rink et al., 1997). 
While bacterial sEHs are expressed constitutively, the expression level is induced to 
a much higher level by the growth substrates cyclohexene oxide and trans-
dihydroxycyclohexane as was observed for the Corynebacterium sp. CI2 epoxide 
hydrolase (Carter and Leak, 1995). 
Recently, a novel degradation pathway of the monoterpene limonene, a plant 
secondary metabolite, by Rhodococcus erythropolis DCL14 was reported and includes 
the conversion of limonene-1,2-epoxide (Figure 12) to limonene-1,2-diol (van der 
Werf et al., 1999b). The enzyme involved, limonene-1,2-epoxide hydrolase (LEH), is 
induced when R. erythropolis DCL14 is grown on monoterpenes. LEH was purified to 
homogeneity and found to be a monomeric cytoplasmic enzyme of only 17 kDa. LEH 
exhibits narrow substrate specificity, i.e. of several compounds tested only limonene-
1,2-epoxide, 1-methylcyclohexene oxide, cyclohexene oxide and indene oxide were 
substrates. LEH belongs to a novel class of epoxide hydrolases (van der Werf et al, 
1998). 
EHs AND THE ot/p HYDROLASE FOLD FAMILY OF ENZYMES 
Soluble and microsomal EH belong to the a/p hydrolase fold family of enzymes 
Amino acid sequence comparison of mammalian sEH and mEH reveals no clear 
similarity or relation between these two enzymes. However, both proteins share 
significant sequence similarity to the bacterial haloalkane dehalogenase (Arand et al., 
1994), which is a member of the a/p hydrolase fold family (Franken et al., 1991). 
Based on the sequence similarity to haloalkane dehalogenase, it was hypothesized that 
sEH and mEH are distantly related enzymes that have evolved, together with 
haloalkane dehalogenase, from a common ancestral protein. Moreover, sEH and mEH 
probably belong to the a/p hydrolase fold family of enzymes, which hydrolyze 
epoxides via an enzyme-substrate-ester intermediate (Arand et al., 1994). 
Consequently, the related structures of these enzymes contain a highly similar a/p 
sheet, which consists of P-sheets connected by a-helices (Figure 13) (Ollis et al., 
1992). The best-conserved structural features of the fold are the loop-borne elements of 
a catalytic triad. The order of the catalytic amino acid residues in the primary sEH and 
mEH structure is always a nucleophilic residue, an acidic residue and a perfectly 
conserved His residue. The nucleophilic residue, Asp, is situated in a nucleophile 
"elbow" and fits in the conserved motif: s-x-n-x-s-s, where "s" is a small residue, "x" is 
any residue and "n" is the nucleophile. The acidic residue is either a Glu or Asp. 
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Figure 13. Schematic representation of the a/p hydrolase fold. P1-P8, p-sheets. oeA-aF, a-helices. The 
positions of the members of the catalytic triad are indicated (Nucleophile, Acid and Histidine). 
The hydrolysis reaction occurs in two steps starting with the formation of a covalent 
intermediate formed between the nucleophile and the substrate. This intermediate is 
stabilized by another conserved motif, the oxyanion hole. The covalent intermediate is 
hydrolyzed in the second step by a water molecule, which is activated by the Asp/Glu-
His pair. 
The gene evolution of epoxide hydrolases was further studied by Beetham et al. 
(1995). The amino acid sequence relationships of mammalian sEH to plant sEH, mEH, 
haloalkane dehalogenase and haloacid dehalogenase were analyzed. Homology was 
found between the carboxy-terminal residues (230-554) of mammalian sEH and 
haloalkane dehalogenase, plant sEH and mammalian mEH. The amino-terminal 
residues (1-229) of mammalian sEH are homologous to haloacid dehalogenase. 
The homology between haloalkane dehalogenase and haloacid dehalogenase does 
not indicate relatedness between these enzymes. Mammalian sEH was suggested to 
derive from a gene fusion based on the homology of the amino- and carboxy-terminal 
residues to the respective dehalogenases. Additionally, the homology of mammalian 
sEH and mEH suggest that they derive from a gene duplication, probably of an 
ancestral bacterial (epoxide) hydrolase gene (Beetham et al., 1995). 
The relatedness of mammalian sEH, mEH, JHEH, plant sEH, bacterial sEH and 
fungal EH is illustrated in figure 14. 
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Figure 14. Phylogenetic tree of several cc/p hydrolase fold EHs. EH, epoxide hydrolase. sEH, soluble EH, 
mEH, microsomal EH. JHEH, juvenile hormone EH. A. thaliana, Arabidopsis thaliana. S. tuberosum, 
Solanum tuberosum. A. radiobacter, Agrobacterium radiobacter. M. sexta, Manduca sexta. T. ni, 
Trichoplusia ni. A. niger, Aspergillus niger. 
The enzymatic mechanism of a/p" hydrolase fold EHs 
Initially, conversion of epoxides by EHs was thought to occur by direct hydrolysis. 
In this mechanism a specific histidine residue of the enzyme activates a water molecule 
by proton abstraction. Subsequently, the activated water hydrolyzes the epoxide by 
nucleophilic attack (Hanzlik et al., 1976; DuBois et ai, 1978). However, an alternative 
two-step-mechanism was proposed (Armstrong et ai, 1980). In this mechanism, an 
acidic amino acid residue of the EH performs a nucleophilic attack at the epoxide ring, 
which results in a covalent intermediate between substrate and enzyme by means of an 
ester bond. Then, a histidine activated water molecule hydrolyzes this bond resulting in 
the diol product and the regenerated enzyme. 
The first experimental results supporting this mechanism came from single-turnover 
experiments showing the transfer of radio-labeled oxygen (180) from mEH to 1,10-
phenanthroline 5,6-oxide, which indicates the formation of a substrate-enzyme ester 
intermediate (Lacourciere and Armstrong, 1993). Additionally, the results of other 
biochemical experiments suggests the covalent linkage of Asp333 of murine sEH to its 
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substrate (Borhan et al, 1995; Pinot et al, 1995). Furthermore, a putative covalent 
enzyme-substrate intermediate was isolated by the brief exposure of murine sEH to 
radio-labeled JHIII (Hammock et al, 1994). Definitive proof for the formation of an 
enzyme-substrate-intermediate was reported by Miiller et al. (1997). An enzyme-
substrate-ester intermediate between rat mEH and l4C-labeled cw-9,10-epoxystearic 
acid was visualized by denaturing SDS protein gel electrophoresis and subsequent 
fluorography. The radio-active signal of the mEH-substrate intermediate could be 
suppressed by inclusion of the competitive inhibitor 1,1,1 -trichloropropene oxide in the 
mEH/c«-9,10-epoxystearic reaction mixture. In a similar way, binding of l4C-labeled 
c«-9,10-epoxystearic acid to rat sEH was demonstrated. 
Based on homology to haloalkane dehalogenase the members of the catalytic triad 
for sEH (Asp333-Asp495-His523) and mEH (Asp226-Glu404-His431) were predicted (Arand 
et al, 1994; Beetham et al., 1995). These candidate catalytic residues have been 
changed in the respective enzymes by site directed mutagenesis. As predicted, murine 
sEH mutants with changes in the positions of Asp333, Asp495, and His523 were 
completely inactive (Pinot et al., 1995; Arand et al, 1996). Similarly, in several other 
reports site specific mutants of mEH revealed Asp226, Glu404 and His431 to constitute the 
catalytic triad (Bell and Kasper, 1993; Laughlin et al, 1998; Tzeng et al, 1998; Arand 
et al, 1999). Members of the catalytic triad of other a/p hydrolase fold EHs have been 
identified and align with the catalytic residues of the respective sEH and mEH enzymes 
(Rink et al, 1997; Arand et al, 1999). 
Enzyme kinetics studies show that for most EHs the first step of the reaction 
proceeds significantly faster than the second step, which is therefore rate limiting 
(Tzeng et al, 1996; Rink et al, 1998; Arand et al, 1999). For example, the mEH rate 
constant of the first step is three orders of magnitude higher than the rate constant of 
the second step with glycidyl-4-nitrobenzoate as substrate (Tzeng et al, 1996). 
X-ray structures of a/p hydrolase fold EHs 
Recently, crystal structures of the EHs from A. radiobacter AD1, murine liver 
cytosol and A. niger were reported (Nardini et al, 1999; Argiriadi et al, 1999; Zou et 
al, 2000). The information of the enzyme's structure confirms previous found data and 
also shows new aspects of the way EHs operate. 
The first three-dimensional EH structure was reported for A. radiobacter AD1 EH 
(Nardini et al, 1999). This enzyme shows a two-domain structure: a core domain 
showing the typical a/p hydrolase fold topology and a second mainly a-helical domain, 
which lies like a cap on top of the core domain. The active site cavity, with the catalytic 
residues Asp107 and His275, is located in a predominantly hydrophobic environment 
between these two domains. However, the acidic member of the catalytic triad, Asp246, 
is forced away from the active site due to crystal packing forces. A side chain of Gin134 
takes the vacant space and thereby mimics a bound substrate. A tunnel, connecting the 
back of the active site cavity and the surface of the enzyme, provides access to the 
active site for the catalytic water molecule. The nitrogen atoms of Phe108 and Tip38 
form the oxyanion hole. 
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Importantly, two previously unanticipated tyrosine residues (Tyr152 and Tyr215) are 
the only acidic functional groups present in the active site (Nardini et al., 1999, 2001). 
These cap domain located tyrosine residues polarize and activate" the epoxide ring by 
hydrogen bond formation, which facilitates the nucleophilic attack by Asp107. As a 
result of the formation of the covalent bond between the primary carbon atom of the 
epoxide and the carboxylic side chain of Asp1 7 a negative charge emerges on the 
epoxide oxygen. This newly formed oxyanion is stabilized by dislocation of the 
negative charge to one of the tyrosines by transferring a proton (Rink et al., 1999, 
2000). 
The crystal structure of murine sEH revealed that the sEH is a dimer (Argiriardi et 
al., 1999). Each sEH monomer is composed of an N-terminal (Arg4-Gly218) and a C-
terminal domain (Val235-Ala544), which are connected by a 16-residue proline-rich 
linker (Thr219-Asp234). The C-terminal domain contains the active site for epoxide 
hydrolysis. Its structure is similar to that of haloalkane dehalogenase and A. 
radiobacter AD1 EH, which have a/p hydrolase folds. The N-terminal domain contains 
a vestigial active site, which is similar to that of haloacid dehalogenase. The vestigial 
domain plays an important structural role by stabilizing the dimer, but does not 
participate in epoxide hydrolysis. The active site of sEH is located at the base of a, 
hydrophobic pocket-containing, L-shaped cavity. In addition to the catalytic triad 
(Asp333-Asp495-His523), a tyrosine residue (Tyr465) was identified, which may function 
in epoxide activation and opening (Argiriardi et al., 1999). Indeed, both Tyr381 and 
Tyr465 are required for full catalytic activity (Yamada et al., 2000). Additionally, the x-
ray structures of alkylurea inhibitors complexed with murine sEH show hydrogen bond 
interactions between the inhibitors and Tyr381 and Tyr465. This suggest that these 
tyrosine residues serve as general acid catalysts that facilitate epoxide ring opening in 
the first step of the hydrolysis reaction (Argiriadi et ai, 2000). 
A. niger EH is a soluble enzyme with an amino acid sequence, which is similar to 
the amino acid sequence of the membrane bound enzyme mEH. However, it lacks the 
N-terminal membrane anchor sequence of mEH. The catalytic triad has been identified 
as Asp1 , Asp 4 and His374. The acid residue of the charge relay is an Asp residue 
(Asp ), whereas the corresponding residue in all other mEHs is a Glu residue. The 
presence of Asp 48 contributes to the high epoxide turnover number of this fungal 
enzyme when compared to other EHs. In the hydrolysis of 4-nitrostyrene oxide by A. 
niger EH the first step in the reaction procedure is rate limiting, which is in contrast to 
the common second step of hydrolysis of the ester intermediate (Arand et al., 1999). 
Despite these differences, the x-ray structure of A. niger EH is of special interest 
because of its relationship to the very important mammalian epoxide-metabolizing 
enzyme mEH. 
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Figure 15. Schematic presentation of the reaction mechanism of a/p hydrolase fold EHs. In the first step, 
the epoxide, which is positioned by tyrosine residues, is attacked by the Asp nucleophile. An enzyme-
substrate-ester intermediate is formed. The intermediate is hydrolyzed in the second step by an Asp/Glu-
His pair-activated water molecule. This results in the formation of the diol and the regenerated enzyme. 
The x-ray structure of A. niger EH revealed a dimer consisting of two 44 kDa 
subunits. Each subunit is composed of three parts. First, there is a core a/(3 hydrolase 
fold, which contains the active site residues. Second, a lid or cap is present, which caps 
the active site and protrudes from the a/(J hydrolase fold. The third part is an N-
terminal meander that in turn caps the lid. The dimer interface results primarily from 
the interaction of the lids and the tips of the N-terminal meanders. The catalytic triad 
Asp192, Asp348 and His374 have been found on expected positions in the crystal 
structure. In analogy to the other EH crystal structures, two tyrosine residues, Tyr 
and Tyr314, have been identified which probably act as proton donors for the epoxide 
ring, thereby facilitating ring opening in the first step of the reaction (Zou et ah, 2000). 
The structure of A. niger EH has been suggested to be representative for the class of 
mEHs (Zou et ah, 2000). Therefore, new insights could be given on several 
unanswered questions concerning mEH. For example, the inability of mEH to 
hydrolyze bulky trans-substituted epoxides could be explained by the shape of the 
substrate-binding site: the catalytic nucleophile waits for the substrate at the end of a 
relative narrow hydrophobic tunnel. Inhibition of mEH by fatty acid amides could be 
explained by the binding of these inhibitors to the two proton donating tyrosine 
residues. The N-terminal part of mEH that precedes the core a/p" hydrolase fold is 
unique to mEHs and could offer the possibility of mEH to interact with other 
xenobiotic metabolizing enzymes such as cytochrome P450-dependent 
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monooxygenases. However, based on the A. niger EH structure a possible role of mEH 
in bile acid transport was rejected (Zou et al., 2000). 
The reaction mechanism of a/p hydrolase fold EHs can be summarized as follows: 
In the first step, the epoxide moiety of the substrate is bound and activated by active 
site located tyrosine residues to facilitate ring opening. A covalent intermediate 
between enzyme and substrate is formed upon nucleophilic attack of de epoxide ring by 
the nucleophilic residue. In the second step, the histidine and acidic residue of the so-
called charge relay activate a water molecule by proton abstraction, which in turn 
hydrolyzes the covalent enzyme-substrate ester intermediate. This step results in the 
diol-product and regenerated enzyme (Figure 15). 
Aspects concerning the catalytic mechanisms of non a/(3 hydrolase fold EHs 
Detailed insight into the catalytic mechanism of the zinc metalloenzyme LTA4 
hydrolase has been obtained by determination of its crystal structure. The structure does 
not show the specific topology of an a/p hydrolase fold. Based on the LTA4 structural 
data a reaction mechanism of LTA4 hydrolysis has been proposed, which is different 
from that of the a/p hydrolase fold EHs (Thunnissen et al., 2001). 
Contrary to LTA4 hydrolase, no information is available on the catalytic mechanism 
of hepoxilin hydrolase. Therefore, no comparison of this enzymatic activity to other EH 
activities can be made. 
Microsomal EH catalyzes epoxides by a base-catalyzed mechanism, whereas 
cholesterol 5,6-oxide hydrolase operates by an acid-catalyzed mechanism (Nashed et 
al., 1986). Mttller et al. (1997) have visualized the covalent intermediates between two 
EHs, mEH and sEH, and their substrates, which is typical for a/p hydrolase fold EHs. 
However, the same experimental approach could not reveal covalent binding of 
cholesterol epoxide to cholesterol 5,6-oxide hydrolase. Therefore, the enzymatic 
mechanism and structure of cholesterol 5,6-oxide hydrolase are different from those of 
sEH and mEH. 
LEH from R. erythropolis DCL14 belongs to a novel class of EHs, which is 
different from the a/p hydrolase fold EH class. For example, the nucleophilic attack of 
LEH on 1 -methylcyclohexene oxide takes place at the more substituted carbon atom, 
which suggests an acid catalyzed reaction mechanism (van der Werf et al., 1999a). 
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APPLICATION OF MICROBIAL EHs IN FINE ORGANIC CHEMISTRY 
Production of enantiopure epoxides using EHs 
Due to their chemical versatility, enantiopure epoxides are recognized as high-value 
intermediates in fine organic chemistry. This is especially true for the synthesis of 
biologically active compounds such as clinical drugs. Indeed, in order to produce safer 
drugs, these products have to be prepared as single enantiomers (Archelas and Furstoss, 
2001). 
The methods used for the production of enantiopure epoxides are based on 
chemical or biological catalysts. Chemically, epoxides are synthesized by e.g. 
epoxidation of alkenes catalyzed by metals. Biologically, enzymes or cells are used in 
e.g. the direct or indirect epoxidation of alkenes by monooxygenases or peroxidases, 
respectively. Alternatively, enzymatic resolution of chemically produced racemic 
epoxides by e.g. lipases and epoxide hydrolases is an attractive alternative methodology 
for the production of an enantiopure epoxide (Figure 16). These chemical and 
biological methodologies have been reviewed by several authors (de Bont, 1993; Besse 
and Veschambre, 1994; Archelas and Furstoss, 1997, 1999). 
EHs are interesting promising biocatalysts for the production of enantiopure 
epoxides for a number of reasons. They are cofactor-independent enzymes and only 
need water for hydrolysis. Consequently, EH-catalyzed production of enantiopure 
epoxides is a clean alternative for the chemical procedure involving toxic metal 
catalysts. EHs are ubiquitous in nature. Therefore, if a specific epoxide conversion is 
desired it seems possible to screen for the epoxide hydrolase, which can perform this 
conversion. Furthermore, microbial EHs can be produced in large amounts from 
various microorganisms. Consequently, research on the application of EHs for the 
synthesis of enantiopure epoxides and diols has focused on microbial EHs and not on 
e.g. mammalian EH due to the low amounts of available enzyme. EHs can be partly 
purified and used as an enzymatic powder without significant loss of activity upon 
storage. They are active in the presence of organic solvents, which allows the use of 
hydrophobic substrates. They often lead to excellent enantiopurity of the remaining 
epoxide and also in some cases of the formed diol, which itself can be used as a 
chemical building block (Archelas and Furstoss, 1997; Swaving and de Bont, 1998). 
A disadvantage of the enzymatic resolution of a racemic epoxide is the maximum 
yield of 50% for the remaining enantiopure epoxide. Nevertheless, EHs are interesting 
biocatalysts and may enable the preparation of enantiopure epoxides starting from 
cheap and readily available racemic epoxides (Archelas and Furstoss, 2001). 
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Figure 16. Example of the enantioselective hydrolysis of an epoxide by an EH. The (R)-enantiomer of a 
racemic sfyrene oxide mixture is hydrolyzed into (R)-1-phenyl-1,2-ethanediol. The (S)-enantiomer of 
styrene oxide is not converted. Consequently, enantiopure (S)-styrene oxide remains at a maximal yield of 
50% of the racemic epoxide mixture. 
Microbial EHs in epoxide biocatalysis 
A general correlation between certain microbial EHs and the substitutional pattern 
of various types of epoxides has been reported (Orru and Faber, 1999). Yeast strains of 
the genera Rhodotorula and Rhodosporidium give the best enantioselectivities with 
monosubstituted epoxides. Fungi such as A. niger and B. bassiana give best results 
with styrene oxide type substrates. Bacterial EHs, especially Actinomycetes such as 
Rhodococcus and Nocardia sp. give the best enantioselectivities with highly 2,2- and 
2,3-disubstituted epoxides (Orru and Faber, 1999). These data might be used as a 
general guideline to make a choice for the potentially best EH for the enantioselective 
hydrolysis of a certain epoxide of interest. In addition, new EH activities are reported 
continuously (van der Werf et al., 1999b; Zocher et al., 2000). 
Enantiocomplementary EH activities have been reported for both fungal and 
bacterial strains (Archelas, 1998; Krenn et al., 1999). For example, the residual epoxide 
of hydrolysis of fr-a/i.s-2-methyl-l-pentyloxirane by the fungus Syncephalastrum 
racemosum had the (\R,2R) configuration, while the opposite enantiomer was isolated 
using Chaetomium globosum. Another example concerns the enantiocomplementary 
EH activities of A. niger and B. bassiana toward styrene oxide and para-substituted 
styrene oxides (Archelas, 1998). Bacterial EHs of matching opposite enantiopreference 
have been found among several species. While Rhodococcus and Nocardia spp. 
hydrolyze (5)-2,2-disubstituted epoxides, methylotrophic bacteria such as Mycoplana 
rubra and Methylobacterium spp. exhibited a preference for the (7?)-enantiomers. Thus, 
the stereochemical course of the reaction can be controlled by choosing the appropriate 
microorganism (Krenn et al, 1999). 
Most reports on EH-containing fungi are related to the use of these organisms in the 
production of enantiopure epoxides and or diols. For example, Zhang et al. (1995) 
screened 80 fungal strains to find an EH activity capable of catalyzing the kinetic 
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resolution of racemic indene oxide into (lS,2R)-mdene oxide, which is a precursor to a 
side chain of the HIV protease inhibitor MK 639. Diplodia gossipina ATCC 16391 was 
found to be the best catalyst (Zhang et al., 1995). Instead of the conversion of a specific 
epoxide, Moussou et al. (1998) screened 42 fungal strains using racemic 1,2-
epoxyhexane and 1 -methyl-1,2-epoxypentane as substrates. Seven strains, Aspergillus 
niger LCP 521, Aspergillus terreus CBS 116-46, Beauveria bassiana ATCC 7159, 
Chaetomium globosum LCP 679, Cunninghamella elegans LCP 1543, Mortierella 
isabellina ATCC 42613 and Syncephalastrum racemosum MUCL 28766, were of 
interest. The group involved (R. Furstoss, Marseille, France) further analyzed A. niger 
LCP 521 and B. bassiana ATCC 7159 (formerly named Beauveria sulfurescens) with a 
focus on the asymmetric synthesis of enantiopure epoxides and or diols. They showed 
the first examples of several-gram-scale enantioselective hydrolysis of geraniol epoxide 
and limonene epoxide derivatives (Chen et al., 1993) as well as substituted styrene 
oxide derivatives (Pedragosa-Moreau et al., 1996) using these fungi. 
styrene oxide 
(racemic) " ^ 
(R)-1-phenyl-1,2- ethanediol 
H OH 
•P \ / \ ^ O H 
(R)-styrene oxide (R)-1-phenyl-1,2- ethanediol 
Figure 17. Enantioselective styrene oxide hydrolysis by A. niger and B. bassiana. For details, see text. 
Interestingly, enantiocomplementary styrene oxide hydrolysis was demonstrated by 
A. niger and B. bassiana (Figure 17). A. niger hydrolyzes (^)-styrene oxide while B. 
bassiana hydrolyzes (5)-styrene oxide. Moreover, both fungi give rise to the (/?)-diol. 
Therefore, A. niger and B. bassiana could be used to obtain these respective 
compounds with high enantiopurity (Pedragosa-Moreau et al., 1993). 
Alternatively, lyophilized cells ofNocardia EH1 gave almost enantiopure (2R,3R)-
heptane-2,3-diol as the sole product in a 79% yield in the hydrolysis of racemic c/s-2,3-
epoxyheptane (Kroutil et al., 1996). These data indicate the versatility and usefulness 
of microbial EHs in the synthesis of enantiopure epoxides and diols. 
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Additional research has been performed to stabilize, improve and / or manipulate 
EH activity and enantioselectivity. For example, immobilization of a partially purified 
EH from Nocardia EH1 through ionic binding onto DEAE-cellulose stabilized the 
enzyme resulting in a 225% increase in activity when compared to free enzyme. 
Moreover, the stabilized immobilized enzyme could be successfully employed in 
repeated batch conditions, which was not the case for whole cell reactions (Kroutil et 
al., 1998). Non-ionic detergents such as thesit and sucrosemonolaurate have been 
shown to affect the R. glutinis EH. Both the specific activity of the enzyme as well as 
the enantioselectivity were stimulated (Kronenburg and de Bont, 2001). Another way 
of stabilizing EH activity and, additionally, improving enantioselectivity has been 
reported by means of immobilized imprinting of R. glutinis EH (Kronenburg et al., 
2001). In this technique, EHs are derivatized with itaconic anhydride, imprinted by 
substrates (imprinters) and co-polymerized with ethylene glycol dimethacrylate to form 
a bioplastic. After removal of the imprinter an enzyme with rationally modified 
properties is obtained, which resulted in e.g. reversion of enantiopreference. 
Preparative scale production of enantiopure epoxides 
Extra points of attention need to be considered when enantiopure epoxides are 
prepared on a larger scale. Analytical scale EH-catalyzed epoxide hydrolysis is usually 
performed in aqueous media. A drawback of these aqueous media is that most epoxides 
are poorly water soluble and that epoxides are unstable in aqueous buffer systems. The 
chemical non-enantioselective hydrolysis of epoxides can result in a drop in yield of the 
enantiopure residual epoxide. Furthermore, chemical epoxide hydrolysis hampers the 
production of enantiopure diols. To avoid these problems organic solvents have been 
applied to improve both epoxide stability and solubility (Nellaiah et al., 1996; Choi et 
al., 1999). However, organic solvents have a toxic effect and are consequently 
inhibitory to EH activities (Goswami et al., 1999; Choi et al., 1999). 
Despite this, several preparative-scale EH-catalyzed hydrolytic resolutions, 
reviewed by Archelas and Furstoss (2001), are conducted under various conditions with 
epoxide concentrations of up to 2 M, in batch reactors with one or two phases and even 
in plain water. Choi et al. (1999, 2000) reported a very interesting system. In their 
cascade two-phase hollow-fiber membrane bioreactor the aqueous cell suspension of 
the biocatalyst R. glutinis is circulated through the shell sides of each hollow-fiber 
membrane module. The organic solvent dodecane, which was used to dissolve 1,2-
epoxyhexane, circulates through the lumen side. Therefore, solvent toxicity is 
minimized. Two additional modules are used to extract enantiopure (S)-l,2-
epoxyhexane and inhibitory levels of formed 1,2-hexanediol. The continuously 
operated system allows long-term operation, which leads to mass production of (S)-1,2-
epoxyhexane. Based on the calculated volumetric productivity (633 (imor'T'-h"1) the 
authors suggest that this system is potentially useful for large-scale industrial 
applications since a volumetric productivity of at least 200 (umof -r'-h"1) is needed to 
be economically viable (Choi et al., 2000). 
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However, due to the increasing environmental pressure on fine chemical industries, 
the employment of environmentally friendly processes is encouraged. The use of toxic 
chemicals such as organic solvents should be reduced or even eliminated. In line with 
this, several reports describe the hydrolysis of high amounts of epoxides (second phase) 
in plain water instead of buffer / organic solvent solutions (Genzel et al, 2001; Manoj 
et al, 2001). 
Nonetheless, EHs have been shown to be applicable in the chemoenzymatic 
synthesis of valuable target-compounds. Among these are («S)-Ibuprofen, which is a 
strong non-steroidal anti-inflammatory drug, (7?)-Nifenalol, which is a (3-adrenergic 
blocker, and Eliprodil, which is a neuroprotective agent (Cleij et al, 1999; Pedragosa-
Moreau et al, 1997; Manoj et al, 2001). 
Recombinant DNA technology in EH research 
Research on the use of EHs in biocatalysis has mainly been focused on microbial 
EHs, because microorganisms can be cultivated in large amounts. Consequently, an 
"unlimited" source of biocatalyst is available. EHs from e.g. mammalian sources were 
simply not available in sufficient quantities. However, the isolation of EH encoding 
genes from various organisms (including microorganisms) and the over-expression of 
these genes in suitable hosts opened the way to evaluate the use of EHs from all 
sources in biocatalysis as well as the biological research focused on the characterization 
of the EH protein and function. 
For example, enantiopure (2/?,3/?)-3-phenylglycidol has been prepared with a 31% 
yield using human sEH, which was produced in the baculovirus expression system 
(Williamson et al, 2000). The preparation of (S)-2-pyridyloxirane has been established 
using a recombinant A. niger strain in which the A. niger LCP521 EH encoding gene 
was over-expressed (Genzel et al, 2000). Escherichia coli has been used to express EH 
genes to e.g. analyze enantioselective epoxide hydrolysis (Lutje Spelberg et al, 1998) 
or to obtain sufficient EH protein for crystallographic studies (Nardini et al, 1999; Zou 
et al, 2000) or to analyze site specific EH mutants (Arand et al, 1999a). 
The elucidation of EH structures and enzymatic mechanisms are a major step 
towards the design of mutant EHs with improved characteristics. Some interesting 
observations concerning EH activity and enantioselectivity have already been reported. 
The replacement of the mEH amino acid residue Glu with Asp leads to a strongly 
increased the Vmax of the enzyme. A 23-fold increase was found with styrene oxide, 
while a 39-fold increase was observed with 9,10-epoxystearic acid (Arand et al, 
1999b). Additionally, substitution of Tyr215 by Phe in the A. radiobacter EH results in a 
2 to 4 fold increase in enantioselectivity toward styrene oxide and derivatives thereof 
(Rink et al, 1999). Thus recombinant DNA technology has already proven to be very 
useful in EH research and it will facilitate both the development of mutant EHs with 
improved characteristics and the production of sufficient EH for biocatalytic purposes 
in the near future. 
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ABSTRACT 
The epoxide hydrolase-encoding gene (EPH1) from the basidiomycetous yeast 
Xanthophyllomyces dendrorhous was isolated. The genomic sequence has an open 
reading frame of 1236 basepairs, interrupted by 8 introns encoding a polypeptide of 411 
amino acids with a calculated molecular mass of 46.2-kDa. The amino acid sequence is 
similar to that of microsomal epoxide hydrolase and belongs to the cc/p hydrolase fold 
family. The EPH1 gene was not essential for growth of X. dendrorhous in rich medium 
under laboratory conditions. The Ephl encoding cDNA was functionally expressed in 
Escherichia coli. A six-fold increase in specific activity was observed using resting 
cells as compared to X. dendrorhous. The epoxides 1,2-epoxyhexane and 1-
methylcyclohexene oxide were substrates for both the native and the recombinant Ephl. 
The isolation and characterization of the X. dendrorhous EH-encoding gene is an 
essential step in developing a yeast EH based epoxide biotransformation system. 
INTRODUCTION 
Epoxide hydrolases (EHs) catalyze the hydrolysis of epoxides to their 
corresponding diols. These enzymes have potential industrial uses in fine chemistry as 
both enantiomerically pure epoxides and 1,2-diols are central building blocks in the 
asymmetric synthesis of biologically active molecules (25, 40). They are found in a 
wide variety of both prokaryotic and eukaryotic organisms where they perform different 
functions. The best studied mammalian EHs are involved in the detoxification of 
epoxides derived from both xenobiotic compounds and endogenous substrates (2, 22, 
30). Plant EHs are believed to be involved in the biosynthesis of cutin (4) and 
components of plant defense mechanisms (17). Insect EH might be involved in the 
regulation of juvenile hormone titers by degrading the hormone in concert with juvenile 
hormone esterase (8). Microbial EHs are' found in bacteria and fungi where they 
perform catabolic functions (5, 6). 
Two types of mammalian EH, soluble EH (sEH) and microsomal EH (mEH), are 
involved in the detoxification of noxious epoxides. Several plant (15, 32) and bacterial 
(18, 28) EHs are similar to sEH whereas the insect juvenile hormone EH sequence is 
similar to mEH (42). Both type of EHs belong to the oc/p hydrolase fold family of 
enzymes (1, 28), a large group of proteins that are structurally and mechanistically 
related (24). Hydrolysis of epoxides by these enzymes occurs via an enzyme-ester-
substrate intermediate (1, 16, 19). In addition to the a/p hydrolase fold enzymes, a few 
EHs belong to other classes of enzymes e.g. leukotriene A4 hydrolase (10), cholesterol 
EH (38) and limonene-l,2-epoxide hydrolase (34). EH activity has been described from 
several fungi e.g. Rhodotorula glutinis (39), Aspergillus niger (20) and Beauveria 
sulfurescens (26), but no EH-encoding gene from an eukaryotic microorganism has 
been reported yet. 
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The broad substrate ranges, high enantioselectivities and reaction rates (40) make 
yeast EHs promising candidates for industrial applications. However, in most cases 
wildtype yeast EHs do not meet the exact demands for a specific epoxide conversion in 
an industrial process. Therefore, our ultimate goal is to develop a yeast EH based 
biocatalyst with tailor-made substrate specificity and enantioselectivity. Isolation and 
characterization of a yeast EH encoding gene, thereby obtaining information about the 
gene and gene product which is needed for the construction of an improved enzyme via 
genetic engineering, would be a first step to take. The EH activity and the availability of 
molecular genetic tools (41) prompted us to isolate and characterize the EH-encoding 
gene from the basidiomycetous yeast Xanthophyllomyces dendrorhous. 
MATERIALS AND METHODS 
Strains, plasmids and DNA manipulations 
X. dendrorhous, perfect state of Phaffia rhodozyma (12), strain CBS 6938 was used 
throughout this study. E. coli XLl-Blue-MRF' (Stratagene, La Jolla, CA, USA) was 
used for transformation and expression experiments. The vectors pGEM-T Easy 
(Promega Benelux BV, Leiden, The Netherlands) and the prokaryotic expression vector 
pKK223-3 (Pharmacia Biotech Benelux, Roosendaal, The Netherlands) were used for 
cloning and expression experiments respectively in E. coli. For the construction of 
pEHKO a 750 bp EPH1 fragment, corresponding to the C-terminal half of the enzyme, 
with a unique EcoRV restriction site was amplified in a PCR using the primers PXD2 
and PXD3 and cDNA as template. This PCR product was cloned into pGEM-T Easy 
and the truncated EPHl fragment was released as a 776 bp £coRI fragment from the 
plasmid. The fragment was purified and ligated into the unique EcoRl restriction site of 
the X. dendrorhous transformation vector pPRlT. This newly constructed vector was 
designated pEHKO. Plasmid pPRIT was constructed by ligating a 0.3 kb BamHl-
Hindlll PCR product, corresponding to the glyceraldehyde-3-phosphate dehydrogenase 
terminator sequence of X. dendrorhous (36), into the corresponding restriction sites of 
the X. dendrorhous transformation vector pPRl (41). If not stated otherwise standard 
molecular cloning techniques were used (29). Chromosomal DNA was isolated from 
SDS-lysed protoplasts of X. dendrorhous and extracted with phenol/chloroform as 
described previously (36). Isolation of plasmid DNA from E. coli was performed using 
Qiagen columns (Westburg BV, Leusden, The Netherlands). Isolation of DNA trapped 
in agarose gel was performed using the QIAEX II Gel Extraction Kit. The non-
radioactive DIG DNA Labeling and Detection Kit (Roche Diagnostics Nederland BV, 
Almere, The Netherlands) was used to label and detect probes in Southern blots or 
colony hybridizations. The construction of the X. dendrorhous genomic and cDNA 
libraries was described previously (36). The standard nomenclature for yeast genes and 
proteins was considered to denominate the X. dendrorhous epoxide hydrolase gene and 
protein (33). 
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Transformation of X. dendrorhous and E. coli by electroporation 
Electrocompetent cells of X. dendrorhous were prepared as described by Wery et al 
(41). Electrocompetent cells were mixed with 5 \ig of linearized DNA and the mixture 
was transferred to a precooled electroporation cuvette (0.2 cm). A pulse was given of 
0.8 kV, 1000 Q and 25 uF using a Bio Rad gene pulser (Bio Rad Laboratories BV, 
Veenendaal, The Netherlands ). Immediately 0.5 ml of YePD medium, containing 1% 
yeast extract, 2% bactopeptone and 2% glucose, was added and the mixture was 
transferred to a sterile 1.5 ml Eppendorf tube. After incubation for 2.5 hours at 21°C, 
100 (al aliquots were spread onto solid YePD plates containing 40 ng/ml G418. Plates 
were incubated at 21°C until colonies appeared. 
E. coli was cultivated in LB (29) medium lacking NaCl to an OD600 of 0.5. Cells 
were washed twice in an equal volume of ice cold demineralized water and once in an 
equal volume of 10% glycerol in demineralized water. After centrifugation (1,000 x g, 
10 minutes) cells were resuspended in 0.05 volume of 10% glycerol in demineralized 
water. Hundred |il of cells were mixed with plasmid DNA and transferred to an 
electroporation cuvette (0.2 cm). A pulse was given of 2.5 kV, 200 Q and 25 uF. 
Immediately 1 ml of SOC medium (29) was added. The transformation mixture was 
transferred to a 1.5 ml Eppendorf tube and incubated at 37°C for 1 hour. Aliquots were 
spread onto solid LB agar plates containing 50 ug/ml ampicillin. 
Polymerase Chain Reaction 
Standard reactions were carried out in an automated thermal cycler (Perkin-Elmer 
Nederland, Nieuwerkerk a/d IJssel, The Netherlands). The reaction conditions were: 5 
min 94°C, followed by 30 cycles: 1 min 94°C, 2 min 45 or 50°C, 1 or 2,5 min 72°C, 
ending with 10 min 72°C. The oligonucleotide primers used are: 
PANEH2: 5'- TCNCTBCCYGGHTAYACNTTYTC-3' (encoding SLPQYTFS of A. 
niger EH). 
PANEH4A: 5'- TCVAGWGCWGCRAARTGDCCDCC-3' (encoding antisense 
GGHFAALE of A. niger EH). 
PXD2: 5'-C4CrGCCCGGCr^Z4CGrrcrCCTCTGGTCCGCAACG -3' (encoding 
LPGYTFSSGPQR of X. dendrorhous EH). 
PXD3: 5'- C4^G^GC4GC4^GrG7CCGCCTCGAGCATG -3' (encoding antisense 
HARGGHFAAL of X. dendrorhous EH). 
Nucleotides printed in italics correspond to a part of the degenerate oligonucleotides 
PANEH2 and PANEH4A found in pxdehl. 
PROKATG: 5'-TTTGAATTCATGACGTCTGCGACATTCCTAC-3'. 
PROKTAA:5'-AGCTCTGCAGTTAAAGCTCGGAATGATAGTTC-3'. 
Restriction sites introduced for subcloning purposes are underlined. 
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EH enzyme assay 
X. dendrorhous strains were cultivated to a high cell density culture for 48 hours at 
21°C in 400 ml YePD medium. E. coli [pKK223-3] and E. coli [precEphl] were grown 
overnight in 100 ml LB medium supplemented with ampicillin (50 ug/ml) and 
isopropyl-(3-D-thiogalactopyranoside (IPTG) (0.84 mM). Cells were harvested by 
centrifugation (1,000 x g, 10 minutes) and washed in 50 mM potassium phosphate 
buffer (pH 7.0). Cell pellets were resuspended in 3 ml 50 mM potassium phosphate 
buffer (pH 7.0) to obtain a concentrated suspension of resting cells. One ml of these 
suspensions were mixed with 5 mM of racemic substrate by vortexing in sealed tubes or 
bottles and incubated shaking at 35°C in a waterbath. To monitor epoxide degradation 
headspace samples were taken over a period of time and were analyzed using GC 
analysis on a Chrompack CP9000 gaschromatograph equipped with an a- or p-
cyclodextrin 120 chiral column (a- or P-DEX respectively, Supelco Inc.). Racemic 1,2-
epoxyhexane (Aldrich, Zwijndrecht, The Netherlands) was analyzed using the P-DEX 
(detection limit: 50 \xM). Racemic 1-methylcyclohexene oxide was analyzed using the 
a-DEX (detection limit: 50 \xM). To determine the protein content, 1 ml of a diluted 
sample was added to 0.5 ml of 0.5 N NaOH and incubated at 100°C for 30 minutes. 
Subsequently 100 ul of this preparation was applied in the Bio-Rad DC Protein Assay 
(Bio-Rad). 
Nucleotide sequence accession number 
The nucleotide sequence of the EPH1 gene has been deposited in the GenBank 
database under accession no. AF166258. 
RESULTS 
Synthesis of a specific EH probe of X. dendrorhous by PCR 
Initial enzyme localization studies showed that most EH activity was located in the 
membrane fraction of a cell free extract of X. dendrorhous (results not shown). 
Therefore, we surmised that X. dendrorhous contains a mEH. We aligned amino acid 
(aa) sequences of mEHs from human (31), rabbit (14), rat (27) and Manduca sexta (42) 
and identified conserved regions. Several conserved peptide sequences were used to 
design degenerate oligonucleotides which could serve as primers in a PCR using X. 
dendrorhous chromosomal DNA as template, but no X. dendrorhous EH fragment was 
amplified. We then used the conserved portion of the amino acid sequence of 
Aspergillus niger EH (11) to design degenerate oligonucleotides using X. dendrorhous 
preferred codons (36). A 1.2 kb fragment was amplified in a PCR using 
oligonucleotides PANEH2 and PANEH4. This fragment was cloned into pGEM-T 
Easy, yielding pxdehl, and the nucleotide sequence of the PCR fragment was 
determined. Comparison of the deduced aa sequence to protein databases revealed 
homology to the C - terminal part of eukaryotic mEHs e.g. rat, mouse and rabbit. This 
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result indicated that a 1.2 kb fragment of the putative X. dendrorhous EH encoding 
gene, denominated EPH1, was cloned. 
Isolation of the X. dendrorhous EPH1 gene 
The 1.2 kb fragment of pxdehl was used to screen a cDNA and a genomic cosmid 
library of X. dendrorhous. The EPH1 cDNA contained an open reading frame (ORE) of 
1236 bp corresponding to a polypeptide of 411 aa with a calculated molecular mass of 
46,185 Da. The two highest scores of a comparison of the total Ephl aa sequence to the 
swissprot protein database corresponded to pig mEH, 32.5% identity, and rabbit mEH, 
32.2% identity. Comparison of the pxdehl nucleotide sequence with cDNA sequences 
revealed the presence of several introns. 
Cosmid pEHcos8 hybridized to pxdehl in a colony hybridization screen, indicating 
that this cosmid carries a chromosomal X. dendrorhous DNA fragment, containing a 
part or the entire EPH1 gene. The nucleotide sequence of the EPH1 gene was 
determined by sequencing pEHcos8 initially with specific oligonucleotides designed 
from the pxdehl sequence and subsequently by a primer walking strategy. We 
sequenced 2931 bp including the EPH1 gene, 716 bp upstream of the putative 
translation initiation codon, and 219 bp downstream of the putative TAA stop codon. 
The EPH1 ORF is interrupted by 8 introns varying in size between 61 and 110 bp. The 
promoter region contains putative elements such as a CCAAT box, TATA-box and 
CAP signal. The 3' nontranslated region contains the sequence 
TATGTATG...TATGT...TTT, which is similar to 3' nontranslated regions of several S. 
cerevisiae genes (21, 43). 
Inactivation of the EPH1 gene in X. dendrorhous by transformation-mediated gene 
disruption 
We inactivated the chromosomal EPH1 by transformation-mediated gene 
disruption. We linearized pEHKO (Fig. 1) by digestion with EcoKV and introduced it 
into X dendrorhous CBS6938 by electrotransformation (41). Transformants were 
selected by G418 resistance. Both X. dendrorhous CBS6938 and putative EPHF 
deletion mutants, further designated CBS6938[pEHKO], were cultivated for 48 h at 
21°C in rich medium (YePD) to reach the stationary growth phase. Apparently, the 
mutation has no lethal effect on X. dendrorhous and EPH1 is not essential for growth 
under these laboratory conditions. 
Both a racemic aliphatic, 1,2-epoxyhexane, and a racemic alicyclic, 1-
methylcyclohexene oxide (MCHO), epoxide were used as substrates to demonstrate 
Ephl activity. X. dendrorhous hydrolyzed 1,2-epoxyhexane with low enantioselectivity 
at an initial reaction rate of 4.8 nmol/min/mg protein. MCHO was enantioselectively 
hydrolyzed at 0.17 nmol/min/mg protein by the wildtype strain. No epoxide hydrolase 
activity was seen on either substrate using transformants CBS6938[pEHKO]l and 
CBS6938[pEHKO]2. 
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EPHl 
EcoRV 1040 EcoRV 1060 ECORV1865 EcoR V 2570 
Hh 
EcoRV 1040 
. E c o R V 1865 
EcoR I 6747 
EcoRV 7128 
EcoR V 7833 
Single copy 
^ + 
EcoR V 1040 
EcoRV 1060 
EcoRV 1865 
EcoR I 2257 
Multiple copies 
EcoR I 12010 
EcoRV 12391 
EcoR V 13096 
Figure 1. Transformation-mediated inactivation of the EPH1 gene. Schematic representation of a single 
copy and multiple copies of plasmid pEHKO integrated into the EPH1 gene. The first EPH1 exon is 
shown by a black box with an arrowhead to indicate the EPH1 direction. Plasmid pEHKO was 
constructed by cloning of a 776 bp EcoRI PCR fragment, containing the truncated EPH1 gene copy 
(corresponding to aa 138-388), in the X. dendrorhous transformation vector pPP.1T. Prior to 
electroporation plasmid pEHKO was linearized by digestion with EcoRV. 
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CBS6938 CBS6938 
CBS6938 [pEHKO]! [pEHKO]2 pEHKO 
1 2 3 4 5 6 7 8 9 10 
!<*- 5.2 kb 
i- 750 bp 
Figure 2. Transformation-mediated inactivation of the EPH1 gene. Autoradiograph of the Southern blot 
analysis of chromosomal DNA of wildtype CBS6938 and transformants CBS6938[pEHKO]1 and 2. Lanes 
1, 4, 7, chromosomal DNA digested with EcoRI. Lanes 2, 5, 8, chromosomal DNA digested with EcoRV. 
Lanes 3, 6, 9, chromosomal DNA digested with EcoRI and EcoRV. Lane 10, plasmid pEHKO DNA 
digested with EcoRI. The hybridizing DNA fragments corresponding to the size of plasmid pEHKO (5.2 
kb) in lanes 5 and 8 and the approximately 750 bp, truncated EPH1 containing, EcoRI fragment of 
pEHKO in lanes 4, 7 and 10 are indicated by arrows. 
We probed DNA from the two transformants on Southern blots with the 1.2 kb 
EcoRI fragment of pxdehl (Fig. 2). Wildtype X. dendrorhous CBS6938 DNA digested 
with EcoRI resulted in a large (> 10 kb) hybridizing fragment. Digestion of 
CBS6938[pEHKO] with EcoRI resulted in three fragments. The presence of the 
approximately 750 bp EcoRI fragment from CBS6938[pEHKO] could be explained by 
multiple copy integration of pEHKO in the EPH1 gene (Fig. 1). This was confirmed by 
the hybridization patterns of genomic DNA digested with EcoRV or EcoRI/EcoRV. 
CBS6938 DNA digested with EcoRV had two fragments of 705 and 805 bp, whereas 
CBS6938[pEHKO] DNA digested with EcoRV had the expected wildtype pattern plus 
an additional fragment of 5.2 kb corresponding to size of the linear form of pEHKO. 
An additional fragment of approximately 385 bp was noticed corresponding to the 
equally large EcoRI-EcoRV fragments of pEHKO. A similar pattern was observed by 
restriction of pEHKO with the same endonucleases. 
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Functional expression of recombinant Ephl in E. coli 
We expressed the Ephl encoding cDNA in E. coli. Therefore, Ephl encoding 
cDNA was amplified in a PWO polymerase (Roche Diagnostics Nederland BV, 
Almere, The Netherlands) catalyzed PCR using the forward primer PROKATG and the 
reverse primer PROKTAA with EPH1 cDNA as template. The 1255 bp PCR product 
was digested with EcoRl and Pst\ and ligated into the corresponding sites of the 
prokaryotic expression vector pKK223-3 yielding precEphl. E. coli[precEphl] was 
subjected to the EH enzyme assay. The initial reaction rates of E. co/z'[precEphl] 
towards 1,2-epoxyhexane and MCHO were 31 and 1 nmol/min/mg protein respectively, 
approximately six fold higher than the values from wildtype X. dendrorhous. As 
expected, no EH activity could be detected using E. co/i'[pKK223-3]. Unlike 1,2-
epoxyhexane, MCHO was selectively degraded by both native Ephl and recEphl (Fig. 
3); 1R,2S-MCH0 was degraded faster than 1S.2R-MCHO. The yield of 1S,2R-MCH0, 
after 1R.2S-MCHO is completely degraded, is 30%. 
Figure 3. Functional expression of X. dendrorhous EPH1 in £. coli. The hydrolysis of 5 mM of racemic 1-
methylcyclohexene oxide was monitored over a period of time. • , 1S.2R-MCHO (35). • , 1 R.2S-MCHO 
(35). 
DISCUSSION 
Ephl from the basidiomycetous yeast A", dendrorhous resembles that of mammalian 
mEHs and belongs to the family of a/(3 hydrolase fold of enzymes which consists of a 
large number of enzymes including sEH and mEH (1, 24). Several conserved sequence 
motifs have been found in this family of enzymes especially in the regions of the highly 
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conserved nucleophile-histidine-acid catalytic triad (24). The consensus of the 
nucleophile motif is sm-x-nu-x-sm-sm, where sm is a small aa, x is any aa and nu is the 
nucleophile. The HGXP motif contains the oxyanion hole of the enzyme (1, 16, 24). 
The three putative members of the Ephl catalytic triad are an aspartate residue at 
position 181, corresponding to the nucleophile motif, a glutamate residue at position 
359, which aligns to the catalytic acidic residue, and a histidine residue at position 385 
could be the catalytic histidine (Fig. 4). 
Ephl M TSANIP TPFQVSFAQQDVDRMMAKIRDTRLPTAPI 36 
RBmEH MLLELLLASVLGFVIYWFVSGDKEESLPLEDGWWGPGSRPVGLEDESIRPFKVETSDEEINDLHQRI —DRIRLTPP 75 
RTmEH MWLELVLASLLGFVIYWFVSRDKEETLPLGDGWWGPGSKPSAKEDESIRPFKVETSDEEIKDLHQRI—DRFRASPP 75 
Ephl VPGASWDYGIDLDWLTELHKYWANEWSWEETEKRINKYPHFRVDIEEISLHFVHIKSKQ PDAIPLILSHGWPS 109 
RBmEH LENSRFHYGFNSNYLKKILSyWRHEFDWKKQVEILNSYPHFKTKIEGLDIHFIHVKPPQVPPGRTPKPLLMVHSHJG 152 
RTmEH LEGSRFHYGFNSNYMKKWSYWRNEFDWRKQVEILNQYPHFKTKIEGLDIHFIHVKPPQLPSGRTPKPLLMVHGWPG 152 
N 
E p h l SFLEFWEVIDELVDPTKAG QPAFHWIPSMPGYTFSSGPQRKGWTWDTARVYNSLMVNVLGYKTYTCGAGDWGS 184 
RBmEH SFFEFYKIIPLLTDPKSHGLSDEHIFEVICPSIPGYGFSQASSKKGFNSVSTARIFYKLMLR-LGFQEFYIQGGDWGA 22 9 
RTmEH SFYEFYKIIPLLTDPKSHGLSDEHVFEVICPSIPGYGYSEASSKKGLNSVATARIFYKLMTR-LGFQKFYIQGGDWGS 229 
* * * * ! • • * * i * * i I * l i * i * i * * i * * * I I * l l l * * i * i * * * • I I * * i * * I I I I I * * * * I 
Ephl WITAQILHDYSEFAWAHFTMIKASVPILNPIYSLPILLGK IPFVPKGVARWLQSLVYTEAEINGLERTDKF 256 
RBmEH LVCTNMAQLVPSHVKGLHLNM ALILRNHYTLTLLLGRRIGGLLGYTERDMELLYP- - - FKEKVFYSLMRES - - 297 
RTmEH LICTNMAQMVPNHVKGLHLNM AFISRSFYTMTPLLGQRFGRFLGYTGKDIELLYP YKEKVFYSIMRES- - 297 
Ephl WKEGLGYQKIQGSKPMTLGAALFDSPVGILSWIGEKYHGWSDPR APSAPSQVTPNHIVTVTALYFLTGSIHT 32 8 
RBmEH GYMHIRATKPDTVGCALNDSPVGLAAYILEKFSTWTNSEFRDLEDGGLERKFSLQDLLTNIMIYWTTGSIVS 36 9 
RTmEH GYLHIQATKPDTVGCALNDSPVGLAAYILEKFSTWTKSEYRELEDGGLERKFSLDDLLVNIMIYWTTGTIVS 369 
A H 
Ephl SFLPYKEY TLSPMAVAVGKKRPIGLSIFPAEITQYPRSWVASSC-KLVNYKVHARGGHFAAVDNPGAYVEDIR 4 00 
RBmEH SQRYYKENLGQGFMAHKHERLKVHVPTGFAAFPCEIMHVPEKWVRTKYPQLISYSYMPRGGHFAAFEEPELLARDIC 44 6 
RTmEH SQRYYKENLGEGIMVHKHEGMKVFVPTGFSAFPSELLHAPEKWVKVKYPKLISYSYMERGGHFAAFEEPKLLAQDIR 44 6 
* * * * II ' * ' * _ * * * ' 1 * 1 * * 1 1 1 * 1 1 * 1 * * * * * * * ! • * 1 * * 1 
Ephl ETIGKNYHSEL 411 
RBmEH KFVG--LVERQ 455 
RTmEH KFVS--LAELQ 4 55 
Figure 4. Amino acid comparison of Ephl to microsomal EHs. Alignment of the amino acid sequences of 
Ephl, X. dendrorhous epoxide hydrolase (this study), RBmEH, rabbit mEH (14) SwissProt datafile 
P04068 and RTmEH, rat mEH (27) P07687. *, character to show that a position is perfectly conserved. ', 
character to show that a position is well conserved. The residues forming the catalytic triad are indicated 
by N, nucleophile; A, acidic residue; and H, histidine. The aa sequence corresponding to the nucleophile 
motif is single underlined. The aa sequence corresponding to the HGXP motif is double underlined. 
The predicted Ephl polypeptide (411 aa) of X. dendrorhous is shorter than most 
mammalian mEHs (455 aa) and the juvenile hormone EH (462 aa). These differences 
are mainly found in the N-terminal regions of these enzymes (Fig. 4). The mEH is 
cotranslationally inserted into the endoplasmic reticulum (13, 23) using a single 
membrane anchor segment in the N-terminus of the enzyme (9). This segment is 
missing from Ephl and its absence may partly explain the difference in length between 
the mammalian mEHs and Ephl. Even though Ephl lacks a membrane anchor segment, 
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it appears to be membrane associated since most of the epoxide hydrolase activity was 
found in the membrane fraction of aX. dendrorhous cell free extract. 
Protein engineering, in which both specific and random amino acids were 
substituted, has been shown to be a powerful tool for the improvement of enzyme 
characteristics (7). For mEH it was shown that the replacement of the catalytic acidic 
residue, Glu at position 404, with an aspartate residue greatly increased the Vmax of 
this enzyme (3). We demonstrated the expression of EPH1 cDNA in E. coli. This 
expression system is a powerful tool for the analysis of Ephl mutants (e.g. Glu359Asp) 
created by protein engineering. Furthermore, it is a simple system for studying the 
substrate range of mutant Ephl. In addition, the Ephl aa sequence information may be 
helpful to clone other yeast EH-encoding genes. 
Recently, we have isolated the EH-encoding gene from the yeast Rhodotorula 
glutinis using the X. dendrorhous Ephl sequence information (37). Comparison of aa 
sequences and substrate specificities might give new insights for protein engineering 
experiments. 
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ABSTRACT 
We cloned and characterized the epoxide hydrolase gene, EPH1, from Rhodotorula 
glutinis. The EPH1 open reading frame of 1230 bp was interrupted by 9 introns and 
encoded a polypeptide of 409 amino acids with a calculated molecular mass of 46.3-
kDa. The amino acid sequence was similar to that of microsomal epoxide hydrolase 
which suggests that the epoxide hydrolase of R. glutinis also belongs to the a/p 
hydrolase fold family. EPH1 cDNA was expressed in Escherichia coli and resting cells 
showed a specific activity of 200 nmol min"1 (mg protein)"1 towards 1,2-epoxyhexane. 
INTRODUCTION 
Epoxide hydrolases (EHs) catalyze the hydrolysis of epoxides to their 
corresponding diols without the need for a cofactor. EHs have great potential in bio-
organic synthesis of fine chemicals. The enantioselective hydrolysis of racemic 
epoxides by EHs can result in enantiopure epoxides and vicinal diols which are both 
valuable intermediates in the pharmaceutical and agrochemical industries. These 
biocatalysts from microbial origin have already been shown to be applicable in fine 
organic chemistry (Archelas and Furstoss 1998). 
Mammalian EHs have been studied in great detail because of their central role in 
the detoxification of xenobiotic compounds in the liver (Oesch 1973). Genes encoding 
EHs have been cloned from various sources e.g. mammals, plants, insects and bacteria. 
Based on amino acid sequence homology studies, these EHs were classified as 
members of the a/p hydrolase fold family of enzymes which are structurally, 
functionally and mechanistically related (Ollis et al. 1992, Arand et al. 1994). 
Moreover, the X-ray structure of bacterial soluble EH (sEH) confirmed that this enzyme 
is an a/p hydrolase fold enzyme (Nardini et al. 1999). Furthermore, the members of the 
catalytic triads from soluble (sEH) and microsomal (mEH) EHs have been determined 
(Arand et al. 1996, Rink et al. 1997, Arand et al. 1999). 
In contrast to the EHs described above, the information about EHs from yeasts 
(Weijers and de Bont 1999) is limited at the molecular level. Botes and co-workers 
(1998) screened 187 yeast strains from 25 genera for the hydrolysis of 1,2-epoxyoctane. 
From the 54 EH positive yeast strains only 8 strains, belonging to the basidiomycetous 
genera Trichosporon, Rhodotorula and Rhodosporidium, showed asymmetric 
hydrolysis of the epoxide. Rhodotorula glutinis, a red pigmented yeast, is able to 
convert a broad range of epoxides of which some with high enantioselectivity (Weijers 
1997). The purification of an EH from R. glutinis strain CIMW 147 was recently 
reported by Kronenburg et al. (1999). 
The properties of the R. glutinis EH make this enzyme a candidate biocatalyst for 
the preparative-scale epoxide hydrolysis in fine chemistry. Its application is even more 
likely if the EH-encoding gene is cloned and over-expressed in a suitable host. In 
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addition, mutant EHs showing optimal activity and enantioselectivity for an epoxide of 
interest can be developed via protein engineering. Therefore, we isolated and 
characterized the EH encoding gene from R. glutinis strain CTMW 147 and over-
expressed it in E. coli. 
MATERIALS AND METHODS 
Strains, plasmids and DNA manipulations 
R. glutinis strain ATCC 201718 (formerly known as strain CTMW 147, Weijers 
1997) was used as a source for the EH gene. E. coli strain XLl-Blue-MRF' (Stratagene) 
was used for transformation and expression experiments. The vector pGEM-T Easy 
(Promega) and the prokaryotic expression vector pKK223-3 (Pharmacia) were used for 
cloning and expression experiments respectively in E. coli. If not stated otherwise 
standard molecular cloning techniques were used (Sambrook et al. 1989). Isolation of 
plasmid DNA from E. coli was performed using Qiagen columns (Westburg BV, 
Leusden, The Netherlands). Isolation of DNA trapped in agarose gel was performed 
using the QIAEX II Gel Extraction Kit (Westburg BV, Leusden, The Netherlands). 
Total RN A isolation from R. glutinis 
R. glutinis was cultivated at 30°C in 200 ml glucose containing medium (Weijers 
1997) to an OD660 = 1- Cells were harvested by centrifugation (16,300 x g, 5 minutes, 
4°C) and washed in cold sterile water. The cell pellet was resuspended in a minimal 
volume of cold sterile water. This cell suspension was transferred to a mortar 
containing liquid nitrogen. Cells were broken by grinding the frozen cell suspension. 
Total RNA was extracted from the broken cells using RNAzol (Cinna/Biotecx 
Laboratories International inc., Texas, USA) and dissolved in diethyl pyrocarbonate 
(DEPC) treated water. 
Chromosomal DNA isolation from R. glutinis 
R. glutinis was cultivated at 30°C in 200 ml glucose containing medium (Weijers 
1997) to an OD660 = 7. Cells were harvested by centrifugation (16,300 x g, 5 minutes, 
4°C) and washed in cold sterile water. The cell pellet was resuspended in a minimal 
volume of cold sterile water. This cell suspension was transferred to a mortar 
containing liquid nitrogen and 1 gram of alumina type-A5 (Sigma). Cells were broken 
by grinding the frozen cell suspension. The broken cells were added to a centrifuge tube 
containing 5 ml of DNA extraction buffer (50 mM Tris, 10 mM MgCl2, 50 mM NaCl, 
1% (W/V) SDS, pH 7.4). Chromosomal DNA was isolated from this mixture by 
repeated phenol/chloroform extractions and an ethanol precipitation step. The co-
purified RNA was degraded by incubation with DNase free RNase A (10 ug/ml). A 
final phenol/chloroform extraction resulted in the purified chromosomal DNA 
preparation. 
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PCR and 573' RACE experiments 
Polymerase chain reactions were carried out in an automated thermal cycler (Perkin-
Elmer). The oligonucleotide primers used in this study are listed in table 1. The reaction 
conditions were: 5 min 94°C, followed by 30 cycles: 1 min 94°C, 1.5 min 45, 50 or 
55°C, 1 or 2.5 min 72°C, ending with 10 min 72°C. The 573' RACE Kit (Roche 
Diagnostics) was applied for the isolation of partial cDNA sequences of the R. glutinis 
EH. 
EH enzyme assay 
E. coli [pKK223-3] and E. coli [pKKRgEphl] were grown overnight at 37°C in 50 
ml Luria-Bertani (LB) medium supplemented with ampicillin (50 ug/ml) and isopropyl-
(3-D-thiogalactopyranoside (IPTG) (0.84 mM). Cells were harvested by centrifugation 
(1,000 x g, 10 minutes, 4°C) and washed in 50 mM potassium phosphate buffer (pH 
7.0). Concentrated cell suspensions were mixed with 20 mM 1,2-epoxyhexane 
(Aldrich) by vortexing in sealed tubes and incubated shaking at 35°C in a waterbath. To 
monitor epoxide degradation headspace samples were taken over a period of time and 
were analyzed using GC analysis on a Chrompack CP9000 gaschromatograph equipped 
with a p-cyclodextrin 120 chiral column (Supelco). Protein contents were determined 
using the Bio-Rad DC Protein Assay. 
Sequence submission 
The EPH1 nucleotide sequence has been deposited in the GenBank database under 
accession number: AF172998. 
Table 1 Oligonucleotide primers used in the PCR experiments. 
Primer 
PEH1 
PP19.1 
SP3.1 
SP5.1 
SP5.2 
PdT 
PEHATG 
PEHTAG 
Sequence (5'-»3') 
CTBCAYGGWTGGCCNGGHTCNTT 
AARTGVCCVCCCTCSGGVGCGTC 
CGTCGCCCCTTCGATGCCTG 
TCATGAGCTTGTCGAAGACCC 
CCAGGCATCGAAGGGGCGACG 
CCCCCCCTCGAGTTTTTTTTTTTTTTTTTT 
TTTTGAATTCATGGCGACACACACATTCGC 
AGCTCTGCAGCTACTTCTCCCACATGACGCC 
Restriction sites for subcloning purposes are underlined. B: C, T or G. Y: C or T. W: A or T. N: A, C, T or 
G. H: A, C or T. R: A or G. V: A, C or G. S: C or G. 
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RESULTS 
Isolation of a chromosomal EH encoding DNA fragment ofR. glutinis by PCR 
Oligonucleotide primer PP19.1 was derived from the amino acid sequence from R. 
glutinis EH peptide P19 (Kronenburg et al. 1999) and oligonucleotide primer PEH1 
was derived from the A. niger EH amino acid sequence (R. Furstoss and M. Arand, 
personal communication). A 1.3 kb fragment was amplified in a PCR using primers 
PP19.1 and PEH1 and chromosomal DNA of R. glutinis as template. This fragment was 
cloned into pGEM-T Easy, yielding pRGEHl, and the nucleotide sequence was 
determined. The deduced amino acid sequence contained sequences resembling those of 
peptides P16: GPAYGVMQQLTP(E)(D)F, P27: YHLHNFASK(S)(G)(R) and P30: (S 
or T or Y)IGTSFLPVSLNPHF from the purified R. glutinis EH (Kronenburg et al. 
1999). These results suggested that a 1.3 kb fragment of the putative R. glutinis EH 
encoding gene, denominated EPH1, was cloned. 
Isolation of the EPH1 gene 
Specific R. glutinis EH primers, SP3.1, SP5.1 and SP5.2 were designed based on 
the protein encoding nucleotide sequence of pRGEHl. These primers were applied in 
the method of rapid amplification of cDNA ends (RACE) using the 573' RACE kit and 
total R. glutinis RNA. The Oligo dT-Anchor primer (573 RACE Kit) and primer SP5.1 
were used in a first round of PCR in the 5' RACE reaction. Subsequently, a 479 bp 
fragment was amplified in a second round of PCR using nested primer SP5.2 and an 
aliquot of the first round PCR reaction mixture as template. The 3' RACE reaction 
using primers SP3.1 and PdT resulted in the amplification of a 908 bp DNA fragment. 
These fragments were cloned into pGEM-T Easy resulting in pEH479 and pEH908 
respectively and their nucleotide sequences were determined. The overlapping cDNA 
fragments in pEH479 and pEH908 were used to reconstruct a full length EH encoding 
cDNA. It contained an open reading frame (ORF) of 1230 bp corresponding to a 
polypeptide of 409 amino acids. The calculated molecular mass of 46,295 Da was in 
agreement with the molecular mass of approximately 45 kDa observed by Kronenburg 
et al. (1999). 
To clone the chromosomal copy of the R. glutinis EH gene oligonucleotides 
PEHATG and PEHTAG were designed based on the terminal sequences of the EPH1 
ORF. A 1825 bp fragment was amplified in a PCR using primers PEHATG and 
PEHTAG and chromosomal DNA as template. This fragment was ligated into pGEM-T 
Easy yielding pRGEH2. Comparison of the pRGEH2 nucleotide sequence with that of 
EPH1 cDNA revealed that the EPH1 ORF was interrupted by 9 introns varying in size 
between 52 and 95 bp (Figure 1). 
The two highest scores of a comparison of the deduced Ephl amino acid sequence 
to the SwissProt protein database by BLAST search corresponded to human mEH 
(Skoda et al. 1988), accession number (ace. no.): P07099, 32% identity and rat mEH 
(Porter et al. 1986), ace. no.: P07687, 31% identity. 
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Functional expression of EPH1 in E. coli 
The first-strand cDNA synthesis reaction mixture from the 3' RACE experiment 
was used as a template in a PCR using the primers PEHATG and PEHTAG in order to 
overexpress a full length EPH1 cDNA in E. coli. A fragment of 1250 bp was amplified, 
purified, digested with endonucleases EcoRl and Pstl and ligated in the corresponding 
restriction sites of the prokaryotic expression vector pKK223-3 resulting in 
pKKRgEphl. Plasmid pKKRgEphl was introduced into E. coli by electroporation and 
transformants, designated as E. co//[pKKRgEphl], were analyzed for epoxide hydrolase 
activity using 1,2-epoxyhexane as a substrate. Resting cells of E. co//'[pKKRgEphl] 
converted 1,2-epoxyhexane at an initial reaction rate of 200 nmol min"1 (mg protein)' . 
As expected, no EH activity could be detected using E. co/z'[pKK223-3]. Comparison of 
cell free extracts of E. co/i[pKK223-3] and E. co//[pKKRgEphl] by SDS-PAGE 
showed no accumulation of a 46 kDa protein (results not shown). 
DISCUSSION 
R. glutinis Ephl is a putative a/p hydrolase fold EH 
The conserved catalytic triad of a/p hydrolase fold enzymes consist of a 
nucleophilic residue (Asp or Ser), an acidic residue (Asp or Glu) and a perfectly 
conserved histidyl residue (Ollis et al. 1992). The nucleophile fits to the conserved 
amino acid sequence motif: sxnsxx, where s is a small amino acid, x any amino acid 
and n the nucleophilic amino acid (Ollis et al. 1992). However, no clear motifs are 
present for the catalytic acidic and histidyl residues although in mEHs the catalytic His 
is situated in the amino acid sequence GGHFAA at the C-terminal end of the enzyme. 
Another conserved amino acid sequence is the HGXP motif containing the oxyanion 
hole of the enzyme (Ollis et al. 1992, Lacourciere and Armstrong 1994). In mammalian 
and plant sEHs the X of the HGXP motif is a Phe residue whereas in the mEHs and 
bacterial sEH it is a Trp residue. 
Figure 1 (opposite page). Nucleotide sequence and deduced amino acid sequence of R. glutinis EPH1. 
The EPH1 nucleotide sequence is given in lowercase letters. The deduced amino acid sequence is given 
in the one letter code below the nucleotide sequence. Introns have been numbered and are indicated 
between brackets. The TAG stop codon is indicated by an asterisk. The regions corresponding to 
oligonucleotides SP5.1 and SP5.2 are indicated by arrows below the nucleotide sequence. The region 
corresponding to oligonucleotide SP3.1 is indicated by an arrow above the nucleotide sequence. 
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atggcgacacacacattcgcttcgcctcccacccgcttcaccgtcgacatcccacagtcg 60 
M A T H T F A S P P T R F T V D I P Q S 20 
gaactcgacgaacttcactcgcgactcgacaagacccgctggccggcgacagagatcgtt 12 0 
E L D E L H S R L D K T R W P A T E I V 40 
ccagaggatgggacggacgatccgacggcgtttgggctcggagcagggccgacgctgccg 180 
P E D G T D D P T A F G L G A G P T L P 60 
ctcatgaaggaattggcgaagggttggcgcgagttcgactggaaaaaggcgcaggaccac 240 
L M K E L A K G W R E F D W K K A Q D H 80 
ctcaacacgtacgggggcttcccaccctctttcgccttgtagtctcgctgacaggttctc 3 00 
L N T[ intron 1 83 
ataacccgcagcttcgagcactacatggtcgaaattgaggacctctcgatccacttcctc 36 0 
] F E H Y M V ^ E I E D L S I H F L 99 
caccatcgctcgactcgcccgaacgctgttcccctcatcctctgccacggctggccaggc 420 
H H R S T R P N A V P L I L C H G W P G 119 
cactttggcgagttcctgaacgttatcccgctcttgacggagccgtcggacccctccgct 4 80 
H F G E F L N V I P L L T E P S D P S A 139 
(SP3.1) 
caggcgttccacg\cgtcgccccttcgaCgcctggctatgcttggtctttgcctcctccg 540 
•^ (SP5.2) 
Q A F H V V A P S M P G Y A W S L P P P 159 
tcctccaagtggaacatgtgcgttcctttaattcaatcgtctcttctggcgtgactgatc 6 00 
S S K W N M[ intron 2 165 
catcccgtttgccaggcctgacaccgcgagggtcttcgacaagctcatgaccgggcttgg 660 
(SPS.l) 
] P D T A R V F D K L M T G L G 180 
c t a c g a g a a g t g c g t c t a c c c g t t c c g c g a c g c t t c t t g a g c t t t c c c c g g a c a c g c a a g 720 
Y E K[ i n t r o n 3 183 
gcgatgctgatagtgcaactcggcaggtacatggcgcagggcggagactggggaagcatc 780 
] Y M A Q G G D W G S I 194 
gccgctcgctgccttggatcgctgcacaaggaccattgcaaaggttcgtcccatcgggtc 840 
A A R C L G S L H K D H C K [ 208 
ttcactcctcctcttcgtcttacccttcacttgacgttaagcgctcgagctaatacctcg 900 
intron 4 
aagtcggcgcaacccgcagccgtccacctcaacttcctccccgtcttcccacccgtcccg 960 
] A V H L N F L P V F P P V P 222 
atgtggcttatcaacccgcacacgctccttgcctgggcaccgcgcttcctcgtgccggag 1020 
M W L I N P H T L L A W A P R F L V P E 242 
aagcaggctgcgcgtatgaagcgcgggttggcgtaccttgagaaggggtgagtcgcagcg 1080 
K Q A A R M K R G L A Y L E K G[ 258 
caggtctcgcgtttccgtagaaagtcctgacaggtcctcctcgtcttgcctcaacgcagc 114 0 
i n t r o n 5 ] 
tccgcctactacgtcatgcagcagttgacggcaagctcagcgaagtctgcattgggaagc 1200 
S A Y Y V M Q Q L T [ i n t r o n 6 268 
aaagctgaccctccgacgcccgcagcctcgcacgcctgcgtacggcctgaccgacagtcc 1260 
] P R T P A Y G L T D S P 280 
cgtcggcttgctggcctggatcggcgagaaggtgcgtcctttcctcatcagcacaagctc 1320 
V G L L A W I G E K [ i n t r o n 7 290 
gaagctgattcgtgagcgtgcagttcgagccgaccattcaggaggcgagcaagcaagccc 13 80 
] F E P T I Q E A S K Q A 302 
agccgacgtacgttctcgccagtagctgccgctcgccgtcttcgctaatgccccgctgcg 1440 
Q P T[ intron 8 3 05 
cagcctgactcgcgacgagctctacttcacctgctcgctctactggttcagtgcgtcgac 1500 
--] L T R D E L Y F T C S L Y W F [ 320 
tccgcacctcccatcgtcgcgcccactgacactaagccgctcctcccaccacacagcccg 1560 
intron 9 ]T R 322 
ctcaatcggcacctccttccttccctactcgctcaacccgcacttcaccaccttcctgac 1620 
S I G T S F L P Y S L N P H F T T F L T 342 
cgacagcaagtaccacctgcccaactttgccctctcgctttacccaggcgagatctactg 1680 
D S K Y H L P N F A L S L Y P G E I Y C 362 
ccccgccgagcgggacgccaagcgcaccggcaacctcaagtggatcaaggacgcgcctga 174 0 
P A E R D A K R T G N L K W I K D A P E 382 
gggaggacactttgctgcgctcgaaaagccggatgtgtttgtcgagcacctcagggaggc 1800 
G G H F A A L E K P D V F V E H L R E A 402 
g t t t g g c g t c a t g t g g g a g a a g t a g 1825 
F G V M W E K * 409 
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Ephl M ATHTF ASPPTR FTVDIPQSELDELHS 28 
I I I I I I II 
RTmEH MWLELVLASLLGFVIYWFVSRDKEETLPLGDGWWGPGSKPSAKEDESIRPFKVETSDEEIKDLHQ 6 5 
Ephl RLDKTRWPATEIVPEDGTDDPTAFGLGAGPTLPLMKELAKGWR-EFDWKKAQDHLNTFEHYMVEI 93 
I I I I I I II II M M I II I I 
RtmEH RIDRFR ASPPLEGS- -RFHYGFNSN YMKKWSYWRNEFDWRKQVEILNQYPHFKTKI 120 
HGXP 
Eph l EDLSIHFLHHRSTR PNAVPLILCHGWPGHFGEFLNVIP.LLTEPSDPS AQAFHWAPSM 151 
I I I I ! I II M i l l I II M i l l I I I II 
RtmEH EGLDIHFIHVKPPQLPSGRTPKPLLMVHGWPGSFYEFYKIIPLLTDPKSHGLSDEHVFEVICPSI 185 
sxnxss 
Ephl PGYAWSLPPPSSKWNMPDTARVFDKLMTGLGYEKYMAQGGDWGSIAARCLGSLHKDHCKAVHLNF 216 
III I I III I M M II I l l l l l l l I I III 
RtmEH PGYGYSEASSKKGLNSVATARIFYKLMTRLGFQKFYIQGGDWGSLICTNMAQMVPNHVKGLHLNM 250 
Ephl LPVFPPVPMWLINPHTLLA-WAPRFLV-PEKQAARM KRGLAY-LEKGSAYYVMQQLTPRTPA 275 
I III III I I I M i l l 
RtmEH --AFISRSFYTMTP--LLGQRFGRFLGYTGKDIELLYPYKEKVFYSIMRESGYLHIQATKPDTVG 311 
Ephl YGLTDSPVGLLAWIGEKFEP-TIQEASKQAQPTLTR DELYFTCSLYWFTRSIGTS--FLPY 33 3 
I MIMI l l l l l l l I I I I II I I I 
RtmEH CALNDSPVGLAAYILEKFSTWTKSEYRELEDGGLERKFSLDDLLVNIMIYWTTGTIVSSQRYYfCE 376 
A H 
Ephl SLNPHFTTFLTDSKYHLPNFALSLYPGEIYCPAERDAK-RTGNLKWIKDAPEGGHFAALEKPDVF 3 97 
I I I I I I M I M I I I 
RtmEH NLGEGIMVHKHEGMKVFVPTGFSAFPSELLHAPEKWVKVKYPKLISYSYNERGGHFAAFEEPKLL 441 
Ephl VEHLREAFGVMWEK 411 
I 
RtmEH AQDIRKFVSLAELQ 455 
Figure 2 Amino acid comparison of R. glutinis EH and rat mEH. The amino acids are given in the one 
letter code. Ephl , R. glutinis Ephl . RTmEH, rat mEH. |, identical amino acid residues at that position. 
HGXP, HGXP motif, sxnxss, nucleophile motif (see text). A, catalytic acidic residue. H, catalytic 
histidine.Other oc/p hydrolase folded microbial EH encoding genes have been cloned from Agrobactehum 
radiobacter AD1 (Rink et al. 1997) and a Corynebacterium sp. (Misawa et al. 1998). These genes encode 
sEHs with subunit sizes of 34 and 32 kDa respectively. The sequence similarity of Ephl to mEHs (this 
study) and enzyme localization studies (Kronenburg et al. 1999) indicate that the 46 kDa EH of R. glutinis 
is a membrane-associated EH. 
Several of these characteristics were also found in the Ephl amino acid sequence 
(Figure 2). The Ephl amino acid sequence GGD190WGS fits perfectly to the 
nucleophile motif and is identical to the amino acid sequence flanking the catalytic 
nucleophile of rat mEH (Arand et al. 1999). Ephl Glu359 aligns to the catalytic acidic 
residue of rat mEH. At the Ephl C-terminus the sequence GGH385FAA is found which 
resembles the rat mEH sequence containing the catalytic histidine. Therefore, the 
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putative catalytic triad of Ephl might consist of: Asp190, Glu359, His385. A Trp residue 
was found at the X position in the Ephl HGXP motif. These results suggest that the R. 
glutinis EH is an cc/p hydrolase fold enzyme. 
A novel non cc/p hydrolase folded bacterial EH, limonene-l,2-epoxide hydrolase, 
was found in Rhodococcus erythropolis DCL14 (van der Werf et al. 1998). It was 
estimated that a minimal molecular mass of 25 kDa is necessary to accommodate the 
reaction mechanism as used by the oc/p hydrolase folded EHs. 
Therefore, the 17 kDa limonene-l,2-epoxide hydrolase of/?, erythropolis DCL14 is 
too small to belong to the a/p hydrolase folded EHs (van der Werf et al. 1998). 
The amino acid sequence did not show similarity to other EHs or to any other 
sequence in protein databases (Barbirato et al. 1998). Furthermore, the imidazole-
modifying compounds 2-bromo-4'-nitroacetophenone and diethylpyrocarbonate did not 
affect limonene-l,2-epoxide hydrolase activity which suggests that, unlike in a/p 
hydrolase folded EHs, no catalytic histidine is involved in this enzyme (van der Werf et 
al. 1998). 
Ephl in biocatalysis 
EPH1 was expressed in E. coli and resting cells showed a high specific activity of 
200 nmol min"1 (mg protein)"1 towards 1,2-epoxyhexane. This activity is 1.7 times 
higher as compared to R. glutinis cells (120 nmol min"1 (mg protein"1), Kronenburg et 
al. 1999). Previously, bacterial EH encoding genes have been expressed successfully in 
E. coli. The echA gene of A. radiobacter AD1 was expressed under control of a T7 
promoter in a soluble and active form up to 40% of the total cellular protein content of 
E. coli BL21(DE3) (Rink et al. 1997). The HmA gene of R. erythropolis DCL14 was 
expressed by the endogenous promoter in E. coli DH5a. However, a 30 times lower 
specific enzyme activity was observed as compared to R. erythropolis DCL14 
(Barbirato et al. 1998). 
The improved EH activity of the recombinant E. coli as compared to R. glutinis and 
the obtained sequence information of EPH1 opens the way to conduct protein 
engineering experiments in order to furnish a R. glutinis mutant Ephl with desired 
properties. The over-expression of such a mutant EH could result in large amounts of 
an efficient epoxide biocatalyst. 
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ABSTRACT 
The Rhodotorula glutinis epoxide hydrolase, Ephl, was produced in the 
heterologous host Escherichia coli BL21(DE3) in order to develop a highly effective 
epoxide hydrolysis system. A 138-fold increase in Ephl activity was found in cell 
extracts of the recombinant E. coli when compared to cell extracts of Rhodotorula 
glutinis, despite the formation of Ephl inclusion bodies. Optimization of cultivation 
conditions and co-expression of molecular chaperones resulted in a further increase in 
activity and a reduction of the inclusion bodies formation. Compared to Rhodotorula 
glutinis cells and cell extracts, a total increase in Ephl activity of over 200 times was 
found for both fermenter-cultured E. coli cells and crude enzyme preparations of 
fermenter-cultured E. coli cells, without loss of enantioselectivity. The improved 
conditions for recombinant Ephl production were used to demonstrate the Ephl-
catalyzed kinetic resolution of a new Ephl substrate, l-oxa-spiro[2.5]octane-2-
carbonitrile. 
INTRODUCTION 
Enantiopure epoxides and their corresponding enantiopure diols are important 
chiral building blocks in the preparation of more complex enantiopure biologically 
active compounds or as end products with biological activity. Therefore, a great interest 
exists in the development of methods for the synthesis of enantiopure epoxides and 
diols. An interesting approach is to use a biocatalytic process that involves the epoxide 
hydrolase (EH) catalyzed racemic resolution of epoxides. These enzymes are 
enantioselective in the cofactor-independent hydrolysis of structurally divergent 
epoxides (1, 26). 
EHs catalyze the hydrolysis of epoxides to the corresponding diols. These enzymes 
are found in both prokaryotic and eukaryotic organisms where they have different 
functions. For example, the intensively studied microsomal EH of mammals is a liver 
enzyme involved in the detoxification of noxious epoxides (16, 18). The limonene-1,2-
EH from the bacterium Rhodococcus erythropolis DCL14, on the other hand, is 
involved in the limonene degradation pathway of this organism (21). Also several 
basidiomycetous yeast species possessing EH activity have been described (2) but a 
biological function of yeast EH has not been revealed yet. 
The EH of the red-colored yeast Rhodotorula glutinis is an enzyme that can accept 
a broad range of substrates, which are hydrolyzed with moderate to high 
enantioselectivities (24, 25). These enzyme characteristics are very interesting for the 
development of a commercial process for the production of enantiopure epoxides and 
diols. However, to enable the application of a R. glutinis EH for preparative purposes 
an increase in EH activity is desired. Attempts to improve the enzyme's production 
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level in R. glutinis by searching for conditions that would induce EH gene expression 
have failed so far (C. A. G. M. Weijers, personal communication). 
Recently the EH-encoding gene, EPH1, from R. glutinis was isolated. EPH1 
function was demonstrated by its expression in Escherichia coli (23). The isolation of 
EPH1 allows the development of Ephl overproducing strains by genetic engineering. 
In this paper we report the construction and analysis of an R. glutinis Ephl 
overproduction system. 
MATERIALS AND METHODS 
Strains, plasmids and DNA manipulations 
Escherichia coli strains BL21(DE3) and BL21(DE3)pLysS, and plasmid pET28a(+) 
were purchased from Novagen Inc. (Madison, WI, USA). The plasmids pTfl6, pG-Tf2 
and pG-KJE8 were a gift from Professor Takashi Yura (14). E. coli strain XL1-
BlueMRF' (Stratagene, La Jolla, CA, USA) was used for general cloning purposes. If 
not stated otherwise standard molecular cloning techniques were used (17). The R. 
glutinis epoxide hydrolase-encoding region (1.2 kb) was released from plasmid 
pKKRgEphl (23) with endonucleases EcoRl and Hindlll. This fragment was cloned in 
frame to a (N-terminal) His-tag encoding sequence in the corresponding sites of 
plasmid pET28a(+) resulting in plasmid pEphl. 
The preparation of electro-competent E. coli cells and the transformation of these 
cells by electroporation was preformed as described previously (22). After 
transformation of E. coli BL21(DE3)(pEphl) cells with pTfl6, pG-Tf2 or pG-KJE8 
positive colonies were selected from Luria-Bertani (LB) agar plates containing both 
kanamycin (50 ug/mL) and chloramphenicol (20 |ag/mL). 
Expression of EPH1 
A single E. coli BL21(DE3)(pEphl) colony was taken from a LB agar plate, 
supplemented with kanamycin (50 ug/mL), and used to inoculate 50 mL LB medium in 
a 250 mL Erlenmeyer flask. This inoculum was incubated at 37°C and 200 revolutions 
per minute (rpm) until the optical density at 600 nm (OD600) reached 0.5-1. Two mL of 
this pre-culture were used to inoculate a 50 mL culture. This culture was grown at 37°C 
and 200 rpm until OD600 reached 0.5-1 and subsequently EPH1 gene expression was 
induced by adding 1 mM isopropyl-P-D-thiogalactopyranoside (IPTG, Diagnostic 
Chemicals Limited, UK). After an additional 3 hours of incubation the cells were 
harvested by centrifugation at 4°C and 20,000 x g for 5 minutes and washed with 50 
mM potassium phosphate (KPi) buffer (pH 7). The cells were resuspended in 5 mL KPi 
buffer. A cell extract was prepared by sonication (5 minutes, duty cycle 30%, output 
control 3) using a Branson sonifier 250. To separate the cell extract in a soluble (S-) 
and insoluble (P-) fraction the disrupted cells were centrifuged for 10 minutes at 4°C 
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and 20,000 x g. The pellet, containing cell debris and insoluble proteins, was 
resuspended in an equal volume of KPi buffer. 
Fermentation conditions 
Five hundred mL of LB medium, supplemented with 50 (xg/mL kanamycin, was 
inoculated with E. coli BL21(DE3)(pEphl). This pre-culture were incubated for 16 
hours at 200 rpm and 37°C and used to inoculate a 15 L fermenter (Applikon, 
Schiedam, The Netherlands), which was filled with 10 L of LB medium supplemented 
with 50 |xg/mL kanamycin, to an OD600 of 0.2. The fermenter content was kept at pH 7, 
stirred by two impellers (250 rpm), cooled (21°C) and aerated (750 mL/min). At an 
OD600 of 0.65 IPTG was added to a final concentration of 100 (xM to induce gene 
expression. After 20 hours the cells were harvested by centrifugation at 10,000 x g for 
5 minutes and 4°C and a cell extract was prepared as described above. 
Ephl assay 
Suspensions of whole cells, cell extract, S- or P-fractions in KPi buffer were pre-
incubated in sealed tubes for 5 minutes at 35°C and 250 rpm in a waterbath. The 
reaction was started by addition of 10 mM 1,2-epoxyhexane and incubated at 35°C and 
250 rpm. To monitor epoxide degradation headspace samples were taken over a period 
of time and were analyzed using GC analysis on a Chrompack CP9000 gas 
chromatograph equipped with a P-cyclodextrin 120 chiral column (Supelco, 
Zwijndrecht, The Netherlands). Protein contents were determined using the Bio-Rad 
DC Protein Assay (Bio-Rad Laboratories BV, Veenendaal, The Netherlands). Specific 
enzyme activities were expressed as units per mg of protein U (mg protein)"1. One unit 
is equivalent to 1 (imol of epoxide converted per minute. 
l-Oxa-spiro[2.5]octane-2-carbonitrile analysis 
Hydrolysis of l-oxa-spiro[2.5]octane-2-carbonitrile was analyzed by the same gas 
chromatography method as was described for styrene oxide hydrolysis analysis by R. 
glutinis (24). However, the oven temperature of the gas chromatograph was set at 
120°C instead of 85°C. 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE analysis was performed according to Laemmli (12). In brief, the 
protein composition of samples was analyzed by separation on SDS-PAGE (12.5%) 
gels using a Hoeffer Mighty Small system (Pharmacia, Roosendaal, The Netherlands). 
After electrophoresis the separated proteins were stained with Bio-Safe Coomassie 
Stain (Bio-Rad). The broad range Precision Protein Standard (Bio-Rad) was used to 
estimate protein size. The Quantity one 4.2.1. software package (Bio-Rad) was used to 
prepare digital images of the gels. 
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RESULTS 
Expression of recombinant Ephl 
The T7 polymerase-based E. coli expression system (pET-System™, Novagen, 
Madison, WI, USA) was chosen because this system can result in the production of 
high levels of heterologous proteins. The R. glutinis Ephl encoding DNA sequence was 
cloned into pET28a(+), yielding plasmid pEphl, in such a manner that upon expression 
a fusion-protein consisting of Ephl with an additional N-terminal histidine-tag would 
be produced. This tag was added to facilitate purification of recombinant Ephl by metal 
affinity chromatography. Plasmid pEphl was introduced into E. coli BL21(DE3) by 
electrotransformation resulting in strain BL21(DE3)(pEphl). EPH1 gene expression 
was induced for 3 hours at 37°C in LB medium containing 1 mM IPTG. Analysis of 
whole cells of E. coli BL21(DE3)(pEphl) using the Ephl assay revealed epoxide 
hydrolase activity towards model substrate 1,2-epoxyhexane, whereas no epoxide 
hydrolase activity could be detected in strain BL21(DE3) carrying plasmid pET28a(+). 
SDS-PAGE analysis of whole cell lysates of E. coli BL21(DE3)(pEphl) and E. coli 
BL21(DE3)(pET28a(+)) showed a protein band of ± 50 kDa only in the lane carrying 
E. coli BL21(DE3)(pEphl) material indicating the presence of recombinant Ephl (data 
not shown). The molecular weight of this band corresponds very well with the 
predicted molecular weight of recombinant Ephl based on the amino acid sequence. 
Subsequently, the cells were disrupted and the soluble proteins (S-fraction) were 
separated from the insoluble proteins (P-fraction) by centrifugation and both fractions 
were analyzed for EH activity. The S-fraction showed an activity of 1.5 U (mg protein)" 
' whereas no EH activity could be detected in the P-fraction. In the SDS-PAGE 
separated S-fraction of these cells no 50 kDa protein band, corresponding to the Ephl 
protein, was distinguishable from the other proteins. Apparently, the amount of soluble 
Ephl was below the detection limit. Although no Ephl activity was measured in the P-
fraction the majority of recombinant Ephl was present in the P-fraction (Fig. 1). It is 
likely that most of the Ephl protein is deposited in an inactive form in inclusion bodies. 
Manipulation of the EPH1 expression level 
The high level expression of heterologous genes in E. coli often results in the 
deposition of the recombinant protein in inclusion bodies. In particular, overproduced 
proteins from eukaryotic sources undergo this problem (9). Because of the high amount 
of Ephl in the inclusion bodies we searched for conditions that would result in more 
Ephl in an active form. One approach was to decrease EPH1 expression (production 
rate) and thereby allowing proper folding of Ephl by the cell's protein folding 
machinery. Three parameters were tested: the temperature of cultivation, the expression 
ofEPHl in E. coli strain BL21(DE3)pLysS and the concentration of inducer IPTG. 
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Figure 1. Coomassie stained protein gel loaded with E. coli BL21(DE3)(pEph1), which was cultured at 
different temperatures. M, protein precision marker. The molecular weights of three marker proteins 
covering the area of interest are indicated on the left of the gel. S, soluble fraction of a cell extract. P, 
insoluble fraction of a cell extract. The arrow at the right indicates the position of the Eph1 band. 
Temperature effect 
It has been shown that expression of heterologous genes in E. coli at temperatures 
lower than 37°C can reduce the formation of inclusion bodies (13, 19). Therefore, 
recombinant EPH1 gene expression was, in addition to 37°C, also tested at 30°C and 
21°C. The specific activity in the S-fractions of E. coli BL21(DE3)(pEphl) could be 
increased 10 times, from 1.5 to 15 U (mg protein)"1 by lowering the temperature from 
37°C to 21°C. Furthermore, SDS-PAGE analysis of the S-fractions showed an 
increasing level of a 50 kDa protein, whereas no significant changes were observed in 
the composition of the total protein content in cells cultivated at lower temperatures. 
However, the Ephl bands present in the P-fractions were still of the same intensity 
(Fig. 1). 
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EPH1 expression in E. coli BL21(DE3)(pLysS)(pEphl) 
An alternative approach to prevent inclusion body formation was to lower the 
expression level of the T7 promoter. Therefore, plasmid pEphl was introduced into E. 
coli strain BL21(DE3)(pLysS) and the resulting strain was denominated 
BL21(DE3)(pLysS)(pEphl). This strain contains plasmid pLysS, which provides the 
cell with a small amount of T7 lysozyme upon expression. T7 lysozyme inhibits T7 
RNA polymerase directed gene expression by binding to T7 RNA polymerase (15). 
Expression of EPH1 was performed at 21 °C with 1 mM IPTG. The specific Ephl 
activity in the S-fraction was 1 U (mg protein)"1. SDS-PAGE analysis revealed the 
absence of Ephl aggregates in the P-fraction but also of soluble Ephl in the S-fraction 
(data not shown). Apparently, the overall level of Ephl produced was very low. 
IPTG concentration effect 
Initially, in our experiments 1 mM IPTG was used to induce EPH1 gene 
expression. However, a lower IPTG concentration might also result in a decreased level 
of EPH1 expression. A lower EPH1 expression level could give the cell more time to 
properly fold Ephl molecules resulting in less inclusion body formation and an 
increased level of soluble Ephl. Therefore, expression of EPH1 was carried out at 21°C 
with different concentrations of IPTG. The results showed that between 100 (iM and 
1,000 uM IPTG there is very little difference in specific enzyme activity. Protein 
analysis by SDS-PAGE showed no difference in the amount and distribution of Ephl 
between the S- and P-fractions. At an IPTG concentration lower than 100 uM an 
overall decrease in enzyme activity was observed. 
Co-expression of molecular chaperones 
The purpose of the experiments described above was to lower EPH1 gene 
expression and therefore to give the cell's folding machinery more time to fold newly 
synthesized Ephl correctly. Another approach to obtain an elevated level of soluble 
Ephl was based on the co-expression of molecular chaperones. The production level of 
nascent, partially (mis)folded recombinant Ephl intermediates is likely to be very high 
in the E. coli BL21(DE3)(pEphl) expression system. A lack of sufficient molecular 
chaperones to correctly fold the recombinant Ephl might be a reason for the 
accumulation of inactive Ephl molecules within inclusion bodies. To overcome this 
problem Ephl was overproduced together with different combinations of the 
endogenous chaperones DnaK-DnaJ-GrpE, GroEL-GroES and trigger factor (TF) (14). 
The folding chaperones DnaK-DnaJ-GrpE are e.g. involved in (i) preventing newly 
synthesized proteins to aggregate and (ii) in assisting off-pathway folding intermediates 
of a protein to reenter the proper folding pathway (4). The ribosome-bound trigger 
factor is the major protein associated with nascent polypeptides and it shows prolyl 
isomerase activity in vitro (5). The TF cooperates with GroEL in the degradation of 
abnormal proteins (7) and with DnaK in protein folding (3). 
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Figure 2. Coomassie stained protein gel of cell material corresponding to E. coli BL21(DE3)(pEph1) with 
or without (control) co-produced molecular chaperones at 37°C. The molecular chaperones are indicated 
above the lanes. Each sample was divided into a soluble (S) and an insoluble (P) fraction. M, protein 
precision marker. Arrows at the right of the gel indicate the molecular weights of three marker proteins 
covering the area of interest. The strong bands present in the P-fractions correspond to Eph1. Arrows at 
the left of the gel indicate the position of chaperones DnaK, GroEL and TF as well as Eph1. 
The expression of the molecular chaperones was induced at the start of the culture 
by the addition of arabinose or tetracycline as described by Nishihara et al. (14). In 
these induced chaperones cultures EPH1 expression was induced at OD6oo = 0-5 by the 
addition of 100 uM IPTG. 
The overproduction of molecular chaperones at 37°C was clearly visible by the 
high amounts of the chaperone proteins in the S-fraction of cells analyzed by SDS-
PAGE (Fig. 2). It should be noticed that none of the molecular chaperones were 
observed as inclusion bodies in the corresponding P-fractions. On the other hand, the P-
fraction of E. coli BL21(DE3)(pEphl) cells still contained the major portion of Ephl. 
Co-expression of the genes encoding DnaK-DnaJ-GrpE seemed to have some effect on 
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the formation of Ephl aggregates. In these cases the level of Ephl aggregates was 
reduced. However, all lanes containing the S-fractions of the various combinations did 
not reveal a significant increase in the amount of soluble Ephl. Moreover, in all 
combinations of expression of EPH1 in the presence of overproduced molecular 
chaperones the Ephl activity was reduced compared to the control (Table 1). 
Table 1. The effect of co-produced molecular chaperones on Ephl activity of the 
soluble fraction of E. coli BL21(DE3)(pEphl) cell extracts. 
Chaperones 
None (control) 
TF 
TF, GroEL, GroES 
GroEL, GroES 
DnaK, DnaJ, GrpE 
GroEL, GroES, DnaK, DnaJ, GrpE 
Relative activity (%)* 
37°C 21°C 
100 100 
7 94 
60 41 
55 70 
24 90 
40 35 
*, The Ephl activity of the control (no chaperones) was set at 100%. Activities of samples containing 
chaperones were compared to the control and given as a percentage thereof. 
As presented earlier, a shift in growth temperature from 37°C to 21°C resulted in a 
10-fold increase in soluble Ephl and Ephl activity. Therefore, the experiment using the 
overproduced chaperones was also conducted at 21°C. Under these conditions co-
expression of the molecular chaperones had a significant effect on the formation of 
inclusion bodies (Fig. 3). The coomassie stained protein gel showed that co-expression 
of TF with Ephl resulted in a slight decrease in the amount of Ephl inclusion bodies, 
whereas inclusion bodies were nearly absent when Ephl was produced together with 
TF and GroEL-GroES. This was also observed when EPH1 was expressed together 
with the chaperone team DnaK-DnaJ-GrpE and / or GroEL-GroES. However, the 
reduction in inclusion body formation did not result in an equivalent increase of soluble 
Ephl. Nevertheless, Ephl activity in presence of TF or DnaK-DnaJ-GrpE increased 
nearly to that of the control when the induction temperature was reduced to 21°C. High 
amounts of molecular chaperone proteins were clearly present in the lanes of a protein 
gel containing the S-fractions (Fig. 3). As a result of this, lower Ephl enzyme activities 
in presence of the molecular chaperones were found as compared to the control (Table 
1). 
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Figure 3. Coomassie stained protein gel of cell material corresponding to E. coli BL21(DE3)(pEph1) with 
or without (control) co-produced molecular chaperones at 21 °C. The molecular chaperones are indicated 
above the lanes. Each sample was divided into a soluble (S) and an insoluble (P) fraction. M, protein 
precision marker. Arrows at the right of the gel indicate the molecular weights of three marker proteins 
covering the area of interest. The strong band present in the P-fraction of the control corresponds to 
Ephl Arrows at the left of the gel indicate the positions of chaperones DnaK, GroEL and TF as well as 
Eph1. 
Increased cultivation volume 
The initial EPHI expression experiments described above were conducted at a 50 
mL scale in a 250 mL Erlenmeyer. The calculated total activity of the S-fraction 
obtained from cells cultivated at 21°C was 195 units for 1,2-epoxyhexane. To increase 
the absolute amount of active enzyme by using a larger cultivation volume, we also 
tested EPHI expression in a 450 mL culture in a 1 L Erlenmeyer and a 10 L culture in a 
15 L fermenter. The 450 mL culture was conducted in a similar way to that of the 50 
mL cultures incubated at 21°C and induced with 100 \iM of IPTG. The S-fraction of 
these cells showed the enantioselective hydrolysis of 1,2-epoxyhexane with an activity 
of 15 U (mg protein)"1, which is the same as obtained from 50 mL of cells. The 
calculated total activity from this batch was 2.6-103 units. Protein analysis showed that 
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most of the enzyme was present in the P-fraction in which no Ephl activity could be 
detected. 
The fermenter culture was induced at an OD600 of 0.65. After 20 hours of induction 
the OD60o had reached the value of 5. Both whole cells and the S-fraction of the cell 
extract of these cells were applied in the Ephl assay. The enantioselective 1,2-
epoxyhexane hydrolysis observed for the S-fraction was comparable to that of R. 
glutinis cell extracts (11). The activity of whole cells was 14 U (mg dw)"1, while the 
activity of the S-fraction was 23 U (mg protein)"1. The calculated total activities of 
these batches of biocatalysts were 2.8-105 and 1.7105 U respectively. Like in the other 
situations, the P-fraction of these fermenter-cultured cells contained most of the 
recombinant Ephl. 
The EPH1 over-expression system described in this paper was developed for the 
efficient hydrolysis of Ephl substrates, especially those for which R. glutinis exhibits 
low EH activity. An example of such a substrate is l-oxa-spiro[2.5]octane-2-
carbonitrile an interesting chiral building block and new R. glutinis Ephl substrate (Fig. 
4). 
O 
^ CN 
Figure 4. Structure of 1-oxa-spiro[2.5]octane-2-carbonitrile. 
R. glutinis showed an activity of 6-10" U (mg dw)" in the hydrolysis of 20 mM 1-
oxa-spiro[2.5]octane-2-carbonitrile. However, the activities of the fermenter-cultured 
E. coli BL21(DE3)(pEphl) cells and the S-fraction thereof were 6-10"2 U (mg dw)"1 and 
3 U (mg protein)"1 respectively. Importantly, in all three cases, the yield of the 
remaining enantiopure epoxide was more than 49%, while the maximal yield is 50%. 
DISCUSSION 
Previously, the R. glutinis Ephl encoding gene was expressed in E. coli using the 
prokaryotic expression vector pKK223-3 to demonstrate the function of the encoded 
enzyme (23). Compared to R. glutinis cells, a two-fold increase in enzymatic activity 
for the hydrolysis of 1,2-epoxyhexane was found with this expression system. The 
results reported here show a strong improvement of enzyme activity using the pET-
system. The enzyme activity for the hydrolysis of 1,2-epoxyhexane found in the E. coli 
BL21(DE3)(pEphl) S-fractions of 15 U (mg protein)"1 corresponds to a 138-fold 
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increase as compared to R. glutinis (11). Furthermore, fermenter-cultured cells showed 
that the activity had increased another 1.5 times to 23 U (mg protein)"1, probably as a 
result of better culture conditions. Therefore, a total increase in activity of over 200 
times was found for the E. coli BL21(DE3)(pEphl) S-fraction when compared to R. 
glutinis cell extract. A similar improvement was observed with whole E. 
co/i'BL21(DE3)(pEphl) cells versus R. glutinis cells as biocatalyst (25). 
Like other heterologous proteins produced in E. coli (13, 19) the majority of Ephl 
produced in E. coli BL21(DE3)(pEphl) is aggregated into inclusion bodies. It is likely 
that the rapid accumulation of Ephl folding intermediates causes the formation of these 
aggregates. Apparently, the cell's protein folding machinery is unable to keep up with 
this production rate probably due to the physical properties of Ephl and an insufficient 
level of molecular chaperones. 
The overproduction of molecular chaperones in E. coli clearly shows that it is 
possible for a cell to have a high concentration of one or a few soluble proteins without 
the formation of aggregates of the same proteins. Therefore, we tried to balance the 
Ephl production rate and the Ephl folding rate in order to gain more soluble Ephl. One 
approach was the decrease of EPH1 expression by lowering the cultivation 
temperature. A 10-fold increase in specific activity was found when Ephl expression 
was performed at 21°C instead of 37°C. However, the level of inclusion bodies was not 
affected. Other attempts to lower EPH1 expression by decreasing the concentration of 
the inducer IPTG and the use of E. coli strain BL21(DE3)(pLysS) were not successful. 
The other approach was to increase the cell's protein folding capacity by the 
overproduction of molecular chaperones. In general, the overproduced chaperones did 
not increase the amount of soluble active Ephl as was observed by protein gel 
electrophoresis and Ephl activity measurements. 
Mouse endostatin, human oxygen-regulated protein ORP150 and human lysozyme 
are proteins that are prone to aggregation when they were expressed in E. coli. 
Nishihara et al. (14) demonstrated that expression of these proteins in E. coli together 
with TF, GroEL-GroES and / or DnaK-DnaJ-GrpE could successfully prevent the 
formation of aggregates. However, although overproduced TF did prevent mouse 
endostatin to aggregate the total yield of mouse endostatin dropped by about 50%. 
Additionally, expression of GroEL-GroES together with mouse endostatin hardly 
increased the amount in the soluble fraction and reduced the total yield. 
A similar situation was encountered in case of Ephl. The chaperone teams DnaK-
DnaJ-GrpE and GroEL-GroES in particular showed a strong reduction in the level of 
Ephl inclusion bodies formation, without an equivalent increase in soluble Ephl. A 
proteolytic degradation event might explain this because molecular chaperones are 
involved both in protein folding as well as in protein degradation. Straus et al. (20) 
have shown that E. coli heat shock gene mutants (dnaK, dnaJ, grpE and groEL) were 
defective in proteolysis and thereby indicated a role of these proteins in this process. 
Moreover, they also showed that overproduction of heat shock proteins led to a more 
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rapid peptide degradation rate. Additionaly, chaperones GroEL, TF, and DnaJ are 
required for the degradation of abnormal proteins in E. coli (6,8). 
Regarding this information misfolded Ephl might also be degraded in the presence 
of overproduced molecular chaperones instead of being folded correctly. However, the 
molecular mechanisms behind the effects of the overproduced molecular chaperones on 
both active and aggregated inactive Ephl remain unclear. 
The recombinant Ephl carries an N-terminal histidine tag. The tag was added to 
facilitate the purification of recombinant Ephl by means of metal affinity 
chromatography. However, initial experiments to purify native recombinant Ephl using 
Ni(II)-loaded columns were not successful. Zou et al (27) reported the X-ray structure 
of the Aspergillus niger EH. The N-terminal meander of this soluble dimeric enzyme is 
involved in the formation of the homodimer. The R. glutinis EH was also found to exist 
as a homodimer (10). The primary stuctures of A. niger EH and R. glutinis Ephl are 
quite similar (29% identity, data not shown). Therefore, it might be possible that 
recombinant Ephl forms a homodimer involving the N-terminus. The histidine tags 
might therefore be inaccessible to the Ni(II)-loaded column. The histidine tags and the 
dimerization might also affect the formation of inclusion bodies in E. coli. 
Three cultivation volumes (50 mL, 450 mL and 10 L) were tested for Ephl yield. 
These cultivation set-ups were different from another and therefore one cannot speak of 
a real scale-up process. Nevertheless, the activity of 15 U (mg protein)"1 of the S-
fraction of shake flask cultured cells was further increased to 23 U (mg protein)"1 by 
cultivation of E. coli BL21(DE3)(pEphl) in a fermenter. Comparing the data of the 10 
L and 50 mL fermentation showed that the calculated total activity of the S-fraction 
was increased 867-fold, whereas the culture volume was increased by a factor of 200 
only. A reasonable explanation for this observation is a higher cell density, caused by 
e.g. better culture aeration, of the fermenter culture. 
These results indicate that a powerful tool for enantioselective epoxide hydrolysis 
was developed. The usefulness of this system was demonstrated by the enantioselective 
hydrolysis of the new R. glutinis EH substrate l-oxa-spiro[2.5]octane-2-carbonitrile 
(Fig. 4). R. glutinis hydrolyzed l-oxa-spiro[2.5]octane-2-carbonitrile in an 
enantioselective manner resulting in a high yield of enantiopure epoxide. Because of 
the excellent enantioselectivity and the high activity, E. coli BL21(DE3)(pEphl) is a 
promising candidate to be used in the enantioselective epoxide hydrolysis on a 
preparative scale. 
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ABSTRACT 
Epoxide hydrolase-encoding cDNA sequences were isolated from the carotenoid 
producing yeast species Rhodosporidium toruloides CBS 349, Rhodosporidium 
toruloides CBS 14 and Rhodotorula araucariae CBS 6031 in order to evaluate the 
molecular data and potential application of this type of enzymes. The deduced amino 
acid sequences were similar to those of the previously cloned epoxide hydrolases from 
Rhodotorula glutinis CBS 8761, Xanthophyllomyces dendrorhous CBS 6938 and 
Aspergillus niger LCP 521, which all correspond to the group of the microsomal 
epoxide hydrolases. The homology between the EH of yeasts and A. niger epoxide 
hydrolase, which belongs to the a/p hydrolase fold family of enzymes, suggests that 
they belong to the same family. The epoxide hydrolase encoding cDNAs of the 
Rhodosporidium and Rhodotorula species were expressed in Escherichia coli. The 
recombinant strains were able to hydrolyze trans-l-phenyl-1,2-epoxypropane in an 
enantioselective manner. The recombinant counterpart of Rhodosporidium toruloides 
CBS 14 was found to be a highly active and enantioselective biocatalyst for this 
substrate, despite the low performance of Rhodosporidium toruloides CBS 14 itself. 
INTRODUCTION 
Epoxide hydrolases (EHs) catalyze the hydrolysis of epoxides to the corresponding 
diols. Presently, six different types of EHs are known. Soluble EH (sEH) and 
microsomal EH (mEH) exhibit broad substrate specificity and are involved in processes 
such as the detoxification of epoxides derived from xenobiotic or endogenous 
compounds [1], catabolism [2] and plant cutin biosynthesis [3]. The other four type of 
EHs, cholesterol 5,6-EH, leukotriene A4 (LTA4) hydrolase, hepoxilin A3 hydrolase and 
limonene-l,2-epoxide hydrolase are rather restricted to their specific substrates i.e. 
cholesterol 5,6-epoxide, LTA4, hepoxilin A3 and limonene-l,2-epoxide respectively 
[4,5]. 
Several sEH and mEH encoding genes from mammalian, insect, plant and bacterial 
sources have been cloned [6-10]. Despite the low level of amino acid sequence 
similarity between sEH and mEH, it was suggested that both type EHs belong to the 
same class of enzymes known as the a/(3 hydrolase fold family [11], which are 
structurally and mechanistically related and hydrolyze their substrates via an enzyme-
ester-intermediate [12]. Several biochemical and molecular studies [13-15] including 
the determination of EH x-ray structures [16-18] confirmed this hypothesis. 
The EH activities of the fungi Aspergillus niger and Beauveria bassiana as well as 
the red yeast Rhodotorula glutinis CBS 8761 were studied in more detail especially 
related to the efficiency and enantioselectivity by which these enzymes hydrolyze 
different types of epoxides [19,20]. These fungal enzymes have been shown to be 
useful in the production of enantiopure epoxides and diols, which are both valuable 
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intermediates in the synthesis of fine chemicals. Therefore, EHs are attractive epoxide 
biocatalysts, which might be applied in a production scheme [21]. For example, A. 
niger EH has been used to perform the enzymatic part of the chemo-enzymatic 
synthesis of several valuable target-compounds such as the (3-adrenergic blocker (R)-
Nifenalol [22]. 
The yeast R. glutinis CBS 8761 exhibits high activities and enantioselectivities 
toward several epoxides [19]. Furthermore, research has been carried out to improve or 
manipulate the properties of partly purified R. glutinis EH by addition of detergents or 
by immobilized imprinting [23,24]. Moreover, the knowledge of EHs from yeasts was 
expanded to the molecular level with the isolation and characterization of the mEH 
related EH-encoding genes (EPH1) from Xanthophyllomyces dendrorhous CBS 6938 
and/?, glutinis CBS 8761 [25,26]. 
Additional yeast strains have been reported to hydrolyze 1,2-epoxyalkanes. Some of 
these strains show good activity and / or enantioselectivity, while others don't [27]. 
We intend to further explore the molecular data and potential industrial use of yeast 
EHs. Therefore, the EH-encoding cDNA sequences from Rhodosporidium toruloides 
CBS 349, Rhodosporidium toruloides CBS 14 and Rhodotorula araucariae CBS 6031 
were isolated and the derived amino acid sequences analyzed. In addition, the cDNA 
sequences were expressed in E. coli and the hydrolysis of trans-l-phenyl-1,2-
epoxypropane by both the yeast strains and the corresponding recombinant E. coli was 
analyzed. 
MATERIALS AND METHODS 
Strains and plasmids 
Escherichia coli XLl-BlueMRF' (Stratagene, La Jolla, CA, USA) and Escherichia 
coli BL21(DE3) (Novagen Inc., Madison, WI, USA) were used for cloning and 
expression experiments respectively. Plasmid pGEM-T Easy (Promega, Leiden, The 
Netherlands) was used for cloning of Supertaq (SphearoQ, Leiden, The Netherlands) 
amplified PCR products. Plasmid pET28a(+) (Novagen Inc., Madison, WI, USA) was 
used for expression of EH-encoding cDNA sequences in E. coli BL21(DE3). Plasmid 
pKKRgEphl was described previously [26]. Rhodotorula glutinis CBS 8761, 
Rhodosporidium toruloides CBS 349, Rhodosporidium toruloides CBS 14 and 
Rhodotorula araucariae CBS 6031 were obtained from the Centraal Bureau voor 
Schimmelcultures (Utrecht, The Netherlands). The latter three yeast strains are also 
referred to as UOFS Y-0471 (CBS 349), UOFS Y-0473 (CBS 6031) and UOFS Y-0472 
(CBS 14) as reported by Botes et al. [27]. R. glutinis strain CBS 8761 is also known as 
R. glutinis ATCC 201718 and R. glutinis CTMW 147. 
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DNA manipulations 
Standard molecular biological techniques were used unless stated otherwise [28]. 
The nucleotide sequences of custom primers, which were used in this study, are given 
in Table 1. Isolation of yeast chromosomal DNA and total RNA was performed as 
described previously [26]. Messenger RNA was purified from total RNA using the 
Qiagen Oligotex mRNA purification kit (Westburg BV, Leusden, The Netherlands). 
The 573' RACE (rapid amplification of cDNA ends) kit (Roche Diagnostics Nederland 
BV, Almere, The Netherlands) was used to generate first strand cDNA sequences by 
reverse transcription (RT) of mRNA. The Noil primer adapter was obtained from 
Promega Benelux BV, Leiden, The Netherlands. The PCR technique was applied to 
amplify partial or full-length EH-encoding DNA sequences using Supertaq DNA 
polymerase (SphaeroQ, Leiden, The Netherlands). The PCR cycle profile using 
degenerate primers and yeast chromosomal DNA as template was as follows: 8'at 
94°C, subsequently 30 cycles of l'at 94°C, l'at 45°C, 2'at 72°C and ending by 5'at 
72°C. The PCR cycle profile using specific primers and RT products or pKKRgEphl as 
template was as follows: 5'at 94°, subsequently 30 cycles of 30"at 94°C, 30"or l'at 
50°C, 55°C or 60°C, l'or 2'at 72°C, and ending by 5'at 72°C. PCR products were 
cloned into pGEM T Easy and transferred to E. coli XLl-Blue MRF' by means of 
electroporation as described previously [25]. 
Table 1 Custom primers used in this study. 
Primer Sequence (5' -> 3') 
PEHATGNCOI TTTTCC ATGGATGGCGAC AC AC AC ATTCGC' 
PEHTAG AGCTCTGCAGCTACTTCTCCCACATGACGCC2 
PSMPGY CCNWSIATGCCNGGNTAY 
PANEH4A TCVAGWGCWGCRAARTGDCCDCC 
P60315N GGACCCCCAGTCACCGCCC 
P60315 CTTGCAGTGTCTTCCATGCCC 
P60313N GTTGTACACCACGCTCTCGC 
P60313 CCTCTTTCCTCCCCTACTCGC 
P6031ATG ATATACCATGGGCGAGCACAGCTTCGAGGCCCCG' 
P6031TGA ATATAGCGGCCGCTC ACGACGACAGCATGGCCTTGACTGCC3 
Nucleotide codes: N: A+T+C+G, W: A+T, S: C+G, I: deoxyinosine, Y: C+T, V: A+C+G, R: A+G, D: 
A+T+G. Restriction endonuclease sites are underlined.1, Wcol.2, EcoRI.3, Nofl. 
Plasmid DNA was isolated from ampicillin-resistant colonies and analyzed by 
DNA restriction analysis. Both DNA strands of all cloned PCR products were 
sequenced by the Laboratory of Molecular Biology (Wageningen University, The 
Netherlands) using AmpliTaq FS DNA polymerase fluorescent dye terminator 
reactions as recommended by the supplier (Perkin-Elmer Nederland, Nieuwerkerk a/d 
IJssel, The Netherlands). The DNASTAR software package was used to analyze 
nucleotide and deduced amino acid sequences. 
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The Ephl-encoding cDNA sequences from R. toruloides CBS 349, R. toruloides 
CBS 14 and R. araucariae have been deposited in the GenBank database under 
accession numbers AF416991, AF416992 and AF416993 respectively. 
Induction of heterologous EPH1 expression 
Expression of recombinant EPH1 cDNA was performed according to the pET 
system suppliers instructions (Novagen) with some minor modifications. In brief, 
EPH1 -expressing E. coli BL21(DE3) strains were cultivated in 100 mL of Luria-
Bertani (LB) medium supplemented with 50 |ig ml"1 kanamycin at 200 revolutions per 
minute (rpm) and at 21°C until the optical density at 600 nm (OD600) reached 
approximately 1. One hundred uM of isopropyl-(3-D-thiogalactopyranoside (IPTG, 
Diagnostic Chemicals Limited, UK) were added to induce EPH1 gene expression. 
After 4 hours of induction the cells were harvested by centrifugation (4°C, 8000 x g, 5 
minutes), washed with potassium phosphate (KPi) buffer (50 mM, pH 7) and stored at 
-20°C in 10 ml of KPi-buffer supplemented with 10% glycerol. 
Cultivation and preparation of yeast cells 
R. glutinis, R. toruloides CBS 349, R. toruloides CBS 14 and R. araucariae were 
cultivated in 5 liter Erlenmeyer flasks containing 500 ml of a mineral medium 
supplemented with 1% w/v glucose and 0.2% w/v yeast extract at 30°C on a shaking 
platform at 60 revolutions per minute (rpm). When the color of the yeast culture turned 
orange to red, i.e. 48-72 hours of incubation, the cells were harvested by centrifugation 
(4°C, 8000 x g, 5 minutes), washed with KPi-buffer and stored at -20°C in a minimum 
volume of KPi-buffer supplemented with 10% glycerol. 
Enzyme assay 
Trans-l -phenyl-1,2-epoxypropane hydrolysis was measured as described 
previously [29]. In brief, cells were mixed with KPi-buffer to give a final volume of 20 
ml in a 100 ml screw-capped bottle. After 5 minutes of pre-incubation at 35°C, the 
reaction was started by addition of 10 mM of trans-l -phenyl- 1,2-epoxypropane. The 
reaction mixture was incubated at 35°C and shaken at 200 rpm. One ml samples were 
taken over a period of time. These samples were centrifuged for 1 minute at 12,000 x g. 
Epoxide was extracted from 500 ul of supernatant using 1 ml ethylacetate and analyzed 
by chiral gas-liquid chromatography as described before [29]. Specific enzyme 
activities were expressed as units per mg of dry cell mass (dry weight, dw): U • (mg 
dw)~ . One unit is equivalent to 1 |amol of epoxide converted per minute. 
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RESULTS 
Isolation of the epoxide hydrolase-encoding cDNA sequences 
Initially, chromosomal DNA was isolated from R. glutinis, R. toruloides CBS 349, 
R. toruloides CBS 14 and R. araucariae. These DNA samples were digested with 
several endonucleases and subjected to Southern blot analysis using the R. glutinis 
EPH1 cDNA as a probe in order to investigate the presence of similar DNA sequences 
in these yeast species. After hybridization at 60°C and washing (50°C, 2 x 1 5 minutes) 
with 2xSSC / 0,1% SDS a film was exposed to the blot. The hybridization patterns for 
R. toruloides CBS 349, R. toruloides CBS 14 and R. glutinis were identical. This 
indicates that the EH-encoding genes are situated on the same restriction fragment. This 
type of conservation suggested that nucleotide sequences of the EPH1 genes from R. 
toruloides CBS 349 and R. toruloides CBS 14 might be very similar to that of R. 
glutinis EPH1. 
Therefore, total RNA was isolated from R. toruloides CBS 349 and R. toruloides 
CBS 14 and applied in an RT-reaction using the Noil primer adapter to generate a first 
strand of cDNA. Because of the identical hybridization patterns mentioned above, the 
specific R. glutinis EPH1 primers PEHATGNCOI and PEHTAG, corresponding to 
both ends of the R. glutinis EPH1 open reading frame, were applied in the PCR using 
first strand cDNA of/?, toruloides CBS 349 or R. toruloides CBS 14 as template. Each 
reaction resulted in the amplification of a DNA fragment of approximately 1.2 kbp, as 
was shown by agarose gel electrophoresis. Both PCR products were cloned, sequenced 
and compared the R. glutinis EPH1 sequence. The nucleotide sequences of the R. 
glutinis EPH1 cDNA and R. toruloides CBS 349 PCR product were identical. The 
nucleotide sequence of the R. toruloides CBS 14 PCR product was 96% identical to 
that of the R. glutinis EPH1 cDNA. 
Based on the Southern blot analysis it seemed that the R. araucariae EH-encoding 
DNA sequence is different from that of R. glutinis. Therefore, it was attempted to 
synthesize a specific EH fragment for R. araucariae using degenerate primes 
corresponding to conserved regions of known EHs. This approach was successful in the 
isolation of the X. dendrorhous EPHl gene [25]. Two degenerate primers named 
PSMPGY, corresponding to conserved domain SMPGY, and PANEH4A, 
corresponding to conserved domain GGHFAALE, were designed. A 1.2 kbp DNA 
fragment was amplified using these primers and chromosomal R. araucariae DNA as 
template. Nucleotide sequence analysis revealed a putative EH-encoding sequence, 
which was interrupted by intron sequences. The presence of the amino acid sequence, 
GGDWG, which corresponds to an a/(3 hydrolase fold EH specific motif [12] 
containing the catalytic nucleophilic residue of these enzymes supports this preliminary 
conclusion. This 1,2 kb R. araucariae EH probe was denominated pRaEHl. 
Based on the pRaEHl nucleotide sequence, the specific primers P60315 and P60313 
were designed. These primers were used for the amplification of the 5'- and 3'-cDNA 
ends using the 573' RACE kit. Primer P60315 was used for the first strand cDNA 
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synthesis in the 5' RACE. An initial PCR with the oligo (d)T anchor primer, targeted 
against the poly adenylated 5'-cDNA ends, and primer P60315 did not result in a PCR 
product. Therefore, a nested PCR was performed using primer P60315N and the oligo 
(d)T anchor primer and on a sample of the first PCR mixture as template. The result of 
this nested PCR was a specific product of approximately 570 bp. This fragment was 
cloned in pGEM T Easy, the ligation mixture was transferred to E. coli XL1-
BlueMRF, yielding the plasmid pRaEH2. The amino acid sequence, deduced from the 
nucleotide sequence of pRAEH2, showed sequence similarity to the N-terminal amino 
acid sequence of/?, glutinis Ephl. Moreover, an a/(5 hydrolase fold EH specific motif, 
HGWP corresponding to the putative oxyanion hole of the enzyme, was present. These 
results indicated that the 5'-end of the R. araucariae EPH1 cDNA was cloned. 
A similar approach was followed in the 3' RACE. The oligo (d)T anchor primer was 
used for the first strand cDNA synthesis in the 3' RACE. An initial PCR using the oligo 
(d)T anchor primer, targeted against the 3'poly (A)+ cDNA end, and primer P60313 
gave no PCR products. The nested PCR with primer P60313N and the oligo (d)T 
anchor primer, however, resulted in the amplification of a 400 bp specific PCR product. 
This DNA fragment was cloned in pGEM T Easy yielding pRaEH3. The nucleotide 
sequence of the insert in pRaEH3 was determined and the deduced amino acid 
sequence shared similarity to the C-terminal amino acid sequence of R. glutinis Ephl. 
Moreover, a conserved amino acid sequence, GGHFAA, found in mEHs and 
containing the catalytic histidine, was present. These results indicated that, in addition 
to the 5' end, also the 3'end of the R. araucariae EPH1 cDNA was isolated. 
Specific primers targeted to the R. araucariae EPH1 ATG start-codon region 
(P6031ATG) and the TGA stop-codon region (P6031TGA) were designed to amplify 
the entire Ephl encoding cDNA sequence. Initially, the RT reaction mixture was used 
as template in the PCR reaction. However, no DNA fragment could be synthesized. 
Therefore, messenger RNA (mRNA) was isolated from total RNA using the Oligotex 
kit (Qiagen). A subsequent RT-PCR reaction, with mRNA as template in the RT 
reaction and primers P6031ATG and P6031TGA in the PCR reaction, resulted in the 
amplification of a DNA fragment of approximately 1,2 kb. This product was cloned 
and sequenced. The deduced amino acid sequence indicated that the complete putative 
Ephl-encoding cDNA of R. araucariae was isolated. 
Ephl amino acid sequence alignment 
The EPH1 cDNA sequences of R. toruloides CBS 349, R. toruloides CBS 14 and R. 
araucariae encode polypeptides of 409, 409 and 410 amino acids respectively. The 
calculated molecular weights correspond to 46 kDa. The amino acid sequences of yeast 
Ephl enzymes, including X. dendrorhous Ephl, as well as the A. niger EH (AnEH) 
were aligned and typical a/(3 hydrolase fold EH motifs were identified, including 
putative active site residues (Fig. 1). The level of amino acid identity between these 
enzymes is depicted in Table 2. 
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Table 2. EH amino acid-sequence similarity. 
AnEH 
XdEphl 
RgEphl 
RtUEphl 
RaEphl 
AnEH 
-
XdEphl 
28.4 
-
RgEphl 
29.4 
30.3 
-
#?14Ephl 
28.6 
30.3 
96.1 
-
RaEphl 
28.6 
27.8 
67.0 
67.5 
-
The amino acid sequence similarity (%) between the EHs from A. niger (AnEH), X. dendrorhous 
(XcEpM), R. glutinis (RgEphl), R. toruloides CBS 14 (Rf14Eph1) and R. araucariae (RaEphl) is given. 
Construction of EPHl-expressing E. coli BL21(DE3) strains 
With regard to this study, the amino acid sequences of the Ephls from R. toruloides 
CBS 14 and R. araucariae were denominated Rt\AEph\ and RaEphl respectively. 
Since the nucleotide and amino acid sequences of R. glutinis and R. toruloides CBS 
349 Ephl were identical, the corresponding enzyme was referred to as RgEphl. 
The Ephl-encoding cDNA sequences were cloned into the Ncol and EcoRI or Notl 
endonuclease sites of the expression vector pET28a(+) and transferred to E. coli 
BL21(DE3) resulting in strains BL21(DE3)flgEphl, BL21(DE3)/frl4Ephl and 
BL21(DE3)/JaEphl. 
Hydrolysis offra/«-l-phenyl-l,2-epoxypropane 
The hydrolysis of trans-l-phenyl- 1,2-epoxypropane hydrolysis by the wild type 
yeast strains and the recombinant E. coli was evaluated (Table 3). In all cases, the 
enantioselective hydrolysis of trans-l -phenyl- 1,2-epoxypropane was observed yielding 
(lR,2R)-trans-l-phenyl- 1,2-epoxypropane as residual epoxide. 
Of the four yeast strains, R. toruloides CBS 349 showed the highest initial reaction 
rate, while the highest yield of (li?,2/J)-/ra«5,-l-phenyl-l,2-epoxypropane was observed 
for R. glutinis. Both, R. toruloides CBS 14 and R. araucariae exhibit low activity and 
enantioselectivity. The highest yields of (li?,2/?)-fr-a«.s-l-phenyl-l,2-epoxypropane 
were obtained with the recombinant E. coli strains BL21(DE3).KgEphl and 
BL21(DE3)/J/14Ephl. Compared to these two E. coli strains, the third strain 
BL21(DE3)7?aEphl gave a rather low initial reaction rate and corresponding yield of 
(lR,2R)-trans-1 -phenyl-1,2-epoxypropane. 
In general, the E. coli strains exhibited much higher activities when compared to 
their yeast counterparts (Table 3). The best improvement was that observed for 
BL21(DE3)#/14Ephl versus R. toruloides CBS 14. 
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Table 3 Hydrolysis of trans-\-phenyl- 1,2-epoxypropane. 
Organism Strain EH activity Yield (%) 
(mU • mg dw'1) 
R. glutinis 
R. toruloides 
R. toruloides 
R. araucariae 
E. coli 
E. coli 
E. coli 
CBS 8761 
CBS 349 
CBS 14 
CBS 6031 
BL21(DE3)flgEphl 
BL21(DE3)#?14Ephl 
BL21(DE3)/JaEphl 
6.5 
3.2 
0.2 
0.3 
810 
970 
52 
40 
42 
10 
21 
46 
48 
40 
Hydrolysis of 10 mM racemic trans-1 -phenyl-1,2-epoxypropane in 20 rriL reaction mixture with wild type 
yeast cells or recombinant E. coli cells, which express the corresponding yeast EPH1 genes. The yield of 
the residual substrate (1R,2R)-frans-1 -phenyl-1,2-epoxypropane is given. Theoretically, when (1S.2S)-
frans-1-phenyl-1,2-epoxypropane is completely converted a maximal yield of 50% enantiopure (1R.2R)-
frans-1 -phenyl-1,2-epoxypropane remains, which represents a 100% enantiomeric excess (e.e.). 
Reactions were stopped when the e.e. of (1R,2R)-(rans-1 -phenyl-1,2-epoxypropane was higher than 98%. 
DISCUSSION 
To explore the biological diversity and potential industrial use of yeast EHs the 
Ephl-encoding cDNA sequences from R. toruloides CBS 349, R. toruloides CBS 14 
and R. araucariae were isolated, characterized and expressed in E. coli. 
The Ephl-encoding cDNA sequence of R. toruloides CBS 349 was 100% identical 
to that of the R. glutinis sequence. This is striking since the Ephl activities and 
enantioselectivities exhibited by these yeasts toward the 1,2-epoxyalkanes [27] and 
trans-\-phenyl- 1,2-epoxypropane are different. Because R. glutinis is the anamorphic 
state of R. toruloides, these yeast species have a highly similar genetic background, 
which could explain the identical EPH1 genes. However, at the Ephl protein level 
contradicting data have been reported. While the size of the purified R. glutinis Ephl 
was 46 kDa large [33], the purified EH from R. toruloides CBS 349 was 54 kDa, 
although heavily glycosylated [34]. We found 39 proline and 5 cysteine residues in the 
R. glutinis Ephl amino acid sequence, whereas these residues were absent in an acid 
hydrolysate of the purified R. toruloides CBS 349 Ephl. Unfortunately, no amino acid 
sequence information of the purified EH from R. toruloides CBS 349 EH has been 
reported, which could support these results. However, based on the Southern analysis 
we found no evidence for more than one Ephl-encoding gene in both R. glutinis and R. 
toruloides CBS 349. Moreover, a single EPH1 gene is present in X. dendrorhous [25]. 
The A. niger EH is a well characterized enzyme, which is related to mEH [35]. The 
AnEH crystal structure is known and active site amino acid residues have been 
identified [16]. AnEH belongs to the a/p hydrolase fold family of enzymes [16] and 
hydrolyzes epoxides via a characteristic two-step mechanism involving an enzyme-
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substrate-ester intermediate. Based on amino acid sequence similarity to AnEH, 
positions of putative active site residues were assigned in the primary structure of the 
cloned yeast Ephls (Fig 1). Additionally, amino acid sequences corresponding to the 
oxyanion hole and nucleophile motifs of cc/p hydrolase EHs were observed in the Ephl 
sequences from yeasts. Therefore, the yeast Ephl is related to mEH as AnEH is and it 
is conceivable that the examined yeast Ephl enzymes belong the a/p hydrolase fold 
EHs and hydrolyze epoxides via an enzyme-substrate-ester intermediate. 
HGXP sxnxss Y 
AnEH 114-LHGWPG-119/ /189-QGGDIGSF-196/ /250-AYA-252 
RgEphl 114-CHGWPG-119/ /187-QGGDWGS•-193/ /260-AYY-262 
KaEphl 115-CHGWPG-120/ /188-QGGDWGS•-194/ /261-AYY-263 
i?tl4Ephl 114-CHGWPG-119/ /187-QGGDWGS •-193/ /260-AYY-262 
XdEphl 104-SHGWPS-109/ /178-GAGDWGSW-185/ /262-GYQ-264 
Y A H 
AnEH 313-TYR-315/ /347-KDL-349/ /372-EGGHFAAL-379 
RgrEphl 330-PYS-332/ /347-GEI-349/ /382-EGGHFAAL-389 
KaEphl 331-PYS-333/ /348-GEL-350/ /383-DGGHFAAL-390 
J?tl4Ephl 330-PYS-332/ /347-GEI-349/ /382-DGGHFAAL-3 89 
XdEphl 332-PYK-334/ /358-AEI-360/ /382-RGGHFAAV-389 
Fig. 1. Comparison of the amino acid sequences of EHs from A. niger (AnEH) [34], R. glutinis I R. 
toruloides CBS 349 (RgEphl), R. toruloides CBS 14 (Rf14Eph1), R. araucariae (RaEphl) and X. 
dendrorhous (XoEphl) [25]. Depicted are, in the one letter code, sequence regions corresponding to the 
conserved oxyanion hole (HGXP) and nucleophile (sxnxss) motifs as well as active site residues. The 
nucleophile motif consists of small residues (s), any residues (x) and the catalytic nucleophilic residue (n). 
The active site residues of AnEH have been determined [16,35]. The corresponding yeast residues are 
appointed based on the homology to AnEH and are therefore marked as putative. All (putative) active site 
residues are in bold face. Tyrosine residues that are possibly involved in substrate binding and activation 
are indicated by Y. Furthermore, the catalytic acidic residue (A) and the catalytic histidine (H) are shown. 
Numbers indicate amino acid positions. The nucleotide sequences of the R. toruloides CBS 349, R. 
toruloides CBS 14 and R. araucariae Eph1-encoding cDNAs have been deposited in the GenBank 
database under accession numbers AF416991, AF416992 and AF416993 respectively. 
Excellent activity and enantioselectivity were observed for R. toruloides CBS 14 
Ephl expressed in E. coli in the hydrolysis of trans-\-phenyl-1,2-epoxypropane, while 
the activity and enantioselectivity of R. toruloides CBS 14 itself were quite low (Table 
3). Apparently, the RtXA&phl enzyme in R. toruloides CBS 14 is either produced at a 
very low level or the enzyme is minimally active due to e.g. unfavorable intracellular 
Ephl conditions, which makes it difficult to determine its enantioselectivity. Therefore, 
by means of over-expression of the EPH1 cDNA in E. coli sufficient Ephl is produced, 
100 
EH-encoding genes from yeasts 
which enables the determination of the actual enantioselectivity of the enzyme in 
question. Consequently, the R. toruloides CBS 14 Ephl revealed to be highly 
enantioselective. These results illustrate the great value of the cloning and over-
expression of genes in heterologous hosts as has now been shown for the EH-encoding 
genes from yeasts in E. coli. In this way, related but better yeast Ephls can be found, 
which would otherwise not be recognized in screening programs due to the low enzyme 
activity of the corresponding host. Therefore, the isolation of Ephl-encoding genes 
from yeasts by (degenerate) polymerase chain reactions should be quite feasible. The 
expression system, which was used in this study, is very suitable for the evaluation of 
the potential of the corresponding Ephl activities. 
Under optimized conditions the maximal yield of {\R,2R)-trans-\-^hcny\-\,2-
epoxypropane from the hydrolysis of 1 -phenyl-1,2-epoxypropane by R. glutinis was 
45% [29]. In this study, moderate yields (-40%) of (lR,2R)-trans-l-phenyl-1,2-
epoxypropane were obtained in the enantioselective hydrolysis of trans-l-phenyl-1,2-
epoxypropane by R. glutinis and R. toruloides CBS 349. R. toruloides CBS 14 and R. 
araucariae exhibited yields of only 10 and 21% respectively. Additionally, low 
(l/?,2^)-^/-a«5-l-phenyl-l,2-epoxypropane yields were also reported for the mammalian 
mEH catalyzed trans-l -phenyl- 1,2-epoxypropane hydrolysis [30]. More promising 
results (-30% yield) have been found by using Beauvaria bassiana (formally named B. 
sulfurescens) and recombinant human sEH [31,32]. Nevertheless, for now, the 
recombinant E. coli that produce R. glutinis or R. toruloides CBS 14 Ephl are probably 
the best choice for the production of enantiopure (\R,2R)-trans-\-phenyl- 1,2-
epoxypropane because (i) the enantioselectivity of these cells is at least equal to, but 
probably better than, that of R. glutinis under optimized conditions, resulting in high 
yields of enantiopure epoxide (up to 48%) and (ii) the recombinant Ephl is over-
produced in E. coli resulting in cells with Ephl activities, which are 2 to 3 orders of 
magnitude higher than that of the wild type yeast cells. 
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INTRODUCTION 
Enantiopure epoxides and diols are versatile chemical building blocks in the 
organic synthesis of fine chemicals such as pharmaceuticals and agrochemicals. 
Epoxide hydrolases (EHs) catalyze the co-factor independent hydrolysis of epoxides to 
the corresponding diols. Interestingly, in many cases mixtures of racemic epoxide can 
be hydrolyzed by EHs in an enantioselective manner yielding enantiopure epoxides and 
/ or diols. Therefore, EHs might be used as a biocatalyst in the production of these 
respective enantiopure compounds. 
EHs are omnipresent and have been characterized from various organisms. The EH 
activity from the basidiomycetous yeast Rhodotorula glutinis in particular exhibits 
interesting characteristics, such as a broad substrate range, a high activity and 
enantioselectivity. Because of these properties R. glutinis is a promising source of an 
EH biocatalyst, which could be applied in the enantioselective hydrolysis of epoxides. 
At the start of this research project no information was available about the 
molecular biology of EHs from yeast species. This kind of information was highly 
desired since it would open the way for the development of an efficient yeast EH-based 
epoxide hydrolysis system. Therefore, the research described in this thesis focused on 
two items. First, the isolation and characterization of EH-encoding genes from 5 yeast 
species elucidated the identities of the yeasts EHs (chapters 2, 3 and 5). Second, the 
yeast EH-encoding genes were overexpressed in the heterologous host E. coli in order 
to develop efficient tools for the EH-catalyzed enantioselective hydrolysis of epoxides 
(chapters 4 and 5). 
ISOLATION AND CHARACTERIZATION OF EH-ENCODING GENES 
FROM YEASTS 
The first aim of the research described in this thesis was to clone and characterize 
EH-encoding genes from yeast species. The EH-encoding gene from 
Xanthophyllomyces dendrorhous CBS 6938 was the first one cloned from a yeast 
species and it was denominated EPHl (chapter 2). Based on this information, 
additional EPHl genes from R. glutinis CBS 8761, R. tomloides CBS 349, R. 
toruloides CBS 14, and R. araucariae CBS 6031 were isolated (chapters 3 and 5). 
These genes all encode polypeptides of approximately 410 amino acids large with 
calculated molecular masses of 46 kDa. Comparison of the Ephl amino acid sequences 
to that of other EH sequences showed a clear similarity to the mEH type of the a/p 
hydrolase fold EHs, while homology to sEH was low (Figure 1). 
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Figure 1. Phylogenetic tree of (putative) a/p hydrolase fold EHs. EH, epoxide hydrolase. Eph1, yeast EH. 
JHEH, juvenile hormone EH. mEH, microsomal EH. sEH, soluble EH. R. glutinis, Rhodotorula glutinis. R. 
toruloides, Rhodosporidium toruloides CBS 14. R. araucariae, Rhodotorula araucariae. A. niger, 
Aspergillus niger. X. dendrorhous, Xanthophyllomyces dendrorhous. M. sexta, Manduca sexta. T. ni, 
Trichoplusia ni. S. tuberosum, Solanum tuberosum. A. thaliana, Arabidopsis thaliana. A. radiobacter, 
Agrobacterium radiobacter. 
Two typical a/(3 hydrolase fold motifs are present in the Ephl sequence. The first 
one is the nucleophile motif s-x-n-x-s-s, where s is a small amino acid, x is any amino 
acid and n is the nucleophilic residue of the catalytic triad. The second motif, HGXP, 
corresponds to the oxyanion hole of the enzyme and consists of His (H), Gly (G), any 
(X) and Pro (P) amino acid residues. The Ephl HGXP motif contains a Trp residue at 
the X position. 
Based on the amino acid sequence homology of yeasts Ephls to mEHs putative 
Ephl active-site residues can be appointed in the primary enzyme structure as they 
align with the active site residues of e.g. rat mEH and A. niger EH (Figure 2). The first 
member of the putative Ephl catalytic triad is an Asp residue, which fits perfectly to 
the nucleophile motif of oc/p hydrolase fold enzymes. The so-called charge relay system 
is represented by the other two members of the catalytic triad, an acidic residue (Glu or 
Asp) and a His residue. Except for the A. niger EH, the acidic residue of the charge 
relay system corresponds to a Glu residue in all mEH sequences. The cloned yeasts 
Ephls make no exception: a Glu residue represents the corresponding acidic residue of 
the putative Ephl catalytic triad. The third putative member is a His residue, which 
aligns to the perfectly conserved catalytic His residues of other EHs. Therefore, the 
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catalytic triad of the putative Ephl active site consists of Asp-Glu-His. Furthermore, 
putative active site Tyr residues are present in the yeast Ephl sequence at positions 
corresponding to two A. niger EH active site Tyr residues, which are involved in 
epoxide positioning and activation. 
Taken together, the cloned yeast Ephls are related to mEH and they probably are 
<x/p hydrolase fold enzymes, which hydrolyzes epoxides via an enzyme-substrate-ester 
intermediate analogous to mEH and sEH. 
The mammalian mEH is linked to the microsomal membrane by means of an N-
terminal membrane anchor sequence. The main difference between mammalian mEH 
and the fungal mEH related enzymes is the absence of this anchor sequence in the A. 
niger EH and the yeasts Ephls. Consequently, both wild type and recombinant A. niger 
EH were found to be a soluble enzyme (Arand et al., 1999a). In agreement with this, 
the active recombinant R. glutinis Ephl is soluble in E. coli. However, the 
corresponding Ephl activity in R. glutinis is membrane associated (Kronenburg et al., 
1999). Additionally, membrane associated Ephl activity was demonstrated in other 
yeasts (Botes et al., 1999; Visser et al., 1999). To clarify this discrepancy, attempts to 
determine the X. dendrorhous Ephl intracellular location were conducted. A gene 
encoding an Ephl-Enhanced Green Fluorescent Protein (EGFP) fusion protein was 
constructed and cloned into a X. dendrorhous transformation vector. The vector was 
targeted to the endogenous EPH1 gene for insertion into the chromosome. Upon 
expression from the endogenous EPH1 promoter the fusion protein would be produced 
and transported intracellularly. By fluorescence microscopy the position of the fusion 
protein would be visualized, which might indicate the cellular location of Ephl in X. 
dendrorhous. Unfortunately, this experiment was not successful. 
FUNCTION OF EPH1 FROM YEASTS 
The mEHs of mammals are a group of important enzymes involved in the 
detoxification of mutagenic and cytotoxic epoxides. They exhibit broad substrate 
ranges, which is a prerequisite property for such an enzyme. 
Similarly, it has been demonstrated that R. glutinis hydrolyzes a versatile group of 
epoxides. This could indicate that also the Ephls from yeasts are involved, just like 
mammalian mEH, in the detoxification of harmful epoxides. However, no paper that 
demonstrates direct evidence for this putative role has been reported. Nevertheless, ii is 
likely that the yeast is challenged by noxious epoxides, either directly or indirectly. 
Directly, the yeast cell might encounter plant or fungal metabolites, which carry an 
epoxide moiety and exhibit anti-microbial properties. For example, the plant genus 
Rutaceae is capable of producing acridone alkaloides. 
108 
General Discussion 
Epm R araucariae 
EpM R. glutinis 
EpM R. toruloides 
Ephl X dendrorhous 
mEH Rat 
EH A. niger 
Epm R. araucariae 
EpM R (//uf/ni's 
EpM R. toruloides 
Ephl X. dendrorhous 
mEH Rat 
EH A. niger 
Ephl R. araucariae 
Ephl R. glutinis 
Ephl R toruloides 
Ephl X. dendrorhous 
mEH Rat 
EH A. niger 
Ephl R araucariae 
Ephl R glutinis 
Ephl R toruloides 
Ephl X. dendrorhous 
mEH Rat 
EH 4. niger 
Ephl R_ araucariae 
Ephl R. glutinis 
Ephl R. toruloides 
Ephl X dendrorhous 
mEH Rat 
EH A niger 
Ephl R. araucariae 
Ephl R. glutinis 
Ephl R. toruloides 
Ephl X. dendrorhous 
mEH Rat 
EH A. niger 
Ephl R. araucariae 
Ephl R. glutinis 
EpM R. toruloides 
Ephl X. dendrorhous 
mEH Rat 
EH A. niger 
EpM R. araucariae 
EpM R. glutinis 
EpM R. toruloides 
EpM X. dendrorhous 
mEH Rat 
EH 4. niger 
EpM R. araucariae 
Ephl R. glutinis 
EpM R. toruloides 
EpM X. dendrorhous 
mEH Rat 
EH A. n^er 
EpM R. araucariae 
EpM R. g/ufin/s 
EpM R toruloides 
Ephl X. dendrorhous 
mEH Rat 
EH A niger 
M | S Ej H | • 
M A T H | • 
M A T H| 
M T S A 
M W L E 
M S A P 
L V L A S L L G F V I Y W F V S R D K E E T 
F A K\F\ 
L P L G D G W W G P G S K P S A K E D E 
- P[S]S A S I S[P]N]_P 
F T V D| F A - P H I E i p L 
F T V D I P Q S~E|_LJD 
F T V D I P QJ [ E V D 
F r a v 
F|KJ v 
F T V 
S F A l Q l Q D l V D 
R;R L"D|N AJR W'P[_T q r n I v>~ 
S J R L D K_T R W P AJTJ E I V P 
F;R L D K | N | R W P A A E I V P 
R M M A K I R D[T^R rL lLP]TJA|'p'' tI_Y P G|A 5 W D 
- — , F R i A j s p p L 
v ^ v s E [ T | E H H N [ A F G 
E | D J - - [ G T D D P T A F G 
E I D I - - G T O D P T A F G 
E T S D E ^ E j I K j D L J ^ Q L R i l T r - - J ^ 
S j l P|D E Q LID D L|K T L V R L S K 
I t 
:1G|S R F H Y|G 
[ i ] A (P] P T Y E S L Q A D G R | F~ G 
L M K E L A[NJG W - | R ! A | F D;Q S A L,Q D H L N S F 
L M K E L A K G W - i R ^ E F D W K K A Q D J ^ L N ^ F 
L M K E L A K G W - | R [ K ! F D W K K A Q D J D | L N T [_F_ 
H ^ K ^ T V A N ^ W SiWE E T E K R i ] N K Y 
V V S Y W R N E F T W | R ^ Q V E l f l N Q V 
w LJ]T]E 
Y]M_KJK 
W L T T 
A G|A;L 
PJN^A V 
pj K!A V 
P D A l l 
R T P K 
E D A V 
M R E K j I l S ^ F D J ^ R P F E A R[L N S F pJoJF j f ] 
H G X P _ _ 
P L I L C H G W P G j G Y H | E F L | H [ V 1 V QJL L T E P 
P L I L C H G W P G j H f F G E F L N V I P L L T E P 
P L I L C H G W P G ] H | F G E F U V I P L L T E P 
P L i j - r i m G w pjsjs F [ L ] E F 
P L j L ^ V ! H G W P G S F Y ! E F 
P I A L L ' H G W P G S F V | E F 
H H R S T I 
H H R 5 T I 
H H R S T I 
F V | H | I K|SJK~I 
HJV K P P I 
Fj A A L F [ U E [i 
- - A DIA Q ^ A T H H I L I V V P S M 
- - p ~ T A Q A F H V V [ A ] P S M 
- - P S A Q A F H V V V P S M 
- - A G Q P U F H V y j l j p S M 
C L S D E H ' v l F ^ i y f l C!P s T l 
- - 0 E T L P [F_H] L [y V P _ S j L 
P S G 
P G Y 
P G Y 
P G Y 
P G Y 
JP G Y 
P G Y 
A F S S P P P,T A i K 
A;W S L P P P S S K 
/ W; S S P_ P P S S K 
T , F " S S G P ! Q R K G 
W G M 
WJNJM 
WJS[M 
W | T V 
G Y S E A S S - K I K I G L N S , _ _ ^ _ ^ 
T , F S V j G P'V' L D | K ) D F ( G ] L M | 6 ] N ] A R L V ] V | D ; Q ] L M[K D 
E D T A R V F D K L H T G 
P D T A R V F D K L M T G 
P D T A R V F JJ K L H T G 
V D T A R V J Y N T ] L M [ V N V 
V [ A J T A R l l [F ] jY [K L MJ}R 
H K D H C| l|A V H 
H K D H C K A V H 
H K D H C K A V H 
N F [C 
N F L] - - -
N F L - - -
A Q G G D W G 
A Q G G D W G 
A Q G G D W G 
T C G_AjG D W G 
l l - [Q G G D W G 
I | I | Q G G D [ I 1 G 
- iJTJA R C 
- I A A R C 
- I A A J^C 
w I[T[AJQ I 
L ^ l j c T N -
F V G R - -
I Y S • Y S E F~A V V A | H [ F T M I K A S V P j l 
I V P N [ H ] V [ K ] G L J H L~NJM - - - - A F I S R S F Y T M 
' G F g A | C K A~V H_L_NJ L C A U « A [ P > E G i P J S I E -
Y 
> Q[Q1_RJA1KITTE1. 
E l K l Q A A R M K 
E|K|Q A AIR M K 
E A| E I N [G L E 
T G K D I E ^ L j L ' 
A [ A ] E K E [ G 1 I A 
P V[P jP P[F P'J^D Q ^ [ ^ T P I R J T L L[Njw[M[P R 
P V F P P V - - - ; P M | W ! L i - - - - n f J N P H T L L A W A P R 
P V F P P V - - - P H ! W | L | - - - - I N P H T L L A W A P R 
i r T L J G K I P F V[PJK G V A R [ W [ L Q S 
PJL L G Q - - - - - - - - - - R F G[R] 
- - R G L A ' Y L E 
- - I R G L A Y : L E 
- - ] R G L A Y [ L E 
- - [RJT D KJF jW K 
P Y K E K V F ; Y S 
- - I K G S A Y Y V M Q Q L T P R T 
- - I K G S A Y Y V M Q Q L T P R T 
- - ;K G S A Y Y^V^M Q Q L_T P R T 
- - E . G j L G|Y|Q K I ] Q [ G S K " ; P : M ] T L 
I M R E ; S " G I Y A T KjPjDJT V 
-[R:M E K ! F ; M T - - D\G] L|A Y | A M E H S T R ^ J S ' L T J I 
  I I Q 
L H l[<J| 
I G E K 
I G E K 
I G E K 
I G E K 
I ^Lj E K 
I G E K 
; P ! G : NlE A S ^ Q - P N;P T L!N|R 
Q E A S K Q; - , A Q P T L T R 
QlE A S K Q : - ! A Q P_T L T R 
D J P R A P S - l _ A l P S Q v ^ r f p 
F S T K ; I ^ S E V R E L E 0 6 G [ L E [R] I 
Y L Q'wiV D"K p - - - - - - - - I L P S • 
Y A L ^ D S P [ I j G 283 
Y P G I L T D S P V G 282 
Y | G | L T D S P V G 282 
AJA L T J D S P V G 28< 
c U L N | D S P V G 320 
H V J L ) S Sis PJI A 2 7 2 
328 
Y H G Wis 
S L N" - P H~F ;S;T F L T[S P R [ Y _R[L" 
S L N ; - - - - - - P ^ H F T T F L T D j S 1 K Y H L 
S L N S H F T T F L T D | S ; K Y H L P I 
. K E Y T S L P H A V A V ^ K i U 
K E;N^L G E G I H VJHJ - - - - K H E|GJM K V F V I 
R E T T P T A S Afp]N G A ^ M l p Q K E L [ Y ; I H K 
R:W Y K]E A ! D D G G H F A A L E K P D V F(S Q H 
K i W . I I K D A P E j G G H F A A L E K P D V F V " i ] » 
K W I ; K | E A ! P | D G G H F A A L E K P D_V F V[D H 
V N ! Y K V H A ! R ! G G H F A A V D N ; P ' G A Y|V "E" D1 
I s Y;S Y M E R |GG H F A A; F[E"| E:P ! K L L A Q I D 
V:F F R JD-H A ! E | G G H F A A L E R ! P R E L K T ! D 
- - -
- - -
_ - -
D A L Y T T L S L Y W F T | N 
D E L Y F T C S L Y W F T(R 
D E L Y F I T C S L Y W F T I R 
S I G T S 
S I G T S 
S I G T S 
N H I V | T | V T » [ I » ; F L T 6 S I H [ T S 
F s L|"D D|'L|L V N I M I ] Y " W | T T GJTJIJV sis 
- - - E T I L E M V S L Y W L i T f E f s ] F P R A 
A 
N F;A L S ! S [ F P G E LJF S I P 
N F A L s L|Y;P G E | I | Y C P 
N F A L S L Y P G E I , Y C P 
P l [ G L S 
P T |G |F :S 
P F G|F;S 
T PJR D A A R T 
A;E R D AH<1R T 
A l E R D A ] K i R T 
I ' F P : A | E [ I T Q Y l p l R S W V l A : S S 
A F P ! S E L | L H A P E K W V K V K 
F F PJK D ] L C P V ; P ' R S W T A J T T 
V ^ R ^ " A y ] K A|M~[L_ S S 
L R E A| FJG V M W E K 
L R E A1 F, G V M W E K 
i l R E;T I ^ J K N Y H S E L 
I RjK FjVIS L A E L Q 
L T A F,V E Q V;W Q K; 
Figure 2. Amino acid sequence compar ison of the mEH related EHs f rom R. glutinis, R. aruacariae, R. 
toruloides CBS 14, X. dendrorhous, A. niger and rat. E p M , yeast EH. Amino acid residues which are 
similar to the consensus sequence are indicated in boxes, sxnxss, nucleophi le motif (see text). HGXP, 
oxyanion motif. Y, (putative) act ive site Tyr residues. A, (putative) acidic residue of the charge relay 
system of the catalytic tr iad. H, (putative) catalytic histidine. 
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O HO 
Figure 3. Chemical structure of rutacridone epoxide. 
When suspension-cultured cells of Ruta graveolens L. are treated with an 
autoclaved culture homogenate of Rhodotorula rubra the plant responds with a rapid 
accumulation of acridone epoxides (Figure 3), which have antibiotic properties (Eilert 
et al., 1984; Eilert and Wolters, 1989). EH activity has been demonstrated in R. rubra 
(Botes et al., 1999). Additionally, a partial sequence similar to Ephl was isolated from 
this yeast (GenBank accession number AY062024, Visser et al., unpublished results). 
Therefore, R. rubra might use an EH to defend itself. However, it is not known whether 
the R. rubra Ephl accepts acridone epoxides as substrates. 
Trichothecenes comprise a group of mycotoxins, which are mainly produced by 
fungi of the genus Fusarium. Trichothecenes are sesquiterpenoid compounds, which all 
possess a double bond at C-9,10 and an epoxide ring at C-12,13. Presently, over 150 
different members of the trichothecenes are known (Coulombe, 1993). These so-called 
12,13-epoxytrichothecenes are cytotoxic to eukaryotes and inhibit protein synthesis. 
Hydrolysis of the 12,13-epoxide group results in a nontoxic compound (Ueno, 1985). 
Therefore, it is tempting to suggest that Ephl could hydrolyze the particular epoxide 
ring, which then implies a detoxifying role of this enzyme in yeast. However, T-2 toxin 
(a 12,13-epoxytrichothecene, Figure 4) has been shown to be toxic to R. rubra, R. 
glutinis and a number of other yeast species tested (Burmeister and Hesseltine, 1970). 
Nevertheless, it might be possible that one or several trichothecenes are detoxified by 
yeast Ephl-catalyzed hydrolysis. 
H3C 
C H 2 
CH 
H3C C H 3 
^ r 
o 
C H ; 
C H 2 I 
O 
I 
c=o 
.OH 
I 
C H 3 
C H 3 
Figure 4. Chemical structure of T2-toxin. The bonds of the epoxide ring are indicated in bold. 
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The metabolism or detoxification of both biotic and xenobiotic compounds may be 
initiated by oxidative reactions conducted by the cytochrome P450 system resulting in 
the formation of an epoxide ring on the specific compound. Therefore, the yeast is also 
exposed to noxious epoxides in an indirect way. Conversion of these epoxides to the 
generally less toxic diol products is important to prevent cell damage. Considering its 
broad substrate range Ephl might perform this conversion. Therefore, Ephl might 
represent an important detoxifying step, analogous to mammalian liver mEH, in the 
degradation pathway of noxious compounds. 
The importance of the EPH1 gene for growth was analyzed for X. dendrorhous. A 
mutant strain, in which the EPH1 gene was disrupted, grew normally in rich medium. 
Therefore, it seems that under these laboratory-conditions X. dendrorhous does not 
need Ephl for growth. 
TOWARDS THE APPLICATION OF RECOMBINANT EPH1 IN 
BIOCATALYSIS 
As already stated above R. glutinis is a promising candidate to be applied in the 
enantioselective epoxide hydrolysis. However, for some substrates it shows a rather 
low activity. This implies that the cell density of the R. glutinis reaction mixture needs 
to be very high in order to convert a relatively low amount of epoxide. From a practical 
point of view it is desirable to have an Ephl production host, which produces higher 
amounts of Ephl than R. glutinis does. Therefore, the second aim of the research 
described in this thesis was to improve Ephl production by over-expression of its 
corresponding gene in a suitable host. 
The use of the prokaryotic T7 RNA polymerase based E. coli expression system for 
heterologous gene expression often leads to very high levels of recombinant gene 
products. Therefore, this system was chosen for the overproduction of recombinant R. 
glutinis Ephl (chapter 4). Compared to R. glutinis the Ephl activity (units-mg protein) 
of the recombinant E. coli (both whole cells as well as cell free extract) toward 1,2-
epoxyhexane was improved over 200 times. Importantly, R. glutinis Ephl was 
overproduced without loss of enantioselectivity. These results are an essential step 
forward towards the industrial application of this yeast enzyme. 
In chapter 5 the same expression system was used for the analysis of the Ephl-
encoding genes from three additional yeast species i.e. R. toruloides CBS 349, R. 
toruloides CBS 14 and R. araucariae CBS 6031. The low epoxide hydrolysis rates and 
concomitant enantioselectivity for trans-\-phenyl-1,2-epoxypropane and a range of 
terminal epoxyalkanes by R. toruloides CBS 14 is the reason why this yeast is not the 
first choice for the enantioselective hydrolysis of these epoxides. However, when the 
corresponding gene was over-expressed in the E. coli system, it revealed to encode an 
enzyme, which is actually highly enantioselective toward trans-X-phenyl-1,2-
epoxypropane. These results indicate that a low enantioselectivity toward a certain 
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epoxide of a yeast species can be caused by a low EH expression level. Higher EH 
expression levels are therefore necessary to be able to determine the actual 
enantioselectivity. Therefore, if e.g. in a screening program for yeasts EHs activities, 
one or more yeast strains with low activity and enantioselectivity are found, it is 
recommendable to clone and express the genes in E. coli or other hosts and analyze the 
recombinant enzyme. Cloning of these genes should be facilitated using the available 
sequence information of the EHs from yeasts and A. niger. In this way, an interesting 
Ephl, like the one from R. toruloides CBS 14 might be obtained. 
On one hand it is important to have a high yield Ephl production system to 
guarantee sufficient Ephl for biocatalysis purposes. However, on the other hand 
molecular data on epoxide hydrolases led to new insights in the way that these enzymes 
operate. This essential information can be used to further improve the efficiency of 
epoxide hydrolysis in another way, namely by adjusting enzyme characteristics by 
means of recombinant DNA technology as has already been shown for other EHs. 
For example, an interesting mutant enzyme of rat mEH was found in the 
characterization of the active site residues of this enzyme (Arand et al., 1999b). The 
replacement of Glu404 (the catalytic acidic residue of the charge relay system) by Asp 
strongly increased the V,™* of the enzyme with styrene oxide (23-fold) and 9,10-
epoxystearic acid (39-fold). Of all known mEHs, the A. niger EH is the only mEH-
related enzyme that contains an Asp at the corresponding position in the native enzyme. 
Consequently, the fungal enzyme exhibits a remarkably high turnover number when 
compared to native mammalian mEHs. Both the A. niger EH as well as the mutant 
(Glu404Asp) rat mEH are interesting tools for the preparation of optically pure epoxides. 
EH crystal structures provide very valuable data such as a detailed spatial view on 
these enzymes. The shape of the catalytic cavity and the active site amino acid residues 
presumably determine the enantioselectivity of the EH. When the crystal structure is 
known computer-modeling experiments with epoxides of interest can be conducted. A 
similar approach was used to explain the enantioselectivity of the A. niger EH 
regarding its model-substrate 4-nitrostyrene oxide. The different direction of the 
nucleophilic attack by Asp192 on the epoxide ring of 4-nitrostyrene oxide, caused by the 
different arrangements of both enantiomers in the catalytic cavity, explains the 
enantiopreference of the A. niger EH for the (R) enantiomer (Zou et al., 2000). 
Therefore, based on the shapes of the EH and the epoxide, it might be possible to 
predict whether a certain epoxide could be a substrate and what the enantiopreference 
of the EH will be. Furthermore, the structural data can be used to alter or improve EH 
properties by adding, removing or changing amino acid residues to result in a kind of 
"tailor-made" enzyme for the (altered) enantioselective hydrolysis of a target epoxide. 
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FUTURE PROSPECTS 
The major drawback of using R. glutinis as a general biocatalyst in the 
enantioselective hydrolysis of epoxides was its low activity towards substrates such as 
l-oxa-spiro[2.5]octane-2-carbonitrile. This problem was eliminated by the Ephl 
overproduction system, which is described in chapter 4. 
To make the R. glutinis Ephl an even more attractive biocatalyst it needs to be 
further analyzed. Similar to the Glu404Asp mutation in rat mEH, which caused a strong 
increase in the substrate turnover number, the Glu residue of the putative catalytic Ephl 
triad could be replaced by Asp. This mutant Ephl should then be analyzed to determine 
whether or not the substrate turnover rate has increased. Given the very valuable 
information that is gained upon determination of the crystal structure of EHs from A. 
niger (Zou et al., 2000), A. radiobacter (Nardini et al., 1999) and mouse (Argiriardi et 
al., 1999), the determination of the R. glutinis Ephl crystal structure is in progress. Its 
structural data can initiate the rational design of Ephl mutant enzymes with improved 
or altered characteristics. 
Additionally, improved Ephl enzymes might be obtained by directed evolution 
using techniques such as gene shuffling (Stemmer, 1994) or error prone PCR (Leung et 
al, 1989). These techniques have been used successfully to alter enzyme properties 
such as the substrate specificity of p-galactosidase (Zhang et al. 1997) or the inversion 
of the enantioselectivity of hydantoinase (May et al., 2000). However, the success of 
this approach is highly dependent on the availability of a good high throughput 
screening method. So far, the absence of such a method has hampered the design of 
new EHs by directed evolution. However, a styrene oxide based screening method with 
high throughput screening potential was reported recently (Zocher et al., 1999). 
These approaches will probably result in a very efficient biocatalyst. Nevertheless, 
a variety of molecules that contain an epoxide ring exist, each having its own 
distinctive properties and structure. Therefore, Ephl has to be optimized with regard to 
the epoxide of interest. 
Whether the industrial potential of Ephl will be exploited depends on a lot of 
factors such as the type of the epoxide or diol of interest, the type of reaction medium, 
the type of reactor, the stability of the biocatalyst, product recovery and so on. The total 
of these factors determines whether or not a biocatalytic process is economically 
feasible (Schmid et al, 2001). An important point to consider is that many epoxides are 
insoluble in water and are toxic to whole cells, including cells of E. coli. Therefore, the 
recombinants, coli strains, which overproduce yeast (R. glutinis orR. toruloides) Ephl 
(chapters 4 and 5) cannot simply be used in an aqueous medium as whole-cell 
biocatalyst in the presence of high concentrations of epoxides. A solution to this 
problem could be to use a two-liquid-phase medium. In this system an aqueous phase 
contains the biocatalyst, while an apolar solvent phase contains the toxic substrate at a 
high concentration. 
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E. coli has been used successfully in the biocatalysis of alkanes, toluene and styrene 
derivatives in two-liquid-phase media, despite the low solvent tolerance of this 
bacterium (Schmid et al., 2001). Both wild type and recombinant E. coli are able to 
withstand the presence of high amounts of apolar phases as long as the cells are 
growing (at growth rates even less than 0.1 h"') and the log P value of the solvent 
exceeds 4.0 (Wubbolts et al., 1996). Moreover, organic solvents such as dodecane, 
hexadecane and bis(2-ethylhexyl)phthalate were used in two-phase biocatalytic 
processes for the production of (5)-styrene oxide from styrene by recombinant E. coli 
(Wubbolts et al., 1996; Panke et al., 2000). A maximal volumetric productivity of 2.2 g 
(5)-styrene oxide per liter of liquid volume per hour has been shown (Panke et al., 
2000). 
Large-scale biocatalysis of epoxides by whole cells of R. glutinis has been reported 
by Choi et al. (1999, 2000). A cascade two-phase hollow-fiber membrane bioreactor 
was used to minimize the toxic effect of dodecane, which was used to dissolve the 
feed-epoxide 1,2-epoxyhexane and to extract residual enantiopure (,S)-1,2-
epoxyhexane. After 12 days of operation this system yielded 38 g of enantiopure (5)-
1,2-epoxyhexane, which corresponds to a volumetric productivity of 3.8 g 1" h" . 
One approach to improve productivity is to increase the amount of enzyme activity 
by overproduction. Exactly this has been done for the R. glutinis Ephl in E. coli and 
this biocatalyst was effective in the enantioselective hydrolysis of 1-oxa-
spiro[2.5]octane-2-carbonitrile (chapter 4). The next step would be to investigate the 
use of the R. glutinis Ephl overproducing E. coli strain in a two-phase biocatalytic 
process, analogous to that described in the previous paragraphs, for the enantioselective 
hydrolysis of epoxides. Given the strong improvement in Ephl activity of the 
recombinant E. coli when compared to R. glutinis it is conceivable that a higher 
productivity can be achieved. 
In addition to whole cells, free (a crude or purified enzyme preparation) 
recombinant Ephl may also be used. This is particularly interesting if e.g. the epoxide 
of interest has difficulty to enter the cell by crossing the cell membrane. The 
functionality of a crude preparation of recombinant R. glutinis Ephl was demonstrated 
in the preparative-scale Ephl-catalyzed kinetic resolution of l-oxa-spiro[2.5]octane-2-
carbonitrile (de Oliveira Villela Filho, 2001). This process was performed in an 
aqueous buffered reaction medium, which is in line with so-called "green-chemistry" 
processes. The objective these processes is to minimize or even exclude environmental 
pollution by e.g. organic solvents that are used in production processes by the chemical 
industries. Nevertheless, catalytic properties of an enzyme such as activity, specificity, 
selectivity and stability can be improved in pure organic solvents (Klibanov, 2001). 
However, Ephl needs water to hydrolyze epoxides. The minimum moisture content of 
crude R. glutinis Ephl to maintain activity in a dodecane-containing reaction medium is 
10% (Weijers, 2001). The scope and limitations of the applicability of R. glutinis Ephl 
in organic solvents can now be explored since it is no longer hampered by the limited 
availability of sufficient Ephl. 
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In some occasions, special requirements such as high solvent tolerance or rigid cell 
structures might prefer the use of another host than E. coli. Bacteria from the genus 
Pseudomonas posses several properties that enable these bacteria to deal with solvents 
with a log P value below 4 (Isken and de Bont, 1998). Therefore, when such a solvent 
would be necessary in an enantioselective Ephl-catalyzed epoxide hydrolysis process 
Pseudomonas would be a better Ephl host than E. coli. When a larger and more rigid 
cell type is desired R. glutinis itself might be the desired host to use. Additionally, it 
harbors the natural Ephl environment, which might be optimal for enzyme activity. 
However, the problem with these alternative hosts is that the tools to genetically 
modify these organisms are limited and not as efficient as is they are for E. coli. 
Therefore, it is difficult to obtain a stable transformant, which expresses recombinant 
Ephl at a high level. Furthermore, Pseudomonas species are well known for their 
ability to degrade toxic compounds such as epoxides or toluene. Consequently, the 
epoxide or diol of interest might be metabolized. 
Among all EHs investigated so far, data concerning the application of EHs as 
biocatalysts has been restricted to that of the microbial EHs. Various types of epoxides 
have been hydrolyzed in an enantioselective manner using microbial EHs. Highly 
substituted (2,2- and 2,3-disubstituted) epoxides are hydrolyzed with good 
enantioselectivity by bacterial EHs, whereas fungal EHs give good results in case of 
styrene oxide-type of substrates (Orru and Faber, 1999). R. glutinis shows a broad 
substrate specificity which is partly complementary to and overlapping with that of the 
other microbial EHs (Weijers, 1997). Moreover, Weijers (2001) reported that the 
asymmetric hydrolysis of meso-epoxides is restricted to R. glutinis EH. Furthermore, R. 
glutinis EH is the only suitable biocatalyst known to date for the kinetic resolution of 
monosubstituted aliphatic epoxides such as 1,2-epoxyhexane oxide and 1,2-
epoxyhexene oxide. Finally, in general, the yeast (R. glutinis) EH hydrolyzes 
monosubstituted aliphatic epoxides, 2,3-disubstituted aliphatic and aryl epoxides, and 
trisubstituted alicyclic epoxides with significant enantioselectivities (Weijers, 2001). 
This pool of information should help the organic chemist to select the most 
appropriate EH for the hydrolysis of the epoxide of interest. Moreover, due to the 
overlapping substrate specificities several EHs might be optional. Clearly, EHs from 
yeasts are a very good option, especially in case of maso-epoxides and monosubstituted 
aliphatic epoxides. Furthermore, the overproduction of recombinant yeasts Ephls 
allows the enantioselective hydrolysis of substrates for which the yeasts themselves 
show low activities and enantioselectivities, such as styrene oxide-type of substrates. 
Therefore, yeast species having EH activities are very interesting for the preparation 
of enantiopure epoxides. The collection of promising yeasts EHs can be enlarged by 
screening additional yeast strains for EH activity or by improving cloned Ephls by 
recombinant DNA technology. In case of the former, the cloning and over-expression 
of Ephl-encoding genes will reveal the actual potential of yeasts Ephls from yeasts 
that show low EH activity and enantioselectivity themselves as was shown in this 
thesis. 
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SUMMARY 
Epoxides are cyclic ethers that readily react with various nucleophilic compounds. 
Consequently, epoxides can be used in many chemical synthesis reactions. Two 
enantiomeric forms of an epoxide are possible if one of the carbon atoms is chiral. This 
means that the epoxide is actually a racemic mixture of its two enantiomers. Due to the 
universal presence of chirality in nature it is important to use the proper epoxide 
enantiomer in the synthesis of compounds such as pharmaceuticals and agrochemicals, 
which should affect biological processes. Therefore, enantiopure epoxides are valuable 
intermediates in the synthesis of biologically active compounds by the pharmaceutical 
and agrochemical industries. 
Epoxide hydrolases (EHs) catalyze the hydrolysis of an epoxide into its 
corresponding diol. Moreover, EHs can hydrolyze racemic epoxide mixtures in an 
enantioselective manner. This results in the hydrolysis of one enantiomer, while the 
other remains unaffected and thus enantiopure. Therefore, EHs might be valuable tools 
to obtain enantiopure epoxides from racemic mixtures. 
EHs from yeast species, Rhodotorula glutinis in particular, have been used to 
hydrolyze various epoxides with high activity and enantioselectivity. Consequently, the 
EHs from yeast species are promising biocatalysts that can be used in the production of 
enantiopure epoxides. 
In chapter 1 the work that is presented in this thesis is introduced. The aims of the 
research project were to gain important fundamental knowledge on EHs from yeasts 
and to develop biotechnological processes based on the use of these enzymes for the 
production of enantiopure epoxides. To introduce EHs in general, a broad overview is 
given in chapter 2 dealing with the molecular biology, biochemistry and potential 
application of these enzymes. 
In order to determine the relationship of these yeasts EHs to other known EHs, the 
EH-encoding genes and cDNA sequences from the yeast strains Xanthophyllomyces 
dendrorhous and R. glutinis were isolated (chapters 3 and 4). The genes were 
denominated EPH1. Whereas the X. dendrorhous EPH1 open reading frame (ORF) of 
1236 bp was interrupted by 8 introns, the 1230 bp-large R. glutinis EPH1 ORF was 
interrupted by 9 introns. The genes encoded polypeptides of 411 and 409 amino acids 
respectively, with corresponding calculated molecular masses of 46 kDa. The deduced 
amino acid sequences were similar to that of mammalian microsomal epoxide 
hydrolases. These enzymes belong to the a/p hydrolase fold family of enzymes, which 
have similar enzymatic structures and mechanisms. The EPH1 cDNA sequences were 
expressed in Escherichia coli to demonstrate their function. The epoxides, 1,2-
epoxyhexane and 1-methyl-cyclohexene oxide, were hydrolyzed in an enantioselective 
manner. The inactivation of the EPH1 gene of X. dendrorhous showed that it was not 
essential for growth in rich medium under laboratory conditions. 
The epoxide hydrolase of R. glutinis was overproduced in the heterologous host 
Escherichia coli BL21(DE3) in order to develop a highly effective epoxide hydrolysis 
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system (chapter 5). A strong improvement in Ephl activity was found in cell extracts of 
the recombinant E. coli when compared to cell extracts of Rhodotorula glutinis, despite 
the formation of inactive Ephl inclusion bodies. Co-expression of genes encoding 
molecular chaperones (DnaK-DnaJ-GrpE, GroEL-GroES, and trigger factor) decreased 
the amount of Ephl inclusion bodies. However, there was no equivalent increase in 
active soluble Ephl. An increase in the level of soluble Ephl was demonstrated by 
lowering the cultivation temperature from 37°C to 21°C and by using a fermenter for 
cultivation. Compared to R. glutinis the total increase in Ephl activity for the 
recombinant E. coli towards 1,2-epoxyhexane was over 200 times, without loss of 
enantioselectivity. The utility of this Ephl overproduction system was demonstrated by 
the hydrolysis of l-oxa-spiro[2.5]octane-2-carbonitrile, which is a new R. glutinis Ephl 
substrate and a versatile building block in organic synthesis. Whereas the recombinant 
E. coli, expressing R. glutinis EPH1, could be used to hydrolyze 1-oxa-
spiro[2.5]octane-2-carbonitrile with high Ephl activity in an enantioselective manner. 
This was not possible using R. glutinis itself. 
To explore the biological diversity and potential industrial use of EHs from yeasts 
the Ephl-encoding cDNA sequences were also isolated from the carotenoid producing 
yeast species Rhodosporidium toruloides CBS 349, Rhodosporidium toruloides CBS 14 
and Rhodotorula araucariae CBS 6031. These cDNA sequences encoded polypeptides 
of 409, 409, and 410 amino acids large respectively with molecular masses of 46 kDa. 
The deduced amino acid sequences were similar to that of the epoxide hydrolases from 
R. glutinis, X. dendrorhous and Aspergillus niger, which all correspond to the 
microsomal epoxide hydrolase sequence. Consequently, these cloned Ephls probably 
belong to the a/(5 hydrolase fold family of enzymes. The epoxide hydrolase encoding 
cDNAs of the Rhodosporidium and Rhodotorula species were expressed in Escherichia 
coli BL21(DE3). The recombinant strains were able to hydrolyze trans-l-phenyl-1,2-
epoxypropane in an enantioselective manner. The recombinant counterpart of 
Rhodosporidium toruloides CBS 14 was found to be a highly active and 
enantioselective biocatalyst for this substrate, despite the low activity and 
enantioselectivity of Rhodosporidium toruloides CBS 14 itself. 
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Epoxiden zijn cyclische ethers die gemakkelijk kunnen reageren met een 
verscheidenheid aan nucleofiele stoffen. Daarom kunnen epoxiden in veel chemische 
synthesereacties gebruikt worden. Er bestaan twee enantiomeren van een epoxide als 
een van de koolstofatomen van het epoxide chiraal is. Dit betekent dat zo'n epoxide 
eigenlijk een racemisch mengsel is van de beide enantiomeren. Chiraliteit is overal in 
de natuur aanwezig. Daarom is het belangrijk het juiste epoxide enantiomeer te 
gebruiken in de synthese van stoffen die een effect op een biologisch proces moeten 
uitoefenen, zoals medicijnen of landbouwchemicalien. Enantiomeerzuivere epoxiden 
zijn om deze reden waardevolle bouwstenen voor de synthese van medicijnen en 
landbouwchemicalien door de farmaceutische en agrochemische industrieen. 
Epoxidehydrolases (EHs) katalyseren de hydrolyse van epoxiden naar diolen. Het is 
zelfs zo dat een groot aantal EHs enantioselectief zijn voor racemische epoxiden. Als 
gevolg hiervan zet, in het meest ideale geval, een dergelijk EH het ene epoxide 
enantiomeer om, terwijl het andere epoxide enantiomeer onaangetast blijft. Op deze 
manier kunnen EHs gebruikt worden om enantiomeerzuivere epoxiden te verkrijgen uit 
een racemisch epoxiden mengsel. 
EHs uit gisten, Rhodotorula glutinis in het bijzonder, kunnen verschillende soorten 
epoxiden met hoge activiteit en enantioselectiviteit hydrolyseren. Deze eigenschappen 
zorgen ervoor dat EHs uit gisten veelbelovende biokatalysatoren kunnen zijn voor het 
verkrijgen van enantiomeerzuivere epoxiden. 
Het werk zoals beschreven in dit proefschrift wordt ingeleid in hoofdstuk 1. De 
twee doelstellingen van het onderzoeksproject waren ten eerste het vergaren van 
belangrijke fundamentele kennis van EHs uit gisten en ten tweede het ontwikkelen van 
biotechnologische processen voor het produceren van enantiomeerzuivere epoxiden 
gebruikmakend van EHs uit gisten. In hoofdstuk 2 wordt ingegaan op de moleculaire 
biologie, biochemie and de potentiele toepassing van EHs om een overzicht van dit 
soort enzymen in het algemeen te geven. 
De genen en cDNA moleculen die coderen voor de EHs uit de giststammen 
Xanthophyllomyces dendrorhous en R. glutinis werden gei'soleerd om de verwantschap 
van deze gist EHs met andere, reeds bekende, EHs te analyseren (hoofdstukken 3 en 4). 
Deze EH coderende genen kregen de naam EPH1. Het X. dendrorhous EPH1 open 
leesraam van 1236 bp bleek te zijn onderbroken door 8 intronen, terwijl het R. glutinis 
EPH1 open leesraam van 1230 bp door 9 intronen werd onderbroken. Deze genen 
coderen voor eiwitten (EHs) met respectievelijke ketenlengtes van 411 en 409 
aminozuren en een berekende moleculaire massa van 46 kDa. De afgeleide 
aminozuurvolgorden vertoonden gelijkenis met die van de microsomale EHs uit 
zoogdieren. Deze enzymen behoren tot de familie van de zogenoemde "oc/p hydrolase 
fold" eiwitten, welke gelijke enzymatische mechanismen en structuren hebben. Om de 
werking van de gevonden EHs te onderzoeken, werden de EPH1 cDNA 
nucleotidenvolgorden tot expressie gebracht in Escherichia coli. De epoxiden 1,2-
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epoxyhexaan en 1-methyl-cyclohexeen oxide werden op een enantioselectieve manier 
gehydrolyseerd. Het EPH1 gen van X. dendrorhous werd uitgeschakeld via insertie 
mutagenese. Hieruit bleek dat dit gen voor de gist niet essentieel is voor groei op rijk 
medium onder laboratorium condities. 
Ten behoeve van de ontwikkeling van een efficient epoxiden hydrolyse systeem 
werd het R. glutinis EH eiwit (Ephl) in de heterologe gastheer Escherichia coli 
BL21(DE3) overgeproduceerd (hoofdstuk 5). De recombinant E. coli gaf een sterke 
verbetering in Ephl activiteit voor 1,2-epoxyhexaan hydrolyse ten opzichte van R. 
glutinis, ondanks de vorming van inactieve Ephl aggregaten. De gelijktijdige expressie 
van EPH1 en genen die coderen voor moleculaire chaperonne eiwitten (DnaK-DnaJ-
GrpE, GroEL-GroES en "trigger factor") resulteerde in een afhame van Ephl 
aggregaten. Helaas resulteerde dit niet in een evenredige toename van epoxide 
hydrolase activiteit. Door echter de E. coli cultuur te kweken in een fermentor en door 
de temperatuur van de cultuur van 37°C terug te brengen tot 21°C werd wel een 
toename bewerkstelligd in de hoeveelheid actief en oplosbaar Ephl. Dit resulteerde in 
een meer dan 200-maal hogere Ephl activiteit ten opzichte van R. glutinis, waarbij ook 
de enantioselectiviteit behouden bleef. Het nut van dit Ephl overproducerende systeem 
werd aangetoond met de hydrolyse van l-oxa-spiro[2.5]octaan-2-carbonitril. Dit is een 
nieuw R. glutinis Ephl substraat en een veelzijdige bouwsteen in de organische 
synthese. Met dit systeem kon l-oxa-spiro[2.5]octaan-2-carbonitril met een hoge 
activiteit op een enantioselectieve manier worden gehydrolyseerd, terwijl dit met R. 
glutinis zelf niet mogelijk was. 
Om de biologische diversiteit en potentiele industriele toepassing van EHs van 
gisten te onderzoeken werden ook de Ephl coderende cDNA moleculen van de 
carotenoi'den producerende gistsoorten Rhodosporidium toruloides CBS 349, 
Rhodosporidium toruloides CBS 14 en Rhodotorula araucariae CBS 6031 gei'soleerd. 
Deze moleculen coderen voor eiwitten met een respectievelijke ketenlengte van 409, 
409 en 410 aminozuren en een berekende moleculaire massa van 46 kDa. De afgeleide 
aminozuurvolgorden vertoonden gelijkenis met de EHs van R. glutinis, X. dendrorhous 
en Aspergillus niger, welke behoren tot de familie van eiwitten met de zogenaamde 
"ct/p-hydrolase fold". De EPH1 cDNA moleculen van de Rhodosporidium en 
Rhodotorula soorten werden tot expressie gebracht in Escherichia coli. Deze 
recombinant E. coli stammen waren in staat om /ra«5-l-fenyl-l,2-epoxypropaan op een 
enantioselectieve manier te hydrolyseren. Rhodosporidium toruloides CBS 14 
vertoonde een lage EH activiteit en enantioselectiviteit. Toen het bijbehorende EPH1 
gen in E. coli tot overexpressie werd gebracht bleek het verantwoordelijke Ephl echter 
zeer actief en enantioselectief voor dit substraat te zijn. 
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